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ABSTRACT 
This programme of work sought to develop autochthonous probiotic solutions for tilapia aquaculture. 
Initial work began with the isolation of isolate 34 bacterial cultures from the tilapia intestine, which 
were tested for probiotic potential in vitro. Fifteen isolates displayed positive probiotic properties in in 
vitro assays. The selection of high potential probiotic candidates was based on multi-parameter 
properties using the Z−score method, which ranked isolates identified as Bacillus sp. CHP02 (Z score = 
1.48), Bacillus sp. RP01 (1.14) and Bacillus sp. RP00 (1.09) as having the greatest potential. These 
isolates, along with Enterobacter sp. NP02 (0.50), were then assessed for their efficacy as probiotic 
candidates in vivo. Six experimental groups: T1: (Bacillus sp. CHP02 + a commercial feed), T2 
(Bacillus sp. RP01 + a commercial feed), T3 (Bacillus sp. RP00 + a commercial feed), T4 
(Enterobacter sp. NP02 + a commercial feed), T5 (P. acidilactici + a commercial feed) and T6 (only + 
a commercial feed) were designed for evaluation in both fry and on-growing stages of tilapia. Bacillus 
sp. RP01 application to feeds induced positive effects on tilapia larvae including improved body 
weight, total weight gain, average daily growth, specific growth rate and resistance to A. hydrophila 
challenge. However, these beneficial effects were not observed when applied in on-growing sized 
tilapia. The results suggest that the Z-score method could be used to select high potential of 
autochthonous probiotics for fry, but the applicability in the current research programme was less 
robust at later life stages. It is hypothesised that different probiotic strains may be required for 
application during different life stages, which may reflect the different physiologies of tilapia, and their 
likely differing microbiomes, at different life histories. Further research is required to select probiotics 
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Aquaculture provides a significant and important source of protein for supporting the human 
population. Total production was 66.6 million tonnes (mt)  in 2012, which constituted 24.7 mt of 
marine aquaculture and 41.9 mt of inland aquaculture (approximately 4 mt of tilapia production). 
Forecasts suggest that aquaculture productions in 2030 may increase to 101.2 mt with tilapia 
accounting for about 30% of volume. The world population in 2012 was 7.06 billion, and may 
increase to 8 billion in 2030 (FAO, 2014; www.prb.org, 2016). Therefore, aquaculture production is 
very important to provide food for people worldwide. Tilapia species are considered to be ‘the fish 
for next-generation aquaculture’ (Yue et al., 2016), which are cultured worldwide.  
 
1.1 Tilapia aquaculture 
Tilapia aquaculture is distributed worldwide in more than 130 countries, including China, 
Indonesia, Philippines, Thailand, Vietnam, Egypt, Columbia, Bangladesh, Brazil, and Egypt (FAO, 
2014). During the first quarter of 2015, Europe imported a total of 7,702 tonnes of frozen tilapia, 
which were produced in China, Vietnam, Thailand, and Myanmar (www.fao.org, 2016).  
Tilapia were originally introduced to Thailand when fifty Nile tilapia (Oreochromis niloticus) as a 
royal tribute from the Emperor of Japan were sent to H.M. King of Thailand on March 25, 1965 
(Department of Fisheries, 2011). These fish were bred at the Chitralada garden in the Dusit Palace. 
Then, fish larvae were transferred to the Department of Fisheries at the Bangkhen University for 
research on feeding and breeding techniques and larvae were then distributed to agricultural 
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farmers. Tilapias have many beneficial properties such as good qualities and taste, easy to rear, 
rapid growth, and a high fecundity (Bhujel, 2013). Since 2003, the department of fisheries (DOF) 
has planned a project on “good aquaculture practice” to promote tilapia aquaculture after as 
economic species to lead tilapia productions having good qualities and safe for consumers 
(Lawonyawut, 2007).  
The tilapia production cycle may be separated into two parts: 1) larval phase and 2) on-growing 
phase (Figure 1.1). The larval phase includes broodstock management, hatching process, nursing 
systems and male production. A main problem in the farms during crop production is facing with 
different sizes of larval growth associating with early maturing of tilapia. Therefore sex reversal 
using synthetic androgenic hormone (17 methyl-testosterone) is used to treat in the fifth stage of 
larval tilapia (Figure 1.2) changing phenotypes to male characterization, which improves the 
consistency of tilapia production (www.fao.org, 2016). The on-growing phase usually rears both in 
the earthen pond and cages within or without the closed system.  
Generally, pathogenic Aeromonas spp. are distributed in aquaculture systems and freshwater fish; 
these may often be present in the gastro-intestinal tract (GIT) of healthy fish (Nedoluha and 
Westhoff, 1997; Spanggaard et al., 2000; Molinari et al., 2003; Al-Harbi and Uddin, 2004, 
2005a&b; Blancheton et al., 2012). Causing pathogenic loads of 105 cfu.g-1 in an aquaculture system 
can induce fish diseases (Buller, 2004), which might be the effect of the dysbiosis of beneficial and 
pathogenic microbes (Ringø et al., 2007). Farmers use a combination of antimicrobials, 
parasiticides, chemicals, drugs, feed additives, and probiotics, to prevent or treat disease outbreaks, 
and to promote healthy fish (FAO, 2014; Rico et al., 2013). Farmers are increasingly under pressure 
today to improve ecological sustainability by reducing the use of drugs and chemicals (Volpe et al., 
2010; Levin and Stevenson, 2012; HLPE, 2014). Probiotics have therefore been suggested to be an 













Brood stock system 
Hatching system 
Culture system 
Open system: Cages 
Close system: Cages 
Close system: Earthen pond 
 
Nursing system 











Figure 1.2 Nile tilapia larval development. 
Source: Modified from Fujimura and Okada (2007) 
 
1.2 Probiotics for aquaculture 
1.2.1 Definitions  
Probiotics are defined as live microbes introduced into the gastrointestinal tract by administration 
via the food or water system, which promote internal microbial balance to promote good health 
(Parker, 1974; Fuller, 1989; Fuller, 1992; Gatesoupe, 1999; Verschuere et al., 2000). The definition 
Stage I: un-eyed stage (1 dpf: yellow egg characteristic) 
Stage II: eyed stage (2 dpf: yellow egg with eye spot characteristic) 
Stage III: per-hatched stage (3-4 dpf: brown egg with eye and tail 
characteristic, this stage can swim) 
Stage IV: hatched fry; Yolk fry stage (4-5 dpf: free 
swimming larvae with have yolk sac) 




given by the FDA (2006) was ‘live microorganisms that are ingested with the intention of providing 
a health benefit’, while the FAO/WTO (2006) defined it as ‘live microorganisms when consumed in 
adequate amounts as part of food confer a health benefit on the host’.  
In 2008, probiotics were suggested for use in aquaculture as an environmentally friendly method in 
disease prevention (Wang et al., 2008). Another definition is ‘microorganisms administered orally 
leading to health benefits, are used extensively in aquaculture for disease control, notably against 
bacterial diseases’ (Newaj-Fyzul et al., 2014). Furthermore, I suggest the meaning of probiotic 
microbes that are beneficial for the host and the user (b), environmentally friendly (e), sustainable 
aquaculture (s) and trust of stakeholders (t).      
Nowadays, commercial probiotics are popular selling in powder form such as Alibio®, Bactocell 
PA10 MD, Bactocell® PA 10, Biomate SF-20, Biogen®, BioPlus® 2B, Cernivet®, Levucell SB 20, 
Sigma, Sporolac, and Toyocerin® (Chang et al., 2002; Raida et al., 2002; Shelby et al., 2006; EL-
Haroun et al., 2006; Aly et al., 2008b; Castex et al., 2010; Harikrishnan et al., 2010; Luis-
Villaseñor et al., 2013). These probiotics are familiar in many aquatic farms such as tilapia, shrimp, 
and pangasius farms in Asia (Figure 1.3). 
Several reviews reported that probiotic usages in aquaculture supported various benefits, which 
included improvements of growth performances, disease resistances, immune enhancement, health 
status, balancing function mechanisms of fishes, sustainability of gut microbes, water quality (as 
bioremediation to improve water quality and break down nutrient), and to enrich the nutrients in 
zooplankton (Gatesoupe, 1999; Gomez-Gil et al., 2000; Verschuere et al., 2000; Marques et al., 
2005; Kesarcodi-Watson et al., 2008; Wang et al., 2008a; Merrifield et al., 2010; Haché and Plante, 
2011). The usage of probiotics can impact both gut microbes and water microbes, which have 





Figure 1.3 Percentage of farmers that use antibiotics, disinfectants, parasiticides, feed additives and 
plant extracts, and probiotics in each of the studied farm groups in Asia. 
Source: Rico et al. (2013) 
1.2.2 Sources of bacterial probiotics 
Generally, microbes are occurring in human, aquatic animals, snow, soils, sediments, groundwater, 
freshwater and seawater and different numbers of bacteria (102 to 1011 cfu.g-1) are observed in biotic 
and abiotic environments (Torsvik et al., 1990; Al-Harbi and Uddin, 2003; Segee, 2005; Senders et 
al., 2007; Liu et al., 2010; Nimrat et al., 2012; Tiago and VerÍssimo, 2012). Exogenous bacteria 
(from air, soil, human etc.) may enter water systems. These microbes could change populations as 
‘microbial communities developing in the culture water’ (Verschuere et al., 2000), which can lead 
different bacteria to colonize in the GIT of aquatic animals. The typical levels of cultivable bacteria 
reported in different sections of fish trials are displayed in Table 1.1. 
The intestinal tract of aquatic animals typical contains around 102 to 109 cfu.g-1 of microbial loads 
(Spanggaard et al., 2000; Al-Harbi and Uddin, 2003, 2004 & 2005a; Molinari et al., 2003; Brunt 
and Austin, 2005; Pond et al., 2006; Balcázar et al., 2007; Wu et al., 2010). Bacterial loads (cfu.g-1) 
in tilapia system have been estimated to vary from 104 to 109 in the GIT, 105 to 108 on the gills, 103 
to 107 in water culture, and 106 to 108 in pond sediment, while pathogenic loads in the GIT of tilapia 





















Figure 1.4 Reported cultivable bacterial levels associated with tilapia. 
Sources: 1 Molinari et al., (2003); 2 Al-Harbi and Uddin (2003): 3 Al-Harbi and Uddin (2004); 4 Boari et al. 
(2008); 5 Shinkafi and Ukwaja (2010); 6 Del’Duca et al. (2015) 
 
103-7 cfu.ml-1 in water culture (2 & 6) 
101-3 cfu.ml-1 of pathogenic 
bacterial loads in water culture (4) 
 
106-8 cfu.g-1 in sediment pond (2 & 6) 
➢   
104-9  cfu.g-1 in the GI tract (1, 2, 3, 5 
& 6) 
101-3 cfu.g-1 of pathogenic bacterial 
loads in the GI tract (4) 
 




Table 1.1 Examples of bacterial identifications from different aquaculture components. 
Bacterial identification Study technique Sources References 
Bre. vesicularis, Methylobacterium spp., Mi. luteus  
and Pseu. pickettii 
Systematic bacteriological 
study, API 20NE, and 
BIOLOG system 
Aquatic biofilm Buswell et al. (1997) 
Aeromonas sp., Acinetobacter sp., Carnobacterium sp., 
Citrobactor sp., Plesiomonas sp., Pseudomonas sp., Proteus 
sp., Shewanella sp., and Serratia sp. 
Systematic bacteriological 
study, RAPD analysis and 
16S rRNA sequencing  
The intestinal tract of rainbow trout 
(Oncorhynchus mykiss) 
Spanggaard et al. 
(2000) 
Ae. hydrophila, A. veronii, Bur. cepacia, Chro. violaceum, Ci. 
freundii, E. coli, Fla. oryzihabitans, and Ple. shigelloides 
Systematic bacteriological 
study and focused on 
Enterobacteriaceae and gram-
negative 
The gastrointestinal tract of Nile 
tilapia  
Molinari et al. (2003) 
A. hydrophila, Bacillus sp., Cellulomonas sp., Cor. afermentas, 
Cor. urealyticum, Cur. pusillum, E. coli, Flavobacterium sp., 
Micrococcus sp., Pasteurella sp., P. pnemotropica, Pho. 
damselae, Psudomonas sp., P. fluorescens, Salmonella sp., Ser. 
liquefaciens, She. putrefaciens, Staphylococcus sp., 
Streptococcus sp. and V. cholera 
Systematic bacteriological 
study, API 20E, API 
20STREP, API 50CD and 
BIOLOG system 
The intestinal tract of hybrid tilapia  Al-Harbi and Uddin 
(2004) 
A. hydrophila, Cor. afermentas, Cor. urealyticum, E. coli, 
Flavobacterium sp., Microcucus sp., Pasteurella sp., Photo. 
damsella, Pseudomonas sp., Ser. liquifaciens, She. 
putrefaciens, Staphylococcus sp., Streptococcus sp.,  
and V. cholerae 
Systematic bacteriological 
study, API 20E, and BIOLOG 
system 
The intestinal tract of hybrid tilapia  Al-Harbi and Uddin 
(2003) 
A. hydrophila, Cor. urealyticum, Cor. liquifaciens, E. coli, 
Flavobacterium sp., Pasteurella sp., Photo. damsella, 
Pseudomonas sp., and She. putrefaciens,  
Systematic bacteriological 
study, API 20E, and BIOLOG 
system 
The gills of hybrid tilapia  Al-Harbi and Uddin 
(2003) 
A. hydrophila, Acin. delafieldii, Cor. urealyticum, E. coli, 
Flavobacterium sp., Microcucus sp., Pasteurella sp., Photo. 
damsella, Pseudomonas sp., Ser. liquifaciens, She. 
putrefaciens, Staphylococcus sp., Streptococcus sp.,  
and V. cholerae 
Systematic bacteriological 
study, API 20E, and BIOLOG 
system 
The earthen pond water of hybrid 
tilapia rearing 
Al-Harbi and Uddin 
(2003) 
Alcaligenes sp., Pseudomonas spp., Pseudoalteromonas sp., 
Roseobacter spp., R. gallaciensis, R. denitrificans, R. litoralis 
Systematic bacteriological 
study, RAPD analysis and 
16S rRNA sequencing 
Turbot larvae (Scophthalmus 
maximus) rearing units 
Hjelm et al. (2004) 
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Table 1.1 Continued… 
Bacterial identification Study technique Sources References 
A. hydrophila, Acid. delafieldii, Bur. glumae, Cor. urealyticum, 
Cor. liquifaciens, E. coli, Flavobacterium sp., Microcucus sp., 
Pasteurella sp., Pseudomonas sp., Pseu. fluorescens, Ser. 
liquifaciens, She. putrefaciens, , Streptococcus sp.,  
and V. cholerae 
Systematic bacteriological 
study, API 20E, and BIOLOG 
system 
The earthen pond sediment of 
hybrid tilapia rearing 
Al-Harbi and Uddin 
(2003) 
Aeromonas sp., A. veronii, A. sobria, Car. piscicola, Clos. 
gasigenes, En. amnigenus, Plesiomonas sp., Ple. shigelloides, 
She. putrifaciens and Plateurella sp.,  
BIOLOG system, API strips, 
RFLP analysis and 16S rRNA 
sequencing 
The intestinal tract of rainbow trout 
(Oncorhynchus mykiss) 
Pond et al. (2006) 
A. allosaccharophila, A. punctata, A. veronii, Acinetobacter 
sp., Agro. tumefaciens, Ano. flavithermus, Ce. somerae, Ce. 
ceti, Chry. haifense, Clostridium spp., Corynebacterium sp., 
Enterobacter sp., Ent. ictaluri, En. saccharominimus,  E. coli, 
Ed. ictaluri, Herbaspirillum sp., L. garvieae, Ochobactrum sp., 
Microbacterium lacticum, Moraxella sp., Myroides 
odoratimimus, Ple. shigelloides, Ralstonia pickettii, Shewanella 
sp., Sh. putrefaciens, Sphingomonas sp., V. cholerae, Yer. 
ruckeri  
16S rDNA sequencing and 
Direct DNA extraction from 
the intestinal samples to clone 
libraries  
The intestinal contents and mucous 
of yellow catfish (Pelteobagrus 
fulvidraco) 
Wu et al. (2010) 
A. hydrophila, A. allosaccharophilla, Ple. shigelloides, 
Shewanellaceae sp., Shewanella sp., and She. purtrefaciens 
PCR-DGGE analysis and 16S 
rDNA sequencing 
The intestinal tract of beluga (Huso 
huso) 
Salma et al. (2011) 
Acientobacter sp., Ac. junii, Bacillus sp., Bre. diminuta, 
Cetobacterium spp., Enterobacteriaceae bacterium, E. coli, 
Serratia sp., and S. proteamaculans 
16S rDNA V3 PCR-DGGE 
fingerprints 
The intestinal tract of hybrid tilapia  He et al. (2013) 
A. hydrophila, Paracoccus chinensis, and Gramma 
poteobacterium 
16S rDNA V3 PCR-DGGE 
fingerprints 






The potential of probiotic candidates has been assessed from different areas such as semi-intensive 
systems, floating cages in a river, farm culture, and natural lakes (Molinari et al., 2003; Hagi et al., 
2004; Hjelm et al., 2004; Chantharasophon et al., 2011; Chemlal-Kherraz et al., 2012; Sugita et al., 
2012), where microbes isolated outside the host are termed allochthonous or exogenous and 
microbes are isolated from inside the host are termed autochthonous or indigenous (Ringø et al., 
2016). 
1.2.3 Probiotics can improve gut microecology and improve host growth performance 
Many vitamins, fatty acids and amino acids, enzymes, are produced by bacteria such as amylase by 
Aeromonas spp., B. subtilis, Bacteridaceae, Clostridium spp., Lactobacillus plantarum and 
Staphylococcus sp., protease by B. subtilis and Lactobacillus plantarum, Staphylococcus sp. and 
cellulase by B. subtilis, Lactobacillus plantarum and Staphylococcus sp. (Sugita et al., 1997; 
Balcazar et al., 2006; Eissa et al., 2010; Efendi and Yusra, 2014; Sarkar and Ghosh, 2014). 
According to Mondal et al., 2008), the tilapia GIT contains amylolytic bacteria (7.3×103 cfu.g-1), 
cellulolytic bacteria (1.5×103 cfu.g-1) and proteolytic bacteria (9.0×103 cfu.g-1). Similarly, Sarkar 
and Ghosh (2014) observed different bacterial groups in different positions of the tilapia gut, which 
are dominantly proteolytic bacteria (7.3×103 cfu.g-1), cellulolytic bacteria (5.0×103 cfu.g-1) in the 
hindgut gut and amylolytic bacteria  (7.3×103 cfu.g-1) at the foregut and the other bacterial groups 
(2.3 to 2.7×103 cfu.g-1) in the mid-gut.  
A rule of the enzymatic digestibility in the intestine of tilapia has the effect on feed intakes to break 
down into molecules. Several enzymes are different releases between the foregut to the mid-gut 
(Figure 1.6), however, non-enzyme activities display in the hindgut (Figure 1.6A-C & 1.6D1-D3). 
Aeromonas spp. can produce amylase to digest carbohydrates, which is a primary source providing 
greater energy in omnivorous (Molinari et al., 2003). Probiotic supplements in fish feed have been 
reported to increase bacteria loads in the GIT (Figure 1.6D1-D3; Jatobá et al., 2011), which may 
improve digestibility and improve growth performances. Microbial varieties were reported to find 
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different bacteria such as A. hydrophila, Ple. shigelloides, Fla. oryzihabitans, E. coli and Chro. 
violaceum in stomach, A. veronii, Ple. shigelloides, Chro. violaceum and unidentified sp in the mid-
gut and A. veronii, Bur. cepacia, Ci. freundii, Ple. shigelloides and unidentified species in the 
posterior gut of tilapia of tilapia culturing in the semi-intensive system (Molinari et al., 2003). 
Gastrointestinal bacterial loading and/or activity may be influenced by diet. Previous studies 
reported that a single dose of probiotic candidates as B. amyloliquefaciens, B. firmus, B. pumilus, B. 
subtilis, Citro. freundii, L. acidophilus, Lactobacillus sp. and P. acidilactici at concentrations of 106 
- 12 cfu.g-1 diet have been supplemented in tilapia feed and the optimal period of probiotic feeding is 
around 4-8 weeks (Aly et al., 2008a,b&c; Nouh et al., 2009; He et al., 2013; Liu et al., 2013; 
Stenden et al., 2013). A commercial probiotic (Biogens: B. subtilis Natto; not less than 6 × 107.g-1) 
B. amyloliquefaciens (108 cfu. g-1 diet) were suggested to mix in fish feed. They provided positive 
effects on FCR (EL-Haroun et al., 2006; Ridha and Azad, 2012). According to He et al., (2013) 
both allochthonous and autochthonous Bacillus were only observed in the probiotic group. The gut 
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Figure 1.5 Enzymatic activities and different number of the gut microbiota in Nile tilapia; A1: right 
view, B1: drawing ventral view (1. HL: hepatic loop, 2. PMC: proximal major coil, 3. GL: gastric 
loop, 4. DMC: distal major coil and 5. TP: terminal portion of the intestine), C1: enzyme activities, 
D1-D3: bacterial loads (cfl.ml-1.cm -1) in the tilapia, D12: 99 days fed probiotic, D22: 40 days fed 
without probiotic, D32: 61 days fed without probiotic, E3: tilapia from natural resource. 



















1.3 How to prove the efficiency of novel probiotic for aquaculture use 
The “Guideline for the Evaluation of Probiotics in Food” is a global standard, which suggests how 
to evaluate probiotics both in vitro and in vivo before using in human (FAO/WTO, 2006). 
Consequently, potential probiotics use in aquaculture may also follow this guideline with some 
parameters adjusted to fit with aquatic animals. Basically, probiotics are declared as safe to use, 
which have information backgrounds of genotype, phenotype, and characterization for users. In in 
vitro trials, several properties of probiotics are usually evaluated acidic and bile salt tolerances, 
adherences and antimicrobial activities and then potential of probiotic candidates are based on the 
results in vitro trials, finally these probiotics are tested in living aquatic animal. Probiotics for 
aquatic animals should be tested as described in the following sections. 
1.3.1 In vitro trials 
In vitro trial can lead to reduce the cost testing and sample sizes of living animals for in vivo studies. 
Often, pathogen antagonism tests are considered a suitable initial screening method to test antagonistic 
activities (Aly et al., 2008b; Balcázar et al., 2008; El-Rhman et al., 2009; Chemlal-Kherraz et al., 
2012). Parameters such as blood hemolysis, antibiotic resistance, adherence assays, pH and bile salt 
tolerances, and the other properties are used investigation for screening the potential of probiotics in 
vitro trials. 
1.3.1.1 Pathogenic inhibitions 
Probiotics are presumed to produce compounds such as bacteriocins, siderophores, lysozymes, 
proteases, and hydrogen peroxides, which can inhibit pathogens (Ringø and Gatesoupe, 1998; 
Gomez-Gil et al., 2000; Verschuere et al., 2000; Lara-Flores et al., 2003; Shelby et al., 2006; 
Abdel-Tawwab et al., 2008; El-Rhman et al., 2009; Nayak, 2010; Ringø et al., 2010; Ridha and 
Azad; 2012). Bacterial pathogens are illustrated in Table 1.1, which are used to indicate potential of 
allochthonous/ autochthonous probiotic candidates for using in tilapia. 
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Probiotics can produce substances or compounds that inhibit pathogenic bacterial growth. 
Therefore, many studies use agar plates to evaluate their potential. A simple technique is “spot on 
the lawn”. This technique begins with a pathogenic bacterium swabbing on TSA plate. The plate is 
incubated and then the potential probiotic candidate is used to spot on this agar plate (Vine et al, 
2004; Chantharasophon et al., 2011). A double-layer method is a quick method to screen bacterial 
isolates, which uses a single colony of isolates to culture on TSA plate. Then, growing colonies are 
removed and added semi-solid TSA containing the bacterial pathogen to cover this plate (Del'Duca 
et al., 2013). A well diffusion is used fresh bacterial cells or bacterial supernatant into holes on the 
plate, which spread with a pathogen (Hjelm et al., 2004; Hai et al., 2007; Apún-Molina et al., 2009; 
Chemlal-Kherraz et al., 2012; Hamdan et al., 2016).  
A familiar protocol is agar diffusion, which begins to use potential probiotic spreading overnight on 
TSA agar and pathogenic testing is used to spot culture on this plate (Aly et al., 2008a; Aly et al., 
2008c; Eissa et al., 2014). Another technique is a disc diffusion method, which uses a paper disc to 
immerse in cell–free supernatant of cultural bacterial broth of isolates. A dried agar plate with a 
pathogen is prepared and then these paper discs are put on this plate (Hai et al., 2007; Balcázar et 
al., 2008). The quorum quenching is used to demonstrate the potential of probiotics to inhibit 
violacein, which produced by C. ciolaceum (Villamil et al., 2014).  
Finally, a ‘cross streaking method’ is used isolated bacteria to streak in the center of the agar plate 
and then removed and killed bacterial growth following to use pathogenic bacteria culture on this 
plate (Hai et al., 2007). The appearance of clear zone of these methods is used to indicate the 
potential of isolates inhibited pathogens. 
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Table 1.2 Exemplary pathogens use to test with potential isolates in vitro trials.  
Pathogens and bacterial testing Potential probiotics Sources Antibacterial activities References 
Gram-negative and rod shape:  
A. hydrophila 
B. firmus, B. pumilus and 
Citrobactor freundii 
The internal organs of Nile tilapia Isolates can inhibit pathogen Aly et al., 2008a 
Gram-negative and rod shape:  
A. hydrophila 
Micro. luteus and 
Pseudomonas sp. 
The gonads and intestine of Nile 
tilapia 
Isolates can inhibit pathogen El-Rhman et al., 2009 
Gram-negative and rod shape:  
A. hydrophila 
Bacilllus UBRU4  The intestinal tract of Nile tilapia Inhibit to pathogen Chantharasophon et al., 
2011 
Gram-negative and rod shape: A. hydrophila, E. 
coli, Ed. tarda, Fla. branchiophilum, Pseu. 
aeruginosa, Pseu. fluorescens, Salmonella. sp. 
and Shigella sp.; 
Gram-positive and cocci shape: Streptococcus sp. 
B. subtilis  
 
The GIT of three species of 
Indian major carps. 
Inhibit to all pathogens Nayak and Mukherjee, 
2011 
Gram-negative and rod shape: E. coli, 
Pseudomonas sp.; 
Gram-positive and cocci shape: Stap. aureus  
Streptococcus sp. and  
Two strains of Lactobacillus 
spp. 
The intestinal tract of Nile tilapia LAB strain BLT31 only 
displays non-inhibition to E. 
coli 
Chemlal-Kherraz et al., 
2012 
Gram-negative and curved-rod shape: Vibrio sp. Pediococcus pentosaceus 
(LAB 37 and LAB 1-6) and 
Pediococcus sp. (LAB 35), 
The intestinal tract of tilapia Isolates display non-
inhibition to pathogen 
Cota-Gastélum et al, 
2013 
Gram-negative and rod shape:  
A. hydrophila, Ed. tarda, Pseu. fluorescens and 
Pseu. putida;  
Gram-positive and cocci shape: Ent. faecalis 
Bacillus sp. (1: autochthonous 
probiotic) and Enterococcus 
sp. (2: allochthonous 
probiotic)  
The intestine of tilapia (1) and the 
pond's sediment (2) 
Bacillus sp. and 
Enterococcus sp. can inhibit 
all pathogens acceptable Ent. 
faecalis  
Del'Duca et al., 2013 
Gram-negative and rod shape:  
Ed. tarda 
L. lactis  subsp. Lactis  The intestinal tract of freshwater 
fish 
Inhibit to pathogen Loh et al., 2014 
Gram-negative and rod shape:  
E. coli and Klebsiella sp. 
Gram-positive and cocci shape: Staphylococcus 
sp.; 
Gram-positive and rod shape: Bacillus. 





1.3.1.2 Blood hemolysis 
Bacterial pathogens such as Aeromonas spp. and Streptococcus spp. are normally found in the GIT 
of fish (Marcel et al., 2013). They contain virulence genes (haemolysin and aerolysin) to hemolyse 
blood cells (Yogananth et al., 2009; Marcel et al., 2013). Hemolytic activities be after can assessed 
using several blood types such as human blood, horse blood, sheep blood, blood fishes, and shrimp 
hemolymph (Apún-Molina et al., 2009; Leyva-Madrigal et al., 2011; Leyva-Madrigal et al., 2011; 
Nayak and Mukherjee, 2011; Cota-Gastélum et al, 2013; Muñoz-Atienza et al., 2013; Loh et al., 
2014; Vijayaram and Kannan, 2014; Hamdam et al., 2016). Bacterial isolates as Bacillus spp., Ci. 
freundii, Lac. plantarum, and Lac. casei have been proved non-harmful on blood hemolysis (Aly et 
al., 2008a; Apún-Molina et al., 2009; Chantharasophon et al., 2011; Chemlal-Kherraz et al., 2012). 
1.3.1.3 Antibiotic resistances 
Microorganisms can produce antibiotics, which are natural substances to prevent or inhibit 
pathogenic microbes (EC 1831/2003, 2003; Serrano, 2005; Rico et al., 2013). Both natural and 
synthesised antibiotics have been used so much in aquaculture. Consequently, the prevalence of 
antimicrobial residues has been remaining in aquatic animals and natural water environments 
(Petersen and Dalsgaard, 2003; Michel et al., 2003; Kemper, 2008; Baquero et al, 2008; Singh et 
al., 2009; Krishnika and Ramasamy, 2013, Nhung et al., 2015). Microbes can display both specific 
resistance and multi-resistance. These resistance genes are inherited from generation to generation 
and might transfer to other bacterial species or strains through horizontal gene transfer. For 
instance, microbial pathogens such as E. coli, Enterococcus spp., and Salmonella spp. have been 
detected resistant genes (Petersen and Dalsgaard, 2003; Michel et al., 2007).  
Several articles reported that probiotic strains as Bacillus spp. show resistance to penicillin and 
kanamycin, some LAB strains displayed on multiple resistances as cefoxitin, chloramphenicol, 
penicillin, kanamycin, and oxacillin (Mourad and Nour-Eddine, 2006; Chantharasophon et al., 
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2011; Chemlal-Kherraz et al., 2012). It has therefore been suggested that probiotics should be free 
of plasmid encoded antibiotic resistance genes" and add a citation for this.  
1.3.1.4 Adhesion/aggregation/colonization 
Bacterial colonization is considered a prerequisite of potential probiotics (Ringø and Gatesoupe, 
1998). Several adhesion assays are used to explore high potential probiotics to adhere to fish 
mucous, epithelial cells, semi-solid media, hard substrate, gelatin, polystyrene and bovine serum 
albumin (Pan et al., 2008; Geraylou et al., 2014; Preito et al., 2014). Furthermore, adhesion has 
been evaluated in terms of bacterial adherence to solvents, hydrophobicity, or biofilm formation 
(Abdulla et al., 2014; Preito et al., 2014).  
An auto-aggregation assay is used to evaluate bacteria adhesion between cells to cells within strains 
or species (Pen et al., 2008; Lazado et al., 2011; Abdulla et al., 2014), while adhesion of cells to 
cells of different strains (between isolates and pathogen) is called a co-aggregation (Grześkowiak et 
al., 2012; Abdulla et al., 2014). A co-aggregation method or co-culture method may be used to 
assess competitive adhesion between bacterial isolate and pathogen (Pan et al., 2008; Lazado et al., 
2011). These assays might be examined in buffer solvents or broth media. 
Several articles reported that the ability of bacterial adhesions is determined with different 
substrates such as the intestinal epithelial cells (IEC), fish mucous, and the epithelial cell line (Pan 
et al., 2008; Grześkowiak et al., 2011; Lazado et al., 2011; Geraylou et al., 2014; Preito et al., 
2014; Etyemez and Balcazar, 2016). The host mucous has been used to demonstrate the adhesive 
efficiency of probiotic candidates (Grześkowiak et al., 2011). In some studies of these articles, 
bacterial isolates have demonstrated displaying high growth rate on mucous than the other medium 
culture. At the same of Geraylou et al. (2014) reported that different isolates were displayed 
differences of the adhesive properties both media culture and on mucous. Adhesive potentials can 
also be determined as microbial adhesion to solvents (MATS) or bacterial adhesion to hydrocarbons 
(BATH) or hydrophobicity (Rosenberg and Rosenberg, 1985; Collado et al. 2008). The solvents 
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used include chloroform, ethyl acetate, n-hexadecane, n-octane, octonol, p-xylene, polystyrene and 
xylene (Van der Mei et al., 1995; Kos et al., 2003; Balcázar et al., 2007; Wang et al., 2007; Pan et 
al., 2008; Grześkowiak et al., 2012; Geraylou et al., 2014; Preito et al., 2014). Furthermore, BATH 
technique as cell surface hydrophobicity is used non-polar solvents for estimating the adhesive 
potential of probiotic candidates (Bellon-Fontaine et al., 1996).  
The estimation of bacterial changes may be achieved by many techniques such as conventional 
methods such as the plate count technique (Pan et al., 2008; Preito et al., 2014; Widanarni et al., 
2015; Etyemez and Balcazar, 2016), and a direct bacterial count (Lazado et al., 2011), an optical 
density (a micro-plate reader) or bacterial-labeled radioactivity and auto-fluorescence monitoring 
(Balcázar et al., 2007; Grześkowiak et al., 2011; Geraylou et al., 2014; Pham et al., 2014).  
1.3.1.5 Tolerance of gastrointestinal tract conditions 
The GIT of fish is a relatively harsh environment comprised of digestive enzymes, pH variations 
and bile salts. The mucous cells in the GIT of Nile tilapia have been observed to resist acidity 
associating with pH ranging from 1.58 to 5.0 in the stomach (Morrison and Wright, 1999; Hlophe et 
al., 2013). Moreover, pH changes ranging 1 to 7.8 in the intestinal tract of fish are occurring during 
the pepsin activity and pH higher than 7.8 during lipid activity (Bone and Moore, 2008; Hagey et 
al., 2010). The potential of isolates to tolerate with low pH is important for selecting probiotics. The 
pH of 2 has been found the effect on the survival rate of probiotics, whilst bile salts were found a 
few effects on probiotic mortality (Mourad and Nour-Eddine, 2006; Balcázar et al., 2008; Nayak 






1.3.2 The selection of potential probiotic using in vitro trials 
Using several numbers of probiotics testing in vivo trial may be related to use facilities, materials, high 
number of lab animals and high budget. Referring to the 3Rs having three components of reducing, 
refinement, and replacing animals are suggested for researcher in response these components as ethical 
awareness (Festing and Altman, 2002). Then, in vitro trials are very important as a pre-study experiment 
without using lab animals.  
Various articles have distributed different methods to select probiotics. For instance, pathogenic 
activities are the initial examination and then followed with safety testing (Aly et al., 2008; 
Balcázar et al., 2008; El-Rhman et al., 2009), blood hemolysis and pathogenic inhibition (Aly et al., 
2008; El-Rhman et al., 2009; Chantharasophon et al., 2011; Gobinath et al., 2012; Del'Duca et al., 
2013), only the property of bacterial aggregation (Grześkowiak, et al., 2012) or used pathogenic 
inhibition and adhesive potentials (Etyemez and Balcazar, 2016). The correlation between cell 
surface hydrophobicity and auto-aggregation has been pointed to select the potential of probiotics  
(Wang et al., 2007). The simplest method to select high potentials of probiotics may use a few 
parameters and use a few isolates in the initial study. The selection of probiotics might be using 
different parameters for evaluating probiotic potentials, which are listed in Table 1.2. 
Multi-parameters such as pathogenic antagonism, susceptibility to antibiotics, ability to produce 
lactic acid and pH, and bile salt tolerances have been used to select probiotics (Chemlal-Kherraz et 
al., 2012). Muñoz-Atienza et al., (2013) reported that the selection of probiotics based on the results 
of hemolysin production, antibiotic susceptibility, bile salt deconjugation, mucin degradation, 
enzymatic activities, and antibiotic resistance gene. Some evidences have found different findings 
of each isolate displaying different parameters such as cell surface properties (Collado et al., 2008), 
auto-aggregation and co-aggregation (Collado et al., 2008, Grześkowiak et al., 2011&2012), and 
adhesive capacities to different substrates (Balcázar et al., 2007; Vendrell et al., 2009; Grześkowiak 
et al., 2011). Moreover, Vine et al., (2004) suggested the ranking index (RI), which used parameters 
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of doubling time and lag period of bacterial growth in vitro testing. This model has the assumption 
that bacterium having a short lag period and short doubling time were displayed a high opportunity 
of probiotic properties (low RI). Different bacterial strains may display varieties of findings and 
each strain might possibly occur different results from different parameters. Then, the point is how 




Table 1.3 Summary of probiotic selection for tilapia using different in vitro criteria. 
Potential probiotic Sources Criteria for evaluation of potential probiotic in vitro trials References 
1. Evaluation of pathogenic inhibition on agar 
plate studies 
2. Assessment of 
safety to use 
3. Evaluations for supporting adhesion 
1.1 1.2 1.3 1.4 1.5 1A 2.1 2.2 2A 3.1 3.2 3.3 3.4 4.1 4.2 4.3 
Bacilllus UBRU4 The GIT of Nile 
tilapia 
− + − − − 1 + + 3 − − − − − − + Chantharasophon et al., 
2011 
B. firmus, B. pumilus 
and Citrobactor freundii 
The internal organs 
of Nile tilapia 
+ − − − − 1 − − − − − − − − − − Aly et al., 2008a 
Micrococcus luteus and 
Pseudomonas 
The organ of Nile 
tilapia 
+ − − − − 1 − − − − − − − − − − El-Rhman et al., 2009 
Enterococcus 
sp.(allochthonous 






− − − + − 5 − − − − − − − − − − Del'Duca et al., 2013 





+ − − − − 1 + − − − − − − − − + Apún-Molina et al., 2009 
B. mojavensis B191 The intestinal 
mucous of Nile 
tilapia 
+ − − − + 2 − − − + − − − − − − Etyemez and Balcazar, 
2016 
L. lactis  subsp. Lactis 
CF4MRS 
The GIT of 
freshwater fish 
− + − − − − + + 6 − − − + − − − Loh et al., 2014 
Lact. plantarum AH78 Marine bacteria + − − − − 6 + + 10 − − − − − − − Hamdan et al., 2016 
Lactobacillus spp. 
BLT1 and BLT3 
The GIT of Nile 
tilapia 
+ − − − − 4 − + 11 − − − − + + + Chemlal-Kherraz et al., 
2012 
Pediococcus sp. and P. 
pentosaceus 
The GIT of tilapia + − − − − 1 + − − − + − − − − + Cota-Gastélum et al, 2013 
Two Lactobacilli strains The GIT of tilapia 
and channa 
− − + − − 4 + + 3 − − + − − − − Vijayaram and Kannan, 
2014 
B. subtilis The GIT of three 
species of Indian 
major carps 
− − + + − 10 + + 10 − − − − − − − Nayak and Mukherjee, 
2011 
1.1 Agar diffusion/ agar well diffusion/ well diffusion/ spent culture liquid; 1.2 Cross streak; 1.3 Disc diffusion; 1.4 Double layer; 1.5 Spot on lawn; 1A Totaled pathogenic strains 
2.1 Blood hemolytic testing; 2.2 Antibiotic resistances; 2A Totaled antibiotic disc 
3.1 Adhesion to many substrates (cells, mucous, semi-solid media, hard substrate, solvents)/biofilm formation; 3.2 Bacterial adherence to hydrocarbons; 3.3 Auto-aggregation; 3.4 
Co-aggregation/ co-culture (solvent, broth);  
4.1 pH tolerance; 4.2 Bile salts tolerance; 4.3 Others: cultural conditions, growth kinetics/ growth, enzymatic production 
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1.3.3 In vivo trials 
The evaluation of potential probiotics for tilapia in in vivo trials was carried out for 2 to 34 weeks. 
The initial weight of tilapia was varied from 1.0 g to 185.0 g. The gap of stocking densities was 
found to be less than 1.0 g.l-1 to a high density (50 g.l-1). The difference of both feeding frequency 
and feeding ration has been found and protein contents in basal diets display varying from 25 to 55 
percentages. These data are represented in Table 1.3. 
The feed ratio and frequency for larval tilapia weighting 1−2 g should be around 10−15% body 
weight per day and 3−8 tpd depending on cultural rearing (www.fao.org, 2016). Fish feeds could be 
reduced and adjusted to upon tilapia growing. In addition, protein levels in tilapia feed and stocking 
density might considerable awareness during culture conditions (Abdel-Tawwab, 2012). Typically, 
probiotic concentrations of 106-7 cfu.g-1 use to mix with fish feed, however, the variation of bacterial 
cells might be ranging from 105 cfu.g-1 to 1014  (Table 1.3).  
The safety to use of potential probiotics before testing in vivo trials have been reported that 
probiotic cells are injected into the fish IP to the observed mortality without severe symptoms of 
pathogens (Aly et al., 2008a,b; El-Rhman et al., 2009; Eissa et al., 2010). Several parameters such 
as growth performances, disease resistances, and different parameters in the GIT as hematological 
studies, histological analysis, and microbial changes have been used to evaluate potential probiotic 
for tilapia following: 
1.3.3.1 Growth performances 
Growth performances may be categorized into main parameters and minor parameters. The main 
parameters consisting of feed conversion ratio, specific growth rate and daily weight growth are 
routine measurements for monitoring by farmers. Other parameters (Table 1.3) such as 
hematological studies, histological studies and molecular studies may provide as minor growth 
performances, which processed in laboratory facilities, which required many chemicals, 
instruments, and materials.  
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Several articles have reported that potential probiotics display the positive effect on growth 
performances (Aly et al., 2008c; Eissa and Abou-ElGheit, 2014). For instance, the autochthonous 
probiotic of the LAB strain use to mix in feed, the other autochthonous Bacilli strain is added to the 
rearing system and both probiotics were combined together for testing in tilapia culture. These are 
found high performances of the final weight, absolute growth, absolute growth rate and specific 
growth than the control group (Apún-Molina et al., 2009). Many minor parameters of probiotic 
testing have shown a higher performance in probiotic groups than the control group. In addition, 
probiotic potential has been reported to provide high efficiency of low protein diets, which may 
reduce the production cost (Ghazalah et al., 2010). Moreover, different probiotic properties (a high 
adhesion and low adhesion) have shown different effects on FCR and weight gain of hybrid tilapia 
(Liu et al., 2013). 
Conversely, the efficiency of probiotics has been demonstrated without high performances at 
extreme conditions of stock densities and protein levels (Lara-Flores et al., 2003). The negative 
effect of probiotics has been reporting lower growth in the tilapia fry stage (Shelby et al., 2006, He 
et al., 2013; Standen et al., 2013).  
1.3.3.2 Pathogenic resistances 
Pathogenic resistances are usually tested with fish finishing probiotic-feeding. These findings might 
be found the positive or negative effects of potential probiotics. Probiotics have been reported to 
provide a higher survival rate than the control group in several articles (Lara-Flores et al., 2003; Aly 
et al., 2008c). Examples, fish fed probiotics at a concentration of 105-9 cells for fifteen days 
displaying against pathogens (Nouh et al., 2009; Liu et al., 2013: Villamil et al., 2014). Conversely, 
fish fed probiotics at a concentration of 105-9 cells for eight weeks without providing the survival 
rate than the control groups (Shelby et al., 2006; Apún-Molina et al., 2009; El-Rhman et al., 2009; 




1.3.3.3 Bacterial changes in the fish intestine 
Both quantitative and qualitative methods are studied to monitor bacterial changes in the GIT of 
tilapia during the probiotic-feeding and finishing feeding probiotics. Differences of quantitative 
methods consisting of direct count in media cultures, direct cell count and bacterial labeled-
fluorescent probe to detect the specific DNA sequence on chromosomes of the GIT for estimating 
bacterial abundances (DeľDuca et al., 2013). Qualitative methods, such as genomic studies as 16S 
rDNA V3 region (Ferguson et al., 2010), are useful for bacterial probiotic monitoring, polymerase 
chain reaction - denaturing gradient gel electrophoresis (He et al., 2013; Liu et al., 2013; Standen et 
al., 2015), which allowed bacterial DNA fragments of the gut microbes to be separated on the basis 
of sequence differences containing guanines (G) and cytosines (C) by using in polyacrylamide gels 
containing of denaturing agents, and high-throughput sequencing (Adeoye et al., 2016) is meta-
genomic microbes in the gut. These are used to identify bacterial species in the tilapia GIT. 
Certainly, fish feed probiotics are occurring massive probiotics than the control group (Ferguson et 
al., 2010; Standen et al., 2015&2016), whilst microbial loads in the fish GI might be found not 
different between probiotic and without probiotics, which displayed approximately 106-7 cfu.g-1 
(Ferguson et al., 2010; Liu et al., 2013; Standen et al., 2013). Using high adhesive probiotic 
(Lactobacilli) at a concentration more than 107 cfu.g-1 diet to feed in fish for 10 days has been 
provided these bacteria to adhere at the GIT of tilapia (Liu et al., 2013). Bacillus spp. was displayed 
in the GIT after fish fed probiotic for 8 weeks, which used an agar plate technique (Standen et al., 
2015). Probiotics were demonstrated to persist in the GIT along fewer three weeks after finishing 
probiotic feed (Ferguson et al., 2010; Standen et al., 2015). Therefore, probiotic cells in fish feed 
may adhere in the GIT, which could be monitored by using different techniques.  
The most important article reported by DeľDuca et al., (2013), who used fluorescent-labeled 
bacterial count in probiotic groups (Bacillus sp., Enterococcus sp. and combined two potential 
probiotics) and the control group. Pathogenic bacteria consisting of Aeromonas sp. (0.35±0.17×106 
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cells.g−1) and Pseudomonas fluorescens (0.51±0.27×106 cells.g−1) displayed higher in the control 
group and also found in three probiotic groups. The Enterococcus group provided high abundances 
(0.42±0.15×106 cells.g−1) in both a single dose and mixing with Bacillus sp., however, this 
bacterium also occurred in all group studies. Similarly, Bacillus sp. displayed the highest abundance 
(1.0±0.47×106 cells.g−1) in the Bacillus group and high abundance (0.63±0.18×106 cells.g−1) in the 
combined probiotics. Furthermore Bacillus sp. seemed to be high (≈0.45±0.13×106 cells. g−1) in 
both the Enterococcus and without probiotics.  
The potential of probiotics accompanying with the GI microbes has been examined, which found 
dominant bacteria of Acinetobacter spp., Enterobacteriaceae bacterium, Serratia sp. Cetobacterium 
sp. in probiotic groups and without probiotic (He et al., 2013). Some articles have used a high-
throughput sequencing analysis to identify bacteria of digesta samples, which identified as 
Burkholderia, Leuconostoc, Acinetobacter, Legionella, Lactobacillus, Corynebacterium, 
Firmicutes, Proteobacteria, and Cyanobacteria, which were dominant in the control group. In 
addition, some bacteria as Actinobacteria, Bacteroidetes, Fusobacteria, Nitrospirae, and 
Spirochaetes were found in both treatments (Standen et al., 2015; Adeoye et al., 2016). Bacterial 
components in the tilapia GI seem to be similar both probiotic and without probiotic groups.  
1.3.3.4 Hematological data 
Basically, many hematological parameters as hemoglobin, hematocrit, hemoglobin, red blood cells, 
and protein content are used to assess the fish health status, and these data have reported to evaluate 
potential probiotics (Table 1.3). Different findings of blood parameters including red blood cells 
levels, hematocrit, hemoglobin, glucose and total protein of probiotic have been reported the 
potential of probiotic studies (Soltan and El-Laithy, 2008: El-Rhman et al., 2009). Positive effects 
of probiotics on blood parameters of high red blood cells, hematocrit, hemoglobin, mean 
corpuscular hemoglobin and mean corpuscular hemoglobin concentration more than the control 
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group have been reported by Eissa and Abou-ElGheit (2014). However, Standen et al. (2013) 
reported all blood parameters showed non-differences between probiotic and control groups. 
1.3.3.5 Histological data 
Epithelial cells and mucous tissues locate in the gastrointestinal tract are very important to the 
innate immune response. These cells have a function as a weapon immediately responses to against 
pathogens. The development of functions might be inducing by the GI microbe (Murray et al., 
1994; Gargiulo et al., 1998; Nayak, 2010). Then, the study of histological changes (microvilli cells, 
the epithelial layer thickness, the intra-epithelial leukocytes, mucous cells, and goblet cells, etc.) 
could be evaluated by using a light microscope and electron microscopes. The potential of probiotic 
has been provided to increase the epithelial layer thickness of the mid-gut (Nakandakare et al., 
2013), to perform a massive number of an absorptive surface index (Ferguson et al., 2010; Standen 
et al., 2015), and microvilli cells of tilapia (Adeoye et al., 2016; Handan et al., 2016). Using 
probiotic at high dose can promote absorptive surfaces, intraepithelial leukocytes and goblet cells 
(Standen et al., 2016). Finally, fish fed probiotic groups were showed enhancement of the ability of 
phagocytes and reduced the intestinal damage cells, causing by a pathogen (Ngamkala et al., 2010). 
Therefore, histological changes might be used to support the potential of probiotics and associated 
with gut immunes, fish health and growth performances.   
1.3.3.6 Gut immunological data 
The recognition of immune responses in aquatic fishes suddenly learns after hatching and contacts 
with water surrounding, which possibly contains chemicals, biochemical agents, or biological 
compounds (Tort et al., 2003; Galindo-Villegas and Hosokawa, 2004). The innate immune response 
is the primary defense mechanism consisting of the gut immunology (humoral parameters: 
complement system, antibacterial peptides and protease inhibitors), and cellular components 
(phagocytic leukocytes and non-specific cytotoxic cell). The adaptive immune response is later 
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acquired by the innate development. Both immune systems are synchronized together (Nayak, 
2010).  
The potential of probiotics has been reported to positively effect on blood cells, lymphocytes, 
monocytes and neutrophils (Aly et al., 2008b; Eissa and Abou-ElGheit, 2014; Standen et al., 2013). 
The other immune parameters have been evaluated by using some enzymatic activities as aspartate 
aminotransferase and alanine aminotransferase may cause damage to the GI tissues, however, the 
negative effect of probiotics on these parameters was found (Soltan and El-Laithy, 2008; El-Rhman 
et al., 2009).  
The phagocytic estimation has found high expression in probiotic groups, which response to 
defense pathogens causing cell damages (Aly et al., 2008b&c; Wang et al., 2008). Probiotics have 
proved association with enzymatic releasing of myeloperoxidease to produce hydochorous acid 
killing pathogens and directly effect to microbial cell lysis (Wang et al., 2008). Some parameters of 
lysozyme activity, neutrophil adherence testing and serum bacterial activities have been 
demonstrated to be increasing in probiotic groups (Aly et al., 2008c; Nouh et al., 2009). 
Conversely, some immunological studies of lysozyme, total serum immunoglobulin, complement, 
specific-streptococcal antibody levels have been determined not different between the probiotic-
feeding and without probiotic (Shelby et al., 2006; El-Rhman et al., 2009). 
1.3.3.7 Gene expression 
Several studies reported that gene expression of cytokine families (IL-1β: interleukin-1 beta, IL-2: 
interleukin-2, IL-10: interleukin-10), TGF- β: transforming growth factor beta and TNF-α: tumor 
necrosis factor alpha) have related to the processing of the innate immune system and combined 
with microbial antigens or damaged cell occurrences (Reyes-Cerpa et al., 2013; Standen et al., 
2016), while transferrin gene can express by pathogenic infection (Uribe et al., 2011). The caspase-
3 gene is indicated to apoptosis (cell death), while PCNA (proliferating cell nuclear antigen) is a 
signal of cell proliferation (Standen et al., 2016). In addition, HSP70 (heat shock protein 70) is used 
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to indicate the stressful condition, which benefit to maintain protein function, folding, and 
translocation (Iwama et al., 1999; Basu et al., 2002). These genes are used to evaluate the potential 
of probiotics.  
Generally, bacterial infections and lipopolysaccharides stimulate the IL-10 expression (Zhang, et 
al., 2009). Fish inflammations are caused by gram-negative bacteria, which may induce TNF-α, and 
IL-1β expressions (Savan and Sakai, 2006). The role of TNF-α gene typically plays varieties of host 
responses consisting of cell proliferation, differentiation, necrosis, and apoptosis, which might be 
induced by other cytokines. The TGF-β regulation as trans-forming growth factor may be expressed 
during the process of the cell development. He et al. (2013) reported that tilapia feed probiotic at a 
concentration of 109 cells g-1 diet displayed different expressions both up-regulated and down-
regulated of these cytokine genes. Liu et al. (2013) found fish fed probiotic have expressed down-
regulation of cytokine expression in the gut. Opposite with He et al. (2013) reported that probiotics 
might induce up-regulation of cytokine genes more than the control group. Similar reported by 
Standen et al., (2016) that up-regulations of cytokines (TLR2, TNF-α, IL-1β, TGF- β and IL-10) 
display in probiotic groups and increase of caspase-3 (indicator of an apoptosis), and PCNA 
(indicator of cell proliferations). 
Fish feed probiotic, which may decrease HSP70 expression (Avella et al., 2010). Generally, both 
pathogens and stressful conditions might activate up-regulation of HSP70 (Liu et al., 2012). 
Previous study, pathogenic infection can induce high HSP70 expression (Panakulchaiwit et al., 
2008). Different doses of the probiotic-feeding have decreased HSP70 expression (He et al., 2013). 
However, the variation of HSP70 expressions in the intestine can display both up-regulation and 
down-regulation, which might depend on microbial changes in the gut of different times (Liu et al., 
2013). Standen et al. (2016) reported that high expression of HSP70 was found in the probiotic 




1.3.3.8 Physiological changes  
The stocking density of tilapia cultures could consider the optimal density to aware the agonistic 
behavior. Fish feed probiotics combining with different densities (3.7 and 40 g.L-1) have shown an 
aggressive behavior at low density, while, high density shown the static behavior (Gonçalves et al., 
2011). Agonistic activity shows no difference between the probiotic group and the control group; 
these fish were reared at 0.3 g.L-1 of the stocking density, as reported by Soltan and El-Laithy 
(2008).  
Probiotics may affect both external and internal effects. The external effect is related to growth 
phenotype while the internal effect is related to the digestive system, gene expressions, histological 
changes and immune systems. Probiotics for fish cultures may use a single dose or mixed doses, 
which can mix in fish feeds and added into the rearing system (Apún-Molina et al., 2009; El-Rhman 
et al., 2009; Cota-Gastléum et al., 2013). Moreover, probiotics can combine with the herb plant for 
supporting growth performances (Soltan and El-Laithy, 2008). Probiotic feed preparations may be 
favorable mixing before pelleted, after pelleted and after extruding processes (Nakandakare et al., 
2013). Their potential effects of probiotics can be evaluated by using many parameters, which 
referred to the above descriptions. 
 
1.4 Thesis aim and objectives 
Research studies were based on standard methods for identifying and evaluating the potential of 
autochthonous bacteria as a novel probiotic for tilapia culture in Thailand (Chapter 2). Then, this 
thesis has proposed to examine a novel autochthonous probiotic for using in tilapia cultures, which 
are separated into two main objectives both in vitro and in vivo studies. These objectives linked 
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Biomate SF-20 (En. faecium), 
Bioplus 2B (B. subtilis+ B. 
licheniformis), Bactocell PA10 
MD (Ped. acidilactici) and 
Levucell SB 20 (Sac. 
cerevisiae) 
109-10 cfu.g-1 diet 50%CP 
(CF) 




GP (WG), CT-SR ID, 
BD (TVC), and (BA, 
CA, LyC, TIg)  
Nile 
tilapia 
Shelby et al., 
2006 




Bacillus sp. and LAB 
(autochthonous probiotics) 
5×104 cfu.g-1 diet 





Ad libitum  
(?) 
Added in system 
every 15 days 
≈19.0 GP (AG, AGR, SGR) Tilapia Apún-Molina et 
al., 2009 
0.15 L: 0.08 
H: 0.15 





ALL-LAC™ (Sac. faecium + 
Lac. acidophilus; AllTech, 
Nicholasville, KY) & Sac. 
cerevisiae (BioSaf™, SafAgri, 
Minne-apolis, MN) 
0.001 g.g-1 diet 27%CP and 
40% CP 
Ad libitum  
(4 tpd) 
9.0 GP (ANU, AOMP, 
APD, CND, FCR, PER, 









Lac. brevis and Lac. acidophilus 
(allochthonous probiotics) 
105,7,9 cells.g-1 diet 42% CP Ad libitum  
(2 tpd) 
5.0 GP (FCR, WG), CT-SR, 
BD (DGGE) and GeE 
(IL-1β, HSP70, TGF- β, 
and TNF-α)  
Hybrid 
tilapia 
Liu et al., 2013 







2.5 & 5 ×105 
cfu.g-1 diet 
36% CP 5% of BW  
(2 tpd) 
8.0 GP (FCR, WG), BD 
(TVC, DGGE) and GeE 




He et al., 2013 




Premalac (Lac. acidophilua, 
Bifedobacteria bifedum, Strep. 
Facecium, torula yeast, 
Aspergillus oryzae extract, skim 
milk, vegetable oil and CaCo3) 
and Biogen (allicin, enzymes, B. 
subtilis, ginseng extract) 
0.001, 0.002 & 
0.003 g.g-1 diet 
 
≈107 cfu.g-1 diet 
32% CP 4% of BW  
(3 tpd) 
≈30.0 GP (ADE, EU, FCR, 
FPV, PUE, PPV, SGR), 
ID (WBC) and CT-SR 
Nile 
tilapia 
Ali et al., 2010 




Premalac (Lac. acidophilua, 
Bifedobacteria bifedum, Strep. 
Facecium, torula yeast, 
Aspergillus oryzae extract, skim 
milk, vegetable oil and CaCo3) 
and Biogen (allicin, enzymes, B. 
subtilis, ginseng extract) 
0.002 g.g-1 diet 25, 25.5 
and 30%CP 
4% of BW  
(3 tpd) 
≈17.1 GP (ADC, ADG, FCR, 
PER) and cost analysis 
Nile 
tilapia 
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106 cells.g-1 diet 24% CP 
(CF) 
10% of BW  
(3 tpd) 
≈2.1 GeE (IL-1β and TGe) 
and CT-SR 
Tilapia Villamil et al., 
2014 




LAB strains (autochthonous 
probiotics)*A 




Ad libitum  
(?) 
≈10.1 GP (SGR) Tilpia Cota-Gastléum 
et al., 2013 
            
            




Micrococcus luteus and 
Pseudomonas sp. 
(autochthonous probiotics) 
107 cells.g-1 diet 55% CP 3% of BW  
(2 tpd) 
≈13.0 GP (FCR, NWG, PER, 
SGR), CT-SR, HD (Gl, 
Ht, Hb, RBC, TPr) and 
ID (BA, LyA)  
Nile 
tilapia 
El-Rhman et al., 
2009 




B. subtilis (allochthonous 
probiotics) and Biogen® 
(Bacillus spp.)*B 
7x109 cells.g-1 diet 30% CP 10, 7 & 4% of 
BW  (2 tpd) 
≈13.0 GP (FCR, PER, SGR), 
HD (Ht, Hb), ID (LyA) 











Pseu. fluorescens strains 
(autochthonous probiotics) 
108 cells.g-1 diet 30% CP 3-5% of BW  
(2 tpd) 
≈6.5 GP (BMG, MGR, SGR, 
WG), CT-SR, HD (Glo, 
Ht, Hb, RBC, TP) and 









Bacillus suntilis (Sigma) and 
Lac. acidophilus (allochthonous 
probiotics) 
107 cells.g-1 diet Not 
reported 
5% of BW  
(?) 
8.0 GP (FCR, K, SGR), SR, 
CT-SR, ID (SBA) and 
HiD (LM-organs)  
Nile 
tilapia 
Nouh et al., 
2009 




PAS TR® (Bacillus subtilis + B. 
toyoi) 
0.004 g.g-1 diet 
(4x108 cfu.g-1) 
36% CP 1% of BW  
(3 tpd) 
9.0 GP (AFC, DWG, FCR), 










B. subtilis and Lac. acidophillus 
(allochthonous probiotics) 




5% of BW (?) 8.0 GP (FCR), CT-SR, BD, 
HD (Ht) and ID (BA, 
PhaA, LyA)  
Tilapia Aly et al., 
2008c 





probiotics) and Organic 
Green™ 
106 & 12 cells.g-1 
diet 
35%CP 3% of BW  
(2 tpd: summer) 
and 1% of BW  
(2 tpd: winter) 
≈34.0 GP (Gr), CT-RLP, HD 
(Ht), and ID (PHaA, 
TLeC, LeT)  
Nile 
tilapia 
Aly et al., 
2008b 






107 cfu.g-1 ml-1 37%CP 3% of BW  
(3 tpd) 
Mixed in rearing 
system every 4 
days 
≈5.7 GP (DWG), HD (TP, 
TSP, Al, Gl, A/G) and 
ID (EnA, LyA, LyC, 
PhaA) 
Tilapia Wang et al., 
2008 




B. pumilus, B. firmus and Ci. 
Freundii (autochthonous 
probiotics) 
107 cells.g-1 diet 25%CP 
(CF) 
5% of BW  
(3 tpd) 
2.0 CT-SR Nile 
tilapia 
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P. acidilactici MA 18/5 M 




44%CP 4% of BW  
(3 tpd) 
6.0 GP (NWG, PER, k, HIS, 
SGR, VSI), BD (TVC), 
HiD (LM: AU, IEL’s, 
GoC; TEM: MiL), HD 
(Ht, Hb, RBC, etc.), ID 
(WBC, LyC, LeT) and 
GeE (TNF-α) 
Tilapia Stenden et al., 
2013 




Bacillus sp. (autochthonous 
probiotic) and Enterococcus 
(allochthonous probiotic)  
>106 cells.g-1 diet 36% CP 
(CF) 
8% of BW  
(3 tpd) 
≈4.5 BD (QBT-FISH) Tilapia Del’Duca et al., 
2013 








Lac. rhamnosus (allochthonous 
probiotics) 




GP (PER, SGR, WG), HD 












108 cfu.g-1 diet 44% CP 
(CF) 
4.5% and 3% BW 
(4 tpd) 
≈14.0 GP (D, FCR, SGR), SR, 
BD (TVC), HD (Ht, Hb, 
RBC, TP) and ID (LeT, 
LyA, WBC)  
Nile 
tilapia 
Ridha and Azad 
(2012) 




Lac. plantarum (autochthonous 
probiotics) 
3.4 & 6.8x108, 
1.3x109 cfu.g-1 
diet 
33-35% CP 3% BW  
(2 tpd) 
≈5.7 GR (FCR, PER, PPV, 
SGR), CH-RPS, HD (Hb, 
RBC), ID (WBC, Tig, 
PhaA, LyA), GeE ((IL-4, 




Hamdan et al., 
2016 




Bacillus spp. (Biogen® ) 0.005, 0.01, 0.015 
& 0.02 g.g-1 diet 
(≈107 cfu.g-1 diet) 
30% CP 3% of BW  
(3 tpd) 
≈18.0 GP (ER, FCR, PPV, SGR, 









B. subtilis, S. cerevisiae and A. 
oryzae (Biogenic group, 
Brazil)  
0.005 and 0.01 g-1 
diet (109 cfu.g-1 
diet) 
28% CP 2% of BW  
(2 tpd) 
6 GP (FCR, NGW), CT-SR, 
HD (Al, Gl. Glo, Hb, Ht, 
MCV, MCHC, TPr) and 
ID (CC, PhaA, TLeC, 
WBC)  
Tilapia Iwashita et al., 
2015 





probiotic, AquaStar® Growout 
(a mix of Bacillus subtilis, 
Enterococcus faecium, 
Lactobacillus reuteri and 
Pediococcus acidilactici) 
0.015, 0.03 g.g-1 
diet 
37-38%CP 1-5% of BW  
(4 tpd) 
6 GP (FCR, PER, SGR), 
BD-DGGE, GeE (caspase-
3, PCNA, HSP70, TLR2, 
TGF-β, IL-10,TNF-α and 
IL-1 β) and HiD (LM-AU, 
IET’s, GoC) 
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H: 2.0 
L: 15,  




B. subtilis (strain C-3102-
Calsporin®) 
5 ×106 cfu.g-1 diet 34% CP Ad libitum  
(3 tpd) 
12 GP (Gr, FCR), SR, HD 
(Gl, Hb, Ht, RBC, MCH, 
MCHC, MCV) and ID 
(CC, IPha, PhaA, LeT, 
LyA, WBC) 
Tilapia Telli et al., 
2014 






(containing B. subtilis, B. 
licheniformis and B. pumilus; 
Sanolife PRO-F) 
1010 cfu.g-1 diet 35% CP 
(CF) 
3% of BW  
(3 tpd) 
7 GP (FCR, PER, SGR, HIS, 
VSI), SR, BD (IPGS-
HtSA), HD (Hb, Ht, MCV, 
MCH, MCHC, RBC), ID 
(LyC, TleC, WBC) and 





Adeoye et al., 
2016 




AquaStar® Growout (Bacillus 
subtilis, Enterococcus faecium, 
Lactobacillus reuteri and 
Pediococcus acidilactici: 
Biomin Holding GmbH, 
Austria) 
0.005 g.g-1 diet 36% CP 1-3% of BW  
(4 tpd) 
8 BD (TVC, BD-DGGE, 
IPGS-HtSA) and HiD 
(LM- AU, GoC, IEL’s, 
Mul; SEM-ASI, MiD; 
TEM;MiL)  
Tilapia Standen et al., 
2015 




Lac. rhamnosus (allochthonous 
probiotics) 
108&10 cfu.g-1 diet CF 0.6% of BW  
(1 tpd) 
2 ID (IHC, LeA, LyA and 
CA) and PMO-HP 
Tilapia Pirarat et al., 
2006 
70 ? 30 
(270) 
Aquaria (?) Pseu. fluorescens 
(autochthonous probiotics) 
108 cells.g-1 diet 26% CP 2% of BW  
(2 tpd) 
≈2.0 MR, HD (Al, Glo, Hb, 
RBC, TP,) and ID (LC, 
Let, WBC)  
Nile 
tilapia 
Eissa et al., 
2014 




Alchem Poseidon, Korea (B. 
subtilis, Lac. acidophilus, Clos. 
butyricum and Sac. cerevisiae)  
107-8 cfu.g-1 diet CF 1-2% of BW  
(2 tpd) 
≈4.0 CT-SR, SST-MC, ID  
(BA, LyA, MC, PA, 
PhaA, OR) and HD (TP, 
Hg)  
Tilapia Taoka et al., 
2006 




Lac. rhamnosus (allochthonous 
probiotics) 
1010 cfu.g-1 diet CF 1% of BW  
(?) 




Ngamkala et al., 
2010 




P. acidilactici MA 18/5 M 
(Bactocell®, Lammeemand Inc, 
Canada) 
107 cfu.g-1 diet 41-42% CP 1.5% of BW  
(3 tpd) 
≈4.6 GP (FCR, PER, SGR) 
HD (He, Hb, TSeP), ID 
(LeT, LyA, PhaA) BD 
(TVC), IPGS) and HiD 
(LM: NL)  
Red 
tilapia 
Ferguson et al., 
2010 




Lac. platarum (autochthonous 
probiotics) 
109 cfu.g-1 diet 32% CP ?  
(2 tpd) 









*A Mixed with prebiotic; *B used herb/plant flower mixing; ** without replicates  
 CRS: closed recirculation system; RWS: recirculating water system; RFW: running fresh water/flow-through system; LS: Lentic system  
GP: growth performance and others- AG: absolute growth; AGR: absolute growth rate; ADC: apparent digestion coefficient; ANU: apparent N utilization; APD: apparent protein 
digestibility; BMG: apparent organic matter and body mass rate; Gr: growth; CND: carcass N deposition; DWG: daily weight gain; D: density; ER: energy retention; EU: energy 
utilization; FCR: feed conversion ratio; FPV: fat productive value; HIS: hepatosomatic index; K: condition factor; NPU: net protein utilization; NWG: net weight gain; MGR: 
metabolic growth rate; PER: Protein efficient ratio; PPV: protein productive value; PUE: protein utilization efficiency; SGR: specific growth rate; VSI: viscerosomatic index; 
SR: Survival rate after evaluating, and CH: after challenging with pathogen- SST: salinity stress test; MR mortality rate; SR: survival rate; RLP: relative level of protection; RPS: 
relative percent survival 
BD: bacterial data- TVC: total viable count, QBT-FISH: quantify bacterial testing uses fluorescent in situ hybridization, GBDNA: genomic bacterial DNA, IPGS: identified 
probiotic by gene sequencing (DGGE: denaturing gradient gel electrophoresis, HtSA: high-throughput sequencing analysis) 
HD: hematological data- Al/Glo ratio, Al: albumin, Glo: globulin, Gl: glucose, MCHC: mean corpuscular hemoglobin concentration, MCV: mean corpuscular volume, MCH: mean 
corpuscular, hemoglobinHt: hematocrit, Hb: hemoglobin, NCC: nucleic acid concentration, Pl: plasma lipids, PC: protein content, RBC: red blood cells, TPr: total protein, TSeP: 
total serum protein  
HiD: histological data- LM: light microscopy (AU: the intestinal perimeter ratio; arbitrary units, EpH: the height of the epithelial layer of the villi, EpT: thickness of the epithelial 
layer, GoC: goblet cells, IEL’s: the number of intra epithelial leucocytes, NL: the number of leucocytes, MCN: Mucous cell number, MuL: mucosal fols lenght); TEM: transmission 
electrons microscopy (MiL: microvilli length, MiD: microvilli diameter); SEM: scanning electron microscopy (ASI: an absorptive surface area, ETAS: enterocyte total absorptive 
surface, EAA, enterocyte apical area, MCVT: microvilli count area) 
ID: immunological data- BA: bactericidal activity, CA: complement activity, CC: cortisol concentration, EnA: enzyme activity, IHC: immunohistochemistry, IPha: index 
phagocytic, LeT: leucocyte types (%), LeA: leucocyte activity, LC: lymphocyte content, LyA: lysozyme activity, LyC: lysozyme content; serum lysozyme, OR: oxygen radicals, 
PhaA: phagocytic activity, PO: plasma osmolality, PA: protease activity, SBA: serum bactericidal activity, Tig: total immunoglobulin, TLeC: total leucocyte count, WBC: while 
blood cells (leukocyte)  
GeE: gene expression- CEA: cytokine expression analysis, HSP70: heat shock protein gene, IL-1β: interleukin-1beta, TGe: transferrin gene, TGF- β: transforming growth factor 
beta, TNF-α: tumor necrosis factors  




The first objective was focused on in vitro trials. It begins by screening the GI bacteria of tilapia 
using conventional and molecular methods. These isolates were studied in vitro trials using multi-
parameter as adhesion assays, auto-aggregations, antibiotic resistances, blood hemolytic assays, bile 
salt tolerances, pH tolerances, and temperature exposures (Chapter 3). Then, potential probiotics 
were used the Z-score method to select probiotic candidates using these parameters. The main 
hypothesis of this study was highly effective of probiotic candidates, which found in high scoring 
isolates.  
Then, the investigation of probiotic selection was tested with the second objective to investigate in 
vivo trials both larval (Chapter 4) and juvenile tilapia (Chapter 5). These studies were monitored 
growth performances, probiotic monitoring in the GIT and intestinal histology (LM, SEM and 
TEM). Moreover, fish samples at the end of the trial were taken to induce extreme inductions, 
which were pathogenic and heat inductions. 
Finally, the whole studies were generally discussed and summarized (Chapter 6), which included in 


























Figure 1.6 Flowed research protocols to evaluate autochthonous probiotic candidates for tilapia 
aquaculture in this study. 
Bacterial identification 
is used 16S rDNA study  
 
Bacterial purification and morphological studies  
 To reject bacteria are 
not inhibited pathogen  
In vitro tests including antibiotic resistance, adhesion, cell surface 
hydrophobicity, auto-aggregation, blood hemolysis, bile salt 
tolerance, pH tolerance, and exposure on different temperatures 
Pathogenic inhibition testing 
Bacteria can inhibit pathogens 
Bacterial isolates form the GI tract of 
differently tilapia cultures 
Biochemical studies 
To accept potential probiotics have high plus score (+) 
In vivo trial of 
larval tilapia  
To reject all 
bacteria has minor 
score (−)  
Multi-parameter selection of potential probiotic 
using Z-score calculation  
Probiotic candidates are 
mixed in fish feed and 
reared for 6 weeks 
In vivo trial of 
juvenile tilapia  
Probiotic candidates are 
mixed in fish feed and 
reared for 10 weeks 
Pathogenic resistance Temperature induction 
Data analysis 






General materials and methods 
 
2.1 Introduction 
In the present study, the intestinal bacterial from the tilapia GIT was isolated to evaluate the 
potential probiotics both in vitro (Chapter 3) and in vivo trials (Chapter 4 & 5), which were 
conducted by using the protocols described in this chapter. Other unique methods to evaluate multi-
parameter of probiotic properties and selection are described in Chapter 3. Unless otherwise 
indicated, chemicals, reagents, and culture media were produced by Merck (Germany), Himedia 
(India), Sigma (USA), Qiagen (USA) and Bioline (USA). All experimental trials were conducted at 
King Mongkut's Institute of Technology Ladkrabang's (KMITL, Thailand) under Animals for 
Scientific Purposes Act and personal license U 1 - 07764 – 2561. 
 
2.2 Fish dissections 
In order to harvest tissue samples for analytical work fish were deprived of feed for 24 hours before 
dissections. Fish were euthanized with an overdose of tricaine methaesulphonate (MS-222, Sigma 
Aldrich Co, USA) to deep sedition and then the spinal cord was cut to minimize suffering. The 
intestine of these fish was removed under aseptic and cold conditions. The mid intestine was 
divided into three parts (Figure 2.1): part 1 for light microscopy (LM), part 2 for transmission 
electron microscopy (TEM) and scanning electron microscopy (SEM) (equally longitudinal section), 
and part 3 for probiotic monitoring or gene expression. The remaining GIT (part 4) was cut into 
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small pieces and crushed with a sterile pestle and mortar. This material was used to study microbial 




Figure 2.1 Regions of the intestinal tract of tilapia used in the experiments; part 1 for LM, part 2 for 
TEM and SEM, part 3 for probiotic monitoring or gene expression, and part 4 for microbial viable 
counts. 
 
2.3 Microbial studies 
2.3.1 Viable counts 
The GIT of individual tilapia (Figure 2.1: part 4) was weighed and homogenized to perform viable 
counts by using serial dilutions and plate methods. Sterile saline (0.8% NaCl) was used as the 
diluent. The homogenized intestinal tract was diluted with sterile 0.8% NaCl (10-1) and then put in a 
vortex mixer for 30 seconds. The homogenate was passed to sterile polyester filter (500µ) and the 
resulting solution was used to produce serial tenfold dilutions. Typically, 100 µL of 10-1, 10-3 to -4, 
10-3 to -4 and 10-7 to -8 of diluted homogenate was used to spread on duplicate plates of de Man, 
Rogosa and Sharpe agar (MRS; Merck, Germany), tryptic soy agar (TSA; Merck, Germany) and 
nutrient agar (NA; Himedia, India), respectively. All plates were closed with elastic paraffin and 








population in the GIT was determined by calculating the number of colony-forming units (cfu.g-1). 
Duplicate or triplicate sets were undertaken per individual fish. 
2.3.2 Bacterial purification and preservation 
A single colony from each plate (section 2.3.1) was selected to produce streak cultures on TSA 
plates, and then a single colony was selected to re-streak again. This process was repeated 5 times 
to ensure the bacterial purification and bacterial cells were than stained to confirm a similar Gram-
phenotype (Figure 2.2). Finally, a single bacterial stock was established by stabbing a colony into 















Figure 2.2 Protocol for bacterial isolation, purification and preserved stock.  
 
Streaked and re-streaked 5 
times to select a single colony 
Re-culture and study 














2.3.3 Bacterial study 
Typically, Enterobacter spp. were cultured on TSA plates and incubated overnight at 37oC, while 
strains of bacilli (Bacillus sp. CHP02, RP01, and RP00) were cultured on selected Bacillus agar 
(BM, Himedia, India) (Figure 2.5: A−C) and the positive control probiotic Pediococcus acidilactici 
MA18/5M (Bactocell, Lallemand SAS) was cultured on MRS plates. 
2.3.4 Sequence analysis of isolates  
2.3.4.1 DNA extraction 
Bacterial genomic DNA (section 2.3.3) was extracted by using the traditional phenol/chloroform 
extraction method (Nishiguchi et al., 2002). In brief, two loops of bacterial cells were collected and 
transferred into 600 μl of sterile TE buffer and then homogenised on a vortex mixer for 10 seconds. 
Samples were centrifuged at 13,709 g for 10 minutes. The supernatant was mixed in 1000 μl of 
chloroform: iso-methyl-alcohol solution (24:1). These were centrifuged at 13,709 g for 10 minutes 
and the supernatant was transferred into 1,000 μl of cold 95% ethanol and stored at −20oC for 24 
hours. Then, these tubes were mixed and taken to centrifuge at 13,709 g for 5 minutes. The DNA 
pellet was then washed three times with 70 % ethanol. Finally, a total volume of 50 μl of TE buffer 
(pH 7.5) was used to re-suspend bacterial genomic DNA. DNA quantity was determined with an 
automated µDrop plate spectrophotometer (Thermo Scientific) and DNA concentration was 
estimated with the Skanlt® software. DNA extracts were kept at −20oC until downstream 
processing. 
2.3.4.2 Polymerase chain reaction (PCR)  
Bacterial genomic DNA amplification was conducted by using the universal primers (27F: R’-
AGAGTTTGATCCTGGCTCAG-3’) and 1442R: (5’-GGTTACCTTGTTAGGACTT-3’). PCR tubes 
contained 12.5 μl of Genei Red Dye PCR Master mix (GeNei™, Merck), 2.5 μl of each primer (5 
pmol), 2 μl of bacterial genomic DNA (2.3.4.1), and 10.5 μl of sterile distilled water. The thermal 
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cycling program (Labnet, Multi Gene II) was automatically controlled with the initial denaturation 
at 94oC for 7 minutes, followed by 35 cycles at 94oC for 30 seconds, 50oC for 30 seconds, 72oC for 
one minute, and the final extension at 72oC for 5 minutes. The quality of PCR products in the 
agarose gel was observed under ultraviolet (UV) light and concentration of PCR products were 
assessed as described in section 2.3.4.1. 
2.3.4.3 16S rDNA sequence analysis  
The SpinPrepTM Gel DNA Kit (Novagen) was used to extract genomic DNA from the band of PCR 
product, according to the manufacturer’s instructions. 16S rDNA samples were sequencing by 
Macrogen Co. Ltd. (South Korea). Sequences were then submitted to a Basic Local Alignment 
Search Tool (BLAST; http://www.blast.ncbi.nlm.nih.gov) to identify bacterial species by using the 
similarity more than 99% to presumed taxonomic unit. 
2.3.5 Probiotic monitoring in the intestine of tilapia  
2.3.5.1 DNA extractions 
The intestinal tract of fish (Figure 2.1: part 3) was used to monitor probiotic populations in the GIT. 
A commercial DNA extraction Kit (QIAamp DNA Stool Mini Kit, Qiagen) and a commercial 
reagent (TRIsureTM, Bioline) were used for extracting bacterial genomic DNA. 
2.3.5.1.1 DNA extraction using DNA kit: 200 mg of the homogenized GIT was added in 1.4 mL of 
ASL buffer, and mixed using the vortex mixer. Samples were incubated at 70oC for 10 minutes. 
Then, these tubes were taken to centrifuge at 16,089 g for one minute before transferring the 
supernatant to a new tube. One Inhibit EX tablet was used to mix with this supernatant and then 
homogenized solution was centrifuged at 16, 089 g for 3 minutes. Later, 500 µL of supernatant was 
centrifuged again at 16,089 g for 3 minutes for removing 400 µL of supernatant to a new tube. 
Twenty µL of Proteinase K was added to the sample followed by 400 µL of AL buffer. These 
samples were incubated at 70oC for 15 minutes, and 400 µL of absolute ethanol was then added. 
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Next, 600 µL of sample was transferred into a collection tube to centrifuge at 13,709 g for a minute. 
The solvent was then discarded and the samples were washed twice with AW1 buffer and AW2 
buffer by ordering, which centrifuged at 16,809 g for 3 minute. Finally, DNA column was taken 
into a new tube and a volume of 50 µL of AE buffer was used to elute genomic bacteria. Bacterial 
DNA was kept at −20oC for the next study. 
2.3.5.1.2 DNA extraction using a commercial reagent: approximately 50-100 mg of the 
homogenized intestinal tract was used to mix with 1,000 µL of Trisure reagent (Bioline). Samples 
were incubated at room temperature for 5 minutes and 200 µL of chloroform was added to mix in 
this tube, which was incubated at room temperature for 3 minutes. Samples were centrifuged at 
16,809 g for 15 minutes (4oC) and supernatant was discarded. The volume of 300 mL cold absolute 
ethanol was used for tender mixing. Samples were incubated at room temperature for 3 minutes 
again. Then, samples were taken to centrifuge at 2,000 g at 4oC for 5 minutes and washed DNA 
pellets with 1,000 µL of 0.1 M Sodium citrate in 10% ethanol. These tubes were incubated at room 
temperature for 30 minutes followed by centrifugation at 2,000 g for 5 minutes (4oC). DNA pellets 
were washed with 1,500 µL of 75% ethanol and centrifuged at 2,000 g for 5 minutes (4oC). The 
supernatant was discarded to let DNA pellet dry. Finally, the DNA was re-suspended in 50 µL of 
TE buffer (pH 7.5). DNA quantity was determined with an automated µDrop plate 
spectrophotometer (Thermo Scientific) and DNA concentration was estimated with the Skanlt® 
software, and bacterial DNA was kept at −20oC for the next study. 
2.3.5.2 PCR  
PCR amplification was performed with specific probiotic primers in Table 2.1, which used Primer3 
and BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). These primers calculated the 
physical properties by using OligoCalc (http://biotools.nubic.northwestern.edu/OligoCalc.html) 




Bacillus spp. monitoring: the PCR mixture contained 12.5 μl of Go Taq ® Green Master buffer 
(Promega), 2.5 μl of 10 µM of Bacillus primers, 1 μl of DNA template and sterile distilled water 
was used to produce a final reaction volume of 25 μl. PCR amplification was carried out with an 
initial denaturation at 94 °C for 5 minutes followed by 35 cycles of denaturation at 94°C for 1 
minute, annealing at 62°C for 1 minute and extension at 72°C for 1 minute. The final extension was 
72°C for 5 minutes. Enterobactor sp. monitoring: sample reactions consisted of 2.5 μl of 10 µM of 
FP47F primer and 2.5 μl of 10µM of FP47R, 1 μl of DNA sample, 12.5 μl Go Taq ® Green Master 
buffer (Promega) and sterile distilled water was used to produce a final reaction volume of 25 μl. 
PCR amplification was carried out with an initial denaturation at 94 °C for 3 minutes followed by 
35 cycles at 94°C for 30 seconds, 65°C for 30 seconds, 72°C for 1 minute, and a final extension 
step of 72°C for 5 minutes. P. acidilactici monitoring: sample reactions consisted of 12.5 μl of 
GoTaq® Green Master Mix, 2.5 µl of 10 µM of each primer (PaceF and PaceR), 1 μl of DNA 
template and sterile distilled water was used to produce a final reaction volume of 25 μl. PCR 
amplification was carried out with an initial denaturation at 94 °C for 5 minutes followed by 35 
cycles at 94°C for 30 seconds, 61°C for 30 seconds, 72°C for 30 seconds and a final extension step 
of 72°C for 5 minutes. 
2.3.5.3 Agarose gel electrophoresis 
Agarose gels containing RedSafe DNA Stain (0.005 %) were used throughout the study at 
concentrations of 1.5% (w/v). A total volume of 5 μl PCR products of (section 2.3.5.2) containing 3 
μl of 20x ultra power safe dye were run on through the agarose gels for 25 min at 100 V. Gels were 
photographed under UV light and recorded using a gel documentation system (Gene Flash). Finally, 
the gel document was interpreted to compare with standard DNA (5 μl of 1 kb DNA ladder 





Table 2.1 Nucleotide sequences of probiotc primers used for monitoring probiotic levels in the GI 
tilapia 
Primers Bacteria Primer sequences (5’-3’) Size 
(Mers) 




TTT TTG GTC TGT AAC 
TGA CGC TGA GGC 
27 62 631 
FP45R ATC CGC GAT TAC TAG 




AGC CGC GGT AAT ACG 
GAG GGG T 
22 65 554 
FP47R GTC TCA GAG TTC CCG 
AAG GCA CCA ATC 
27 64.8 
PaceF Probiotic P. 
acidilactici 
TTT TAA CAC GAA GTG 
AGT GGC GGA CG 
26 59.5 795 
PaceR GCG GAT TAC TTA ATG 
CGT TAG CTG CAG C 
28 63 
 
2.4 Probiotics and fish feed trials 
2.4.1 Probiotic preparation 
Selected isolates (section 2.3.3) were cultured in TSB overnight at 37 0C and then bacterial cultures 
were centrifuged at 2800 g for 15 min. Bacterial cell pellets were washed twice with sterile 0.85% 
NaCl and fresh probiotics were adjusted to make stock concentration at 10x in sterile 0.85% NaCl 
by using the optical density at 600 nm. These probiotic solutions were kept at 4oC for mixing in 
basal fish feeds to produce experimental diets for use in chapters 4 and 5. A commercial probiotic 
Pediococcus acidilactici MA18/5M (Bactocell, Lallemand SAS) was cultured in MRS. The final 
concentration of a commercial probiotic was adjusted to produce a 10x stock solution in sterile 





2.4.2 Fish feed and preparation of probiotic feeding  
Three commercial feeds were used as the basal diets (Figure 2.3 & Table 2.3) for the in vivo feeding 
trials in Chapters 4 and 5. The first feed was in a fine form with sizing less than 1 mm (CP 9000 
diet from CP Co., Ltd., Thailand; containing 40% of crude protein, 6% of total fat and 3% of ash) 
and was used in the first half (day 0 to end of third week) of the larval trial in Chapter 4. The second 
feed was in a crushed form with sizing between 1.0 to 1.5 mm (CP 9001 diet from CP Co., Ltd., 
Thailand; containing 38% of crude protein, 5% of total fat, and 3% of ash), and was used in the 
second half (End of week 3 until the end of week 6) of the larval trial in Chapter 4). The third feed 
was in a pellet form with sizing 4.0 mm of diameter (Prema diet from Premafeed Co., Ltd., 
Thailand: 30% of crude protein, 3% of total fat, 6% of crude fiber, 12% of ash, 37 of % NFE and 
3,350 Kcal/kg); this feed was used in in vivo juvenile trial (Chapter 5). 
 
 
Figure 2.3 Different forms of commercial feeds, A: fine form used in the initial larval rearing 
(Chapter 4), B: crushed form used at 3 weeks to the end of the larval trial (Chapter 4), and C: pellet 
form used in juvenile trial (Chapter 5). 
A                                                                      B                                                                      C 
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All three basal feeds were used to produce six treatment diets are described in Table 2.2. These 
diets were prepared by using 200 mL of probiotic stock (section 2.4.1) to mix with 1000 g of basal 
feed, which was then dried at 40−45 0C for 6−10 hours. The control group (T6) was produced by 
adding 200 mL of sterile 0.85% NaCl with 1000 g of the basal diet. During feed incubations, the 
weight before and after incubations was accepted 0.1% of different weight. Fresh diets were 
prepared on a weekly basis. 





of in vivo trials 
A commercial feed + Bacillus sp. CHP02 6−7×106 T1 
A commercial feed + B. aryabhattai RP01 2−4×106 T2 
A commercial feed + B. megaterium RP00 1−2×106 T3 
A commercial feed + Enterobacter sp. NP02 5−8×107 T4 
A commercial feed + P. acidilactici 9−107 T5 
A commercial feed  − T6 
 
The nutritional compositions as dry matter was estimated by using temperature at 85°C for constant 
drying, crude protein with a micro-Kjeldahl apparatus, crude lipid with Soxhlet extraction, and ash 
with a muffle furnace of the experimental diets were estimated using proximate analysis according 
to AOAC (1997). Different fish feeds after adding probiotics were found the moisture content 
ranging from 6.5 to 7.5 of the first feed, 6.7 to 6.9 of the second feed and 7.7 to 8.7 of the third feed. 




Table 2.3 Percentage of nutritional compositions of experimental groups after adding different 
probiotics for in vivo trials. 
Groups 
The first feed The second feed The third feed 
Crude 
protein  
Lipid Ash Crude 
protein  
Lipid Ash Crude 
protein  
Lipid Ash 
T1 42.6±0.32 4.9±0.19 12.5±0.04 41.2±0.21 5.0±0.25 12.8±0.19 41.2±0.21 5.0±0.25 12.8±0.19 
T2 42.7±0.07 5.0±0.00 12.5±0.11 41.1±0.85 5.0±0.27 12.8±0.11 41.1±0.85 5.0±0.27 12.8±0.11 
T3 42.1±0.76 4.9±0.09 12.5±0.14 41.5±0.23 5.0±0.46 12.9±0.11 41.5±0.23 5.0±0.46 12.9±0.11 
T4 42.0±0.16 4.9±0.60 12.5±0.12 41.7±0.17 5.1±0.32 12.8±0.00 41.7±0.17 5.1±0.32 12.8±0.00 
T5 42.3±0.24 5.1±0.02 12.5±0.07 41.3±0.12 4.8±0.11 12.7±0.02 41.3±0.12 4.8±0.11 12.7±0.02 
T6 42.6±0.37 5.1±0.23 12.5±0.17 41.4±0.18 4.8±0.07 12.8±0.19 41.4±0.18 4.8±0.07 12.8±0.19 
 
2.5 Growth parameters 
The weight and total length of tilapia in the growth trials were monitored weekly after a feed 
deprivation period of 24 hours.  
Larval fish (Chapter 4) were randomized into a small container with having paper tissue moister 
and a standard scale. Then, fish samples were recorded total weight and total length. At the end 
(week 6) of the larval trial (Chapter 4), fish were individually weighed and measured. Fish samples 
in Chapter 5 were individually recorded by using microchip identification. The microchip (8 mm 
long × 1 mm diameter, low−frequency around 134.2 kHz which refer to ISO11784/11785 animal 
ID transponder FDX−B) was injected into the ventral cavity of juvenile tilapia (3-4 g of weight) for 
individual recording. These fish were acclimated for three weeks to allow the epidermis to heal post 
injection before undertaking the feeding trial (Meeanan et al., 2009). Experimental fish was 
automatically recorded the total weight and total length of individual fish by using Retina System, 




Figure 2.4 The automatic recording system (Matcha IT, Thailand) was used to monitor individual 
tilapia growth 
 
2.5.1 Parameter estimations 
Data recording was used to calculate the following: average wet weight (g), average total length 
gain (TLG, %), average of increasing weight (IW: g.week-1), average weight gain (WG, %), 
average total length (TL: cm), specific growth rate (SGR, %.day-1), average daily growth (ADG, 
g.day-1), Fulton’s condition factor (K), feed conversion ratio (FCR) and the relative intestinal length 




𝑇𝐿𝐺 (%) = 100 ×
(𝑇𝐿𝑇−𝑇𝐿𝑇0)
𝑇𝐿𝑇0
       …(1) 
𝐼𝑊 (%) = 𝑇𝑜𝑡𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡𝑤𝑒𝑒𝑘𝑛 − 𝑇𝑜𝑡𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡𝑤𝑒𝑒𝑘𝑛−1 …(2)            
𝑊𝐺 (%) = 100 ×
(𝑊𝑇−𝑊𝑇0)
𝑊𝑇0
       …(3) 




𝑆𝐺𝑅 (%, 𝑝𝑒𝑟 𝑑𝑎𝑦) = 100 × [
𝐿𝑛𝑊𝑇−𝐿𝑛𝑊𝑇0
𝑇
]      …(4) 
 𝐴𝐷𝐺 = [
𝑊𝑇−𝑊𝑇0
𝑇





       …(6) 
𝐹𝐶𝑅 =
(𝑇𝑜𝑡𝑎𝑙 𝑓𝑒𝑒𝑑 𝑖𝑛𝑡𝑎𝑘𝑒𝑇 –𝑇𝑜𝑡𝑎𝑙 𝑓𝑒𝑒𝑑 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑇)
(𝑊𝑇+𝑇𝑜𝑡𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑑𝑒𝑎𝑑 𝑓𝑖𝑠ℎ𝑇−𝑊𝑡𝑇0)
     …(7) 
𝑅𝐼𝐿 =
(𝑡𝑜𝑡𝑎𝑙 𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑡ℎ𝑒 𝐺𝐼𝑇)
(𝑇𝐿)
       …(8) 
Where 𝑊 = wet weight (g), 𝑇𝐿 = total length (cm), 𝑇0 = the initial time of the trial, 𝑇 =duration of 
feeding (days). 
2.5.2 Survival rate 
The percentage of survival rate (SR, %) was reported after finishing trial. The survival rate was 
defined as the ratio of the total number of fish at the initial to the total number of fish at the end of 
the trial as follows:  
𝑆𝑅 (%) = 100 ×
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑖𝑛𝑎𝑙 𝑓𝑖𝑠ℎ
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑓𝑖𝑠ℎ
     …(8) 
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2.5.3 Histological studies of the intestinal tract 
2.5.3.1 Light microscopy (LM) 
Small samples (Chapter 4) of the GIT (Figure 2.1: part 1) were placed between sponges within 
cassettes while large samples (Chapter 5) were placed in a cassette without a sponge (Mumford 
2004). These samples were preserved in 10% buffered formalin. Sample cassettes were placed into 
the tissue processor (Leica, TR 1020). The program was set to immerse in each container of 
different percentages of graded alcohol (50, 70, 80 and 95%), three containers of absolute alcohol, 
and two containers of melted paraffin; this program emerged the samples in each container for 1 
hour. Samples in paraffin blocks were prepared, trimmed and then cut with a semi-automatic 
microtome (Microm, Germany) to produce 5 μm sections transverse cross sections of the intestine. 
Sections were stained with hematoxylin and eosin (H&E) regarding following Mumford (2004). 
Stained slides were mounted on a permanent medium under a glass coverslip.  
Triplicate samples of each replicate in treatment were recorded intestinal photographs to count the 
goblet cell density (cell/0.1mm2) by using the NIS-Elements D 3.2 Ink software in a PC computer, 
which has the Nikon’s digital sight DS-U3 interfacing the camera in a compound light microscope 
(20-40X: Olympus BX51). 
2.5.3.2 Transmission electron microscopy (TEM) 
Samples (Figure 2.1: part 2) were processed according to Schneider (2014) with some 
modifications. Samples were cleaned with phosphate-buffered saline (PBS; pH 7.3) twice before 
maintaining in 2.5% glutaraldehyde at 4oC. Samples were cleaned in cold 0.1 M Na-cacodylate 
buffer (pH 7.2) three times. Then, samples were fixed in 1% osmium tetroxide (OsO4) in darkness 
for 1 hour, and removed to clean in Na-cacodylate buffer (pH 7.2). These samples were dehydrated 
with different percentages of ethanol series following as follows: 30% (30 minutes), 50% (30 
minutes), 70% (30 minutes), 80% (30 minutes), 90% (30 minutes), 95% (30 minutes), and absolute 
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ethanol (3 times: 30 minutes each). Samples were then processed with infiltration of different 
concentrations of resin (LR white resin, Sigma) as follows: 30% resin (24 hours), 50% resin (5 
hours), 70% resin (5 hours), and 100% resin (24 hours). Finally, accelerator (1% v/v) was used to 
mix in absolute resin, and 580 μl of this solution was pipetted into beem capsules and the samples 
were then placed in the beem capsule. Capsules were placed at room temperature for resin 
polymerization. Samples were trimmed and cut into semi-thin sections using a diamond knife 
(DiATOME). Samples (0.5 um) were picked up into drop water on the glass slide and dried on the 
hot plate (90oC) to stain with methylene blue, and then initially screened by a light microscope. The 
position on block was marked for cutting. The ultrathin section of selected block (≈90 nm) was 
placed on copper grids, and stained with saturated uranyl for 30 minutes. These were rinsed with 
distilled water and stained with Reynolds lead citrate (Lewis and Knight, 1977) for 30 minutes. 
Finally, samples were recorded by using a TEM (Phillips: Techni20, Holland) for using 
measurement of microvilli lengths (hmi) and microvilli widths (wmi) of these micrographs (Figure 
2.5).   
 
 











2.5.3.3 Scanning electron microscopy (SEM) 
Samples were prepared according to Schneider (2014) with some modifications. The pieces of the 
GIT (Figure 2.1: part 2) were cleaned with phosphate-buffered saline (PBS; pH 7.3) for twice and 
then these samples were washed in 1% S-carboxymethyl-L-cysteine for a minute to dissolve mucus 
before transferring to 2.5% glutaraldehyde. Samples were cleaned and dehydrated with different 
percentages of ethanol series following as follows: 30% (30 minutes), 50% (30 minutes), 70% (30 
minutes), 80% (30 minutes), 90% (30 minutes), 95% (30 minutes), and absolute ethanol (3 times: 
30 minutes each). Samples were then critically point dried (SPA 400). Dried samples were 
transferred onto aluminum stubs for coating gold (Cressington Sputter Coater, 108 auto). Samples 
were then screened (Carl Zeiss: EVO® HD SEM, USA) to record micrographs of microbial 
colonization of the intestine.  
 
2.6 Statistical analysis 
Data analysis began by testing normal distribution and then calculating depended on the 
experimental design. The findings were displayed in terms of mean ± standard deviation. A 
significant difference between groups was accepted for P < 0.05. Some parameter’s data were 
transformed to calculate analysis of variance (ANOVA). These data were analyzed using the Systat 





In vitro assays for selecting the potential probiotics  
3.1 Abstract 
Thirty-four microbial colonies were isolated from the intestine of tilapia (n=19), which cultured 
from differed sources. Fifteen isolates displayed inhibition of pathoginic bacteria (A. hydrophila 
or/and S. iniae). These bacteria were identified as B. cereus CHP00, B. cereus NP00, B. cereus 
NP01, Bacillus sp. RP00, Mac. caseolyticus CHP03, Stap. arlettae CHP04, Stap. sciuri NP04, 
Bacillus sp. RP01, Bacillus sp. CHP01, Bacillus sp. CHP02, Bacillus sp. RC00, Bacillus sp. RC01, 
Bacillus sp. RC02, Enterbactor sp. NP03, and Enterbactor sp. NP02. These bacteria were then 
carried out to evaluate potential probiotic in vitro trials by using multi-parameter: antagonistic 
activity, cell-adhesive potentials, hemolytic activities, antibiotic resistance, pH and bile salt 
tolerances and specific growth rates. The results of cell-adhesive potentials and specific growth 
rates between isolates were shown different significances  (P≤0.05). Seven of fifteen isolates 
(Bacillus sp. RP00, Bacillus sp. RP01, Bacillus sp. RC00, Bacillus sp. RC01, Bacillus sp. CHP02, 
Mac. caseolyticus CHP03 and Stap. sciuri NP04) were shown acceptable to twelve antibiotics 
tested, and five isolates: B. cereus CHP00, NP00, and NP01 and Bacillus spp. CHP01 and RC02 
were positive effect on haemolytic activities. All isolates were resistant to 6% bile salts condition 
and all Bacillus strains were able to tolerate pH 2. The findings were then combined and sigma 
scores (Z−score) were used for ranking the most promising isolates. The top three ranking 
candidates after using the Z−score for calculation were found to be Bacillus sp. CHP02 (Z=1.14), 
Bacillus sp. RP01 (Z=1.09) and Bacillus sp. RP00 (Z=0.94). These probiotic candidates were then 





Probiotic properties have been reported using many parameters in in vitro trials, such as safe use 
(antibiotic resistance and hemolysis activity), probiotic characterizations as a resist to gastric acidity 
and bile acid, adherence, and pathogenic antagonism (Ringø and Gatesoupe, 1998; Gatesoupe, 
1999; Gomez-Gil et al., 2000; Gaggìa et al., 2010; Merrifield et al., 2010; and Chemlal-Kherraz et 
al., 2012), which assessed to select potential probiotics as the classical method in in vitro trials.  
Different techniques, parameters and bacterial isolates have been carried out to select potential 
probiotics  (Aly et al., 2008; El-Rhman et al., 2009; Chantharasophon et al., 2011; Chemlal-
Kherraz et al., 2012; Gobinath and Ramanibai, 2012; Del'Duca, 2013; Muñoz-Atienza et al., 2013). 
These have produced many findings including pathogen inhibition, blood hemolysis, susceptibility 
to antibiotics, ability to produce lactic acid and pH, bile salt tolerances, mucin degradation and 
enzymatic activities, which used to support the selection of potential isolates. A key question is how 
to combine different parameters by using a systematic calculation to elucidate high potential 
qualities of selected probiotics. In this study, the protocol to select high potential of probiotic 
candidates was improved by using the standard normal distribution (Z−score) as a classical method 
(Best and Kahn, 1998; Gordon, 2006). This method combined the results of multi-parameter by 
calculating standard deviations of each parameter from their means. These results were ranked by 
isolate-scores, which assumed high scoring isolates as highly effective of probiotic candidates. 
The objectives of this study were to isolate, characterize and identify the autochthonous bacteria 
from the intestinal of tilapia, determine their potentials of probiotic properties (multi-parameter) 
such as adherence with the intestinal epithelial cells of tilapia, adhesion to hydrocarbons, auto-
aggregation, antibiotic resistance, blood hemolysis, bile salt and acid tolerances, and temperature 
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exposures in in vitro trials. Finally the Z−score was proposed to select probiotic candidates as 
combined selection. 
 
3.3 Materials and Methods 
3.3.1 Bacterial isolation 
3.3.1.1 Tilapia samples  
Tilapia were located from different sources such as closed system (Nile tilapia KMITL strain: group 
1 and Nile tilapia Chitralada strain: group 2), an earthen pond (Nile tilapia: group 3 and red tilapia: 
group 4), and a cage culture (red tilapia: group 5). They were acclimatized in the closed 
recirculating system for four weeks. This system has 760 l of capacity and filled with freshwater to 
constant level. The flow rate was adjusted to 10 l.min-1. During the acclimation period, water 
qualities in the system were 2.3−3.4 mg.l-1 (DO), 27−29oC (water temperature), and 7.56−8.24 
(pH). These fish were fed once daily with a commercial fish feed (Inteqc Feed, no.461).  
3.3.1.2 Bacterial isolation and purification 
Fish samples were starved for two days and then individually killed as detailed in section 2.2. These 
fish (n=19) ranged from 4 to 288 g in weight, 7 to 26 cm of total length, 5 to 21 cm of body length, 
34 to 172 cm of intestinal length, and 0.17 to 5.65 g of the intestinal weight, which used the GIT to 
isolate bacteria. The viable counts were studied as described in section 2.3.1 by using pour plates. 
Finally, photographs of agar plates were recorded and calculated cfu of each plate by using manual 
calculation of ImageJ 1.48 software. 
A single colony was screened from each plate and then purified to preserve for next study as 
followed in section 2.3.3. In addition, bacterial Gram-stain phenotypes of isolates were recorded 
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photographs by using the NIS-Elements D 3.2 Ink software in a PC computer, which has the 
Nikon’s digital sight DS-U3 interfacing the camera in a compound light microscope (20-40X: 
Olympus BX51). 
3.3.2 Pathogenic bacterial inhibition 
3.3.2.1 Bacterial pathogenic preparations 
In this study, bacterial pathogens A. hydrophila and S. iniae were supplied by the Inland Aquatic 
Animal Health Research Institute (AAHRI), Thailand. Bacterial virulence was activated for two 
times by injecting 100−300 μl (107 cells.ml-1) of fresh cells into the dorsal muscle of healthy Nile 
tilapia (weight 20 to 30 g). Samples were reared in glass containers with aeration to observe 
pathogenic infections for three days. The pathogenic symptoms include skin lesions for A. 
hydrophila and erratic swimming behavior for S. iniae. A sterile loop was used to scrape skin 
lesions of diseased fish caused from A. hydrophila to streak on TSA plates, and liquid behind the 
eye of S. iniae diseased fish was used to streak on TSA plates. All plates were incubated at 32oC for 
24 hours and then the process was repeated to activate again. Prior to upscaling to prepare 
inoculating solutions, a single colony of the pathogenic bacterium was confirmed species 
identification by using Gram-stain and API20 kit (Biomérieux).  
3.3.2.2 Antagonistic screening 
The antagonistic protocol was performed according to Vine et al. (2004) with some modifications. 
In brief, fresh bacterial pathogens (section 3.3.2.1) were spread on TSA plates and incubated at 
32oC for 2 hours and bacterial isolates (prepared as 2.3.3) were then spotted in these agar plates. 




3.3.3 Phenotypic characterizations  
Bacterial isolates displaying inhibition to pathogenic bacteria (section 3.3.2.2) were studied 
phenotypic traits such as carbohydrate fermentation, triple sugar iron, methyl red, Voges-Proskauer, 
citrate utilization, oxidation-fermentation, oxidase, catalase, decarboxylase, indole, motility, granule 
staining, endospore and capsule forming (Prescott, 2002; Collins et al., 2004).  
3.3.4 16S rDNA identification 
Bacterial isolates were cultured as 2.3.3, and bacterial DNA were extracted following 2.3.4.1. These 
genomic extractions were amplified by using universal primers (section 2.3.4.2). PCR products 
were studied by using agarose gel electrophoresis (section 2.3.4.3). Finally, DNA sequencing of 
bacterial isolates were submitted to presume species identification with reference in GenBank 
(section 2.3.4.4) by using the similarity more than 99% to presumed taxonomic unit. 
3.3.5 In vitro trials 
3.3.5.1 Adherence assay to the tilapia intestinal cells 
Tilapia intestinal cells were collected according to Balcázar et al., (2007) and Grześkowiak et al., 
(2012). In brief, five healthy tilapia were sacrificed with an overdose (MS222) for removing the 
intestinal tract under aseptic conditions. The sterile loop was used to scrape the epithelial cells of 
the mid-gut intestine and transferred into a sterile plate with containing PBS (pH 7.5) and then, the 
epithelial cell solution was filtered through an autoclaved filter (500m). Cell samples were 
centrifuged at 16,089 g for 10 minutes and twice washed using PBS (pH 7.5). Finally, the cell 
density was adjusted to approximate 0.02 of the optical density (OD600).  
The initial study, 5 ml of each bacterial preparation (9×108 cells.ml-1) was mixed with 5 ml of the 
epithelial cell solution. The total volume of 1.2 ml of this suspension was transferred into the 
Eppendorf tube with totally 8 tubes and allowed adhesion at room temperature (25oC). Duplicate 
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tubes of the samples at the incubation times in 0, 2, 4, and 6 hours were recorded the absorbance 
(OD600). A dye exclusion test (the trypan blue) was used to monitor bacterial adhesion to epithelial 
cells (Longo-Sorbello et al., 2006).  
3.3.5.2 Adhesion to hydrocarbon solvents 
Bacterial adhesion to hydrocarbon solvents was examined according to Rosenberg and Rosenberg, 
(1985), Kos et al., (2003), Collado et al., (2008) and Grześkowiak et al., (2012) with some 
modifications. Bacterial cells in PBS (pH=7.5) were adjusted to approximately 1 (OD600). A volume 
of 1.5 ml of cell suspension was transferred to gently mix with 1.5 ml of chloroform for 30 seconds 
and incubated at room temperature (25oC). The initial exposure (A0) of the samples in duplicates 
was recorded the absorbance (OD600). After incubation for 30 minutes, the aqueous phase in the 
upper solution of duplicates of each isolate was transferred to measure the absorbance (A1: OD600). 
In order to determine adhesion in hexane was performed as the same chloroform, however the 
aqueous phase at the bottom tube was used to measure the absorbance (OD600).  
3.3.5.3 Auto-aggregation assays  
Auto-aggregation assays in both PBS and sterile 0.85% NaCl were performed according to Collado 
et al., (2008) and Grześkowiak et al., (2012), with some modifications. At the initial assay, stock 
cell concentrations in PBS (pH 7.5) of bacterial testing were adjusted to approximately 1 at OD600. 
A volume of 100L cell suspension of each isolate was transferred into the Eppendorf tubes in the 
duplicates and allowed to adhere for 0, 2, 4, and 6 hours. After incubation in these times, a total 
volume of 900 μl PBS (pH 7.5) was used to mix with each tube and then recorded the absorbance 
(OD600). Auto-aggregation assay using sterile 0.85% NaCl, approximately 1 at OD600 of bacterial 




3.3.5.4 Antibiotic susceptibility test  
Antibiotic susceptibility test using the disk diffusion method was evaluated according to Bauer et 
al. (1966) with some modifications. In brief, a volume of 100 μl (9×108 cells.ml-1) of fresh 
bacterial preparations were spread on TSA plates and dried in the laminar flow cabinet for 45-60 
minutes. Twelve commercial antibiotic discs (Oxiod, UK) having ampicillin 10 μg (AMP 10), 
cephalothin 30 μg (KF 30), enrofloxacin 5 μg (ENR 5), erythromycin 15 μg (E 15), gentamycin 10 
μg (CN 10), kanamycline 30 μg (K 30), neomycin 30 μg (N 30), nitrofurantoin 300 μg (F 300), 
oxolinic acid 2 μg (QA 2), oxytetracycline 30 μg (OT 30), sulphamethoxazole/thrimethoprim 25 μg 
(SXT 25), and tetracycline 30 μg (TE 30) were added to the plate in the duplicate discs. These 
plates were incubated at 32o C for 24 hours. The apparent of clear zone around antibiotic discs was 
measured a diameter (mm) and interpreted to susceptible (S), intermediate (I), or resistant (R). 
3.3.5.5 Hemolytic activities 
Sheep blood (MDX1407077) and tilapia blood were used to determine hemolytic activities of 
samples according to Apún-Molina et al., (2009) and Nayak and Mukherjee (2011) with some 
modifications. A 1 ml syringe containing heparin was used to take blood samples form ten healthy 
tilapia (averaged 400 g) and then mixed with autoclaved blood agar (5%v/v in Brain heart infusion 
agar; HIMEDIA, India). These blood agar plates were sterilized with UV in the laminar flow 
cabinet for 45-60 minutes. Four wells having 0.6 cm diameter were made in these agar plates, and 
then 20 l of fresh bacterial preparation (9×108 cells.ml-1) was transferred into duplicate wells. 
These plates were incubated overnight at 32oC under aerobic conditions. Hemolytic activities were 
observed by using apparent clear zone around wells and these diameters were recorded. Moreover, 
visualizations of blood hemolysis were recorded possible as non-hemolysis (γ hemolysis), partial 
hemolysis with greenish surrounding well (α hemolysis) and complete hemolysis with clear zone (β 
hemolysis) (FDA’s BAM, 2001; Sánchez-Ortiz et al., 2015).  
 
 95 
3.3.5.6 Bile salt tolerance  
Bile salt tolerance was determined by visual observation of bacterial growth to culture on agar 
plates. TSA plates containing different concentrations of bacteriological bile salt (HIMEDIA) at 2, 
4, 6, 8, 10, and 12% (w/v) were prepared. A loop of an overnight bacterial isolate was used to 
spread on duplicate plates of each concentration and duplicate plates without bile salt as the control. 
Plates were incubated at 32oC for 96 hours and then observed bacterial growth as visible growth or 
no-growth. 
3.3.5.7 Acid tolerance 
Acid tolerance was recorded by visual observation of bacterial culture on agar plates after 
incubating bacterial isolates in PBS adjusting the pH at 2 and 4 for 24 hours. In brief, an overnight 
loop of bacterial isolate was transferred in 1 ml of PBS solutions at pH 2 or 4. These tubes were 
incubated overnight at room temperature (25oC) and a volume of 100 L of these samples was used 
to spread on TSA plates. These plates were incubated at 32oC for 96 hours to observe bacterial 
growth as visible growth or no-growth. 
3.3.5.8 Specific growth rate assay 
Specific growth rate (𝜇) of isolates was determined according to Lindqvist and Barmark (2014). In 
brief, a volume of 100 l (9×108 cells.ml-1) of approximated cell density) of fresh bacterial 
preparation was used to mix with 900 l of PBS (pH7.5) in the duplicates. These samples were 
incubated at 15, 32, and 42oC for 24 hours, which represented optimize and extreme conditions as 
low and high for tilapia culture in Thailand. The optical density (OD600) at the beginning, 8 and 24 





3.3.5.9 The protocol to select probiotic candidates  
Multi-parameter studies were categorized into three groups consisting of general parameters, safety 
parameters and survival parameters. General parameters included pathogenic antagonism and 
adhesion assays, which had several articles distributing these properties to select probiotics (Gullian 
et al., 2004; Hjelm et al., 2004; Aly et al., 2008; El-Rhman et al., 2009; Das et al., 3013; Del’Duca 
et al., 2013; Abdulla et al., 2014; Geraylou et al., 2014; Widanarni et al., 2015; Etyemez and 
Balcazar, 2016). The potential of probiotics without antibiotic resistance is a strong 
recommendation (FAO/WTO, 2006; WTO, 2014) referring to microbial pathogens to contain 
resistance genes may transfer these genes to human pathogens whose cannot treat disease infection 
using antibiotics. According to hemolytic activity is very important of probiotic properties, which 
display non-hemolytic to the blood host. Then, both antibiotic resistance and hemolytic parameters 
are indicated the safety use. Growth and survival parameters as probiotic qualities to survive in the 
GI environment have been suggested to select probiotics (Vine et al., 2004; Mourad and Nour-
Eddine, 2006; Balcázar et al., 2008; Geraylou et al., 2014). Therefore, parameters and sub-
parameters were determined to get different scores. Finally, the coefficient index was then 
calculated by using these scores (Table 3.1). The score of isolates was calculated by using results in 
vitro assays, which had assumptions following:  
(I) A total score of 100 was given isolates inhibiting two pathogens and 50 for inhibiting only one 
pathogen.  
(II) A score of 100 was given isolates displaying the highest average percentages of adhesion/ auto-
aggregation/ hydrophobicity/ specific growth rate, and then the rest scores were calculated the norm 
with the highest value.  
(III) A score of −100 was allocated to isolates showing the highest numbers of R to antibiotics 
tested (12 antibiotic discs), −50 for I and 100 for S and then another rest was scored by normalizing 
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with the highest value; finally, each isolate was allocated a score by summarizing these scores of R, 
I and S. 
(IV) A score of −100 was given to isolates displaying blood hemolysis and 100 without hemolysis.  
(V) A total score of 100 was given to isolates tolerating to bile salts at 12% and 50 for tolerating to 
bile salts at 6%.  
(VI) A score of 100 was given to isolates tolerating to pH 2 and 0 displaying non-tolerance. 
The score of bacterial isolates was calculated using the following equations:  
𝑇𝑖 = 𝑐𝑖1𝑆1𝑖 + 𝑐𝑖2𝑆2𝑖 + 𝑐𝑖3𝑆3𝑖 + ⋯ 𝑐𝑖𝑛𝑆𝑛𝑖    
Where: T is the total score of each isolate, 𝑐𝑖 is the coefficient index, and 𝑆 is the isolated score of 
each parameter in vitro trials. 







                                                                






Table 3.1 Summary of determination scores to calculate the coefficient index 
Parameter (P) Parameter 
Score (PS) 










30 Pathogenic resistance 10 3 0.03 
 Adhesion to the tilapia 
intestinal cells  
50 15 0.15 
 Adhesion to 
hydrocarbon solvents  
20 6 0.06 





50 25 0.25 
 Hemolytic testing 50 25 0.25 
Survival 
parameters 
20 Bile salt tolerance  20 4 0.04 
 Acid tolerance  50 10 0.10 





3.3.6 Data analysis 
Percentages of adhesion to the intestinal epithelial cells, hydrocarbon solvents, auto-aggregations, 





Where, 𝐴𝑡 represents the absorbance at time t and Ao is the absorbance at the initial absorbance.  
Specific growth rate (𝜇) of isolates was measured by using the following equation: 
𝜇 = (
ln 𝑂𝐷𝑛 − ln 𝑂𝐷0
𝑡𝑛 − 𝑡0
) 
Where, 𝑂𝐷𝑛 represents the absorbance at time tn and 𝑂𝐷0is the absorbance at the initial absorbance.  
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All percentages of parameter studies are transformed to normal distribution. The calculation of 
these data was performed to check for significant differences within isolates by using one-way 
analysis of variance (ANOVA). Statistical significance was accepted at P ≤ 0.05, which was then 
followed with pairwise comparison probabilities for comparing different isolates. These data were 
analyzed by using the Systat software ver. 5.02 (Illinois, USA). 
 
3.4 Results 
3.4.1 The total colony counts (TCC) and microbial isolation 
The TCC (cfu.g-1) in the GI tract of tilapia culturing in MRS-agar, TSA, and NA plates were in 
ranges of 1.0−4.0×102, 5.4×106−2.7×107, and 3.2×108−1.3×109, respectively. Microbial loads in the 
same medium were found non-significant difference (P>0.05) between different groups of tilapia 
(Table 3.2).  
 
Table 3.2 Bacterial loads (mean ± standard deviation: (n) in the tilapia intestine from different 
sources based on colony forming unit (cfu.ml-1).  
Sources of tilapia (N) MRS-agar TSA NA 
Group 1: (5) 4.7×103±2.8×103  1.28×107±5.2×106  6.2×108±3.0×108  
Group 2: (4) 4.8×102±1.5×102  2.6×107±3.5×107  1.2×109±1.3×109  
Group 3: (4) 2.0×103±1.1×103 8.9×106±5.8×106  8.5×108±1.6×108  
Group 4: (4) 4.0×103±2.6×103  1.17×107±2.3×106  9.4×108±3.1×108  




A total of 265 microbial colonies (41 from MRS-agar, 124 from TSA and 100 from NA plates) 
were isolated. These colonies were sub-cultured, streaked, and re-streaked on TSA plates for 
purification. Only bacterial isolates were classified into simple groups by using morphological 
colony and Gram-stain characterizations. Finally, we found thirty-four isolates having different 
characterizations, and these isolates displayed to be colonial consistency.  
3.4.2 Antagonistic screening 
Eight of fifteen isolates were able to inhibit both bacterial pathogens A. hydrophila and S. iniae. 
Fourteen isolates were able to inhibit A. hydrophila, and nine isolates were against S. iniae (Table 
3.3). Finally, fifteen isolates with inhibitory activities were accepted as potential probiotic 
candidates, and subjected to furthure testing. 
 
Table 3.3 In vitro tests of the intestinal bacterial isolates showed inhibition against pathogenic 
bacteria A. hydrophila and S. iniae. 
Isolate no. 
Pathogenic bacteria 
A. hydrophila S. iniae 
1 − + 
2 + + 
3 + + 
4 + + 
5 + − 
6 + + 
7 + + 
8 + + 
9 + − 
10 + − 
11 + − 
12 + + 
13 + − 
14 + − 
15 + − 
+ = inhibition  , − = non-inhibition 
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3.4.3 Phenotypic characterizations of probiotic bacterial candidates  
Most of bacterial isolates had a circular whole colony, entive colony edge, convex elevation, 
opaque colony color, and 0.1−0.5 mm of diameter. Bacterial isolate no.14 displayed different 
morphology (filamentous and lobated colony), no.15 and 23 had a flat colony, and isolates no.18, 
21, and 23 had a diameter less than 1 mm. Three isolates (13 to 15) were Gram-positive cocci-
shaped bacteria, eleven isolates  (1 to 10) were Gram-positive rod-shaped bacteria, and three 
isolates (11 to 12) were Gram-negative with rod-shaped bacteria. All Gram-positive with rod-
shaped bacteria displayed endospores in the cells.  
The morphological and biochemical characters as carbohydrate fermentation test (glucose, lactose, 
sucrose, maltose, and mannitol), triple sugar iron (TSI), methyl red, Voges–Proskauer, citrate 
utilization, oxidation-fermentation test (O-F test), oxidase, catalase, dihydrolase test (lysine, 
ornithine and arginine), indole production, motility, granule, endospore and capsule were presented 







Table 3.4 Bacterial characterizations and biochemical tests of bacterial colonies isolated from the 


































































































































































































1 Rod (+) − − − − − A/A; − − − − − − V + − − − − − + + + 
2 Rod (+) − − − − − A/A; + + + − − − V + − − + − + + + + 
3 Rod (+) − − − − − A/A; + + + + V V V + − − + − + + + + 
4 Rod (+) − − − − − K/A; + + + − V  V  V  ++ − − + − + + + + 
5 Rod (+) − − − − − A/A; − − − + V V − + V V V − − + + + 
6 Rod (+) − − − − − K/A; + + + + V V − ++ − − + − + + + + 
7 Rod (+) − − − − − A/K; − − − + V V − ++ V V − − − + + + 
8 Rod (+) − − − − − A/K; − − − + V V − ++ V V − − − + + + 
9 Rod (+) − − − − − A/K; − − − + V V − +++ V V V − − + + + 
10 Rod (+) − − − − − K/A; + + − − V V V +++ − − + − − + + + 
11 Rod (−) + + + + + K/K; + + − − + + + − + + + + + − − + 
12 Rod (−) + + + + + K/A; + − + + + + − − V V + − + − − + 
13 Coccus (+) − − − − − A/K; − + + − V V V +++ − − − − − − − + 
14 Coccus (+) − − V V − A/K; − − − − V V − − − − − − − − − + 
15 Coccus (+) V − − − V A/K; − − − − V V V + − − − − − − − + 
+ = Positive; ++=rather strong positive;  +++ = the most strong positive; − = Negative; V= variable (mostly positive 
with some negative); A (slant)=ferments lactose and/or sucrose (yellow); K (slant)=does not ferment either lactose or 
sucrose (red); A (butt)= some fermentation has occurred, acid has been produced, it is a facultative anaerobe (yellow); 
K (butt)= no fermentation, the bacterium is an obligate aerobe (red). 
 
3.4.4 16S rDNA identification 
The PCR amplification was expected size (1500 bp) of a fragment from the 16S rRNA gene for the 
fifteen isolates for indicating bacterial identification. BLAST searches results using the obtained 
sequences revealed the closest know neighbors (see Table 3.5). Ten isolates were identified as 
Bacillus spp. (isolates: RP01, CHP00, NP00, NP01, RP00, CHP01, CHP02, RC00, RC01 and 
RC02), two as Staphylococcus spp. (isolates: CHP04 and NP04), two as Enterbactor spp. (isolates: 




Table 3.5 Summary of the intestinal bacterial identification by using 16S rDNA. 






Strain of this 
study 







2 B. cereus 98 DQ339648.1 CHP00 
3 B. cereus 98 KF032688.1 NP00 
4 B. cereus 96 KJ948667.1 NP01 
5 Bacillus sp.  97 KC429572.1 RP00 







7 Bacillus sp. 93 JF701958.1 CHP02 







9 B. megaterium 



























13  Mac. caseolyticus 97 KJ638988.1 CHP03 
14 Stap. arlettae 97 KP753921.1 CHP04 





3.4.5 In vitro trials 
3.4.5.1 Adherence assay to tilapia intestinal cells 
The adhesive levels of probiotic candidates were no significantly different (P>0.05) for the two 
incubation periods of 2 and 6 hours, except the adhesive-potential incubated for 4 hours (P<0.5) (Table 
A.2 of Appendix 2). The adhesion abilities of isolates were tended to increase with exposure times of 2, 
4 and 6 hours (Figure 3.1 & 3.2), which were 4.67±1.36, 7.52±1.19, and 10.10±2.64%, respectively. 
High adhesive potential of exposure times were found for three Bacillus strains as Bacillus sp. CHP02, 
B. cereus NP01 and Bacillus sp. RP01, which had 13.05±1.67, 11.29±1.15, and 10.70±2.75%, 
respectively. Conversely, low adhesive potentials were displayed by Enterobacter sp. NP03, Stap. sciuri 
NP04, and Bacillus sp. RC02 which had 4.34±2.67, 2.78±1.92, and 2.71±2.99%, respectively. The 
adhesive potential of the pathogenic A. hydrophila and S. iniae strains used in this study were 
3.62±0.73, and 1.35±1.06%, respectively. 
3.4.5.2 Adhesion to hydrocarbon solvents 
The abilities of adhesive-potential of isolates to chloroform and hexane (Table A.3 & A.4 of 
Appendix 2) studied. A greater adhesion to chloroform than hexane was observed, 45.37±2.89 and 
8.55±0.92%, respectively (Figure 3.3). Bacterial isolates of Enterobacter sp. NP02 (94.10±0.48%), 
Stap. sciuri NP04 (80.84±3.37%) and Bacillus sp. CHP02 (74.49±3.09%) displayed the highest 
adhesions to chloroform, and the lowest adhesions were found for Enterobacter sp. NP03 
(24.45±2.98%), Stap. arlettae CHP04 (14.71±0.07%) and Bacillus sp. RC02 (9.11±6.31%). 
Moreover, adhesion to chloroform for A. hydrophila and S. iniae was 71.58±5.74, and 
42.58±3.71%, respectively. 
The highest adhesions to hexane were occurred with Enterobacter sp. NP02 (48.58±0.38%), 
Bacillus sp. RC02 (18.08±1.06%) and Stap. sciuri NP04 (14.12±1.36%). On the other hand, the 
lowest adhesions were observed for B. cereus NP01 (3.52±1.66%), Bacillus sp. CHP01 
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(3.45±0.51%) and Stap. arlettae CHP04 (0.52±0.34%). High adhesive capacity to both 
hydrocarbons was displayed by Enterobacter sp. NP02 and Stap. sciuri NP04. Despite Bacillus sp. 
RC02 showing a high potential of adhesion to chloroform it displayed a low adhesive capacity to 
hexane. Finally, the ability of adhesions to hexane for A. hydrophila and S. iniae was to be 





Figure 3.1 Adhesion of Bacillus sp. RP00; A1: adhesion at 2 hours, A2 adhesion at 4 hours, and 







Figure 3.2 Adhesive percentages to the tilapia epithelial cells at different time exposures of 
potential probiotics. Standard error of the mean bars (n=2) and different letters in column denote 
significant differences (P<0.05) in each time. 
 
 
Figure 3.3 The adhesive abilities to hydrarbons of potential probiotics. Standard error of the mean 





































































































































































































































































































































































































































































































3.4.5.3 Auto-aggregation assays 
There were significant differences (P≤0.05) between auto-aggregation in PBS of isolates at 4 and 6 
hours of incubation times (Figure 3.4 & Table A.5 & A.6 in Appendix 2) and non-difference 
(P>0.05) was observed at 2 hours. The highest abilities of three exposure times in PBS were 
observed for Stap. sciuri NP04 (48.38±7.79%), Bacillus sp. RC02 (41.41±0.92%) and Mac. 
caseolyticus CHP03 (35.86±1.54%) and the lowest adhesive-potentials were displayed as Stap. 
arlettae CHP04 (28.40±1.02%), Bacillus sp. RP01 (27.92±3.93%), and B. cereus NP00 
(23.59±1.03%). Auto-aggregations in PBS of A. hydrophila and S. iniae was 36.52±1.22, and 
24.24±4.87%, respectively. 
Statistically significant differences (P≤0.05) of auto-aggregation in sterile 0.85% NaCl during three 
times of incubations were observed (Figure 3.5 & Table A.7, A.8 & A.9 in Appendix 2). The highest 
abilities were detected in Bacillus sp. RC02 (43.09±2.24%), Stap. sciuri NP04 (33.13±4.74%), and 
Mac. caseolyticus CHP03 (27.27±0.47%). The lowest adhesive abilities in sterile 0.85% NaCl were 
displayed by Enterobacter sp. NP02 (16.31±0.74%), B. cereus CHP00 (16.02±5.53%) and Bacillus 
sp. RP01 (15.79±1.98%). In addition, bacterial pathogens: A. hydrophila and S. iniae were to be 
27.72±2.22, and 10.25±0.47%, respectively. 
The increasing of auto-aggregations in both buffer solvents tended to depend on incubation times. 
Bacterial isolates displayed high adhesions in PBS than in sterile 0.85% NaCl. High adhesions in 
both PBS and sterile 0.85% NaCl were observed for Stap. sciuri NP04, Bacillus sp. RC02 and Mac. 
caseolyticus CHP03, while low adhesive isolates in both buffers were displayed by B. cereus CHP00 




Figure 3.4 Auto-aggregation percentages at different time exposures in PBS of potential probiotics. 
Standard error of the mean bars (n=2) and different letters in column denote significant differences 
(P<0.05) in each time. 
 
Figure 3.5 Auto-aggregation percentages at different time exposures in sterile 0.85% NaCl of 
potential probiotics. Standard error of the mean bars (n=2) and different letters in column denote 









































































































































































































































































































































































































































































































































3.4.5.4 Antibiotic susceptibility test 
Fifteen isolates showed some degree of resistance to the antibiotics tested (Table 3.6). Seven 
isolates: Bacillus sp. RP01, Bacillus sp. RP00, Bacillus sp. CHP02, Bacillus sp. RC00, Bacillus sp. 
RC01, Mac. caseolyticus CHP03 and Stap. sciuri NP04 displayed sensitivity to all antibiotic discs. 
Eight of the fifteen isolates were resistant to at least one of the antibiotics. Three isolates of Bacillus 
cereus (CHP00 NP00 and NP01) and Bacillus sp. RC02 were resistant to 
Sulphamethoxazole/Thrimethoprim, and two strains of Enterobactor sp. (NP02 and NP03) and 
Stap. arlettae CHP04 were resistant to erythromycin. Only Bacillus sp. CHP01 showed multi-
resistance to ampicillin, cephalothin and sulphamethoxazole/thrimethoprim. Moreover, two isolates 
of Bacillus sp. RC00 and Enterobactor sp. NP02 displayed intermediate resistance to ampicillin and 
neomycin, respectively. 
3.4.5.5 Hemolytic activities 
All B. cereus strains (CHP00, NP00, and NP01) and Bacillus spp. (CHP01 and RC02) displayed 
consistent β-hemolysis for sheep blood and tilapia blood (Table 3.7). Ten isolates were non-
hemolytic for both blood types. B. cereus isolates CHP00, NP00 and NP01 showed greater 
hemolytic activities to tilapia blood than sheep blood, with clearing zones measuring 25−26 mm for 
tilapia blood and 19−22 mm for sheep blood. Bacillus sp. CHP01 displayed equal hemolytic 
activities to both blood agars (6-9 mm). However, Bacillus sp. RC02 displayed greater haemolysis 
of tilapia blood (18−19 mm) than sheep blood (9−11 mm). The pathogenic A. hydrophila strain 
affected both blood types activities, with 6 mm clearance of sheep blood and 16−18 mm of tilapia 

















































































































































































































Ampicillin 10 𝜇g:  AMP10 S S S S S R S I S S S S S S S 
Cephalothin 30 𝜇g: KF30  S S S S S R S S S S S S S S S 
Gentamycin 10 𝜇g: CN 10   S S S S S S S S S S S S S S S 
Kanamycin 30 𝜇g: K 30  S S S S S S S S S S S S S S S 
Neomycin 30 𝜇g: N 30  S S S S S S S S S S I S S S S 
Enrofloxacin 5 𝜇g: ENR 5  
 
S S S S S S S S S S S S S S S 
Erythromycin 15 𝜇g: E 15  
 
S S S S S S S S S S R R R S S 
Tetracycline 30 𝜇g: TE 30   S S S S S S S S S S S S S S S 
Oxolinic acid 2 𝜇g: QA 2   S S S S S S S S S S S S S S S 
Oxytetracycline 30 𝜇g: OT 30   S S S S S S S S S S S S S S S 
Nitrofurantoin 300 𝜇g: F 300  S S S S S S S S S S S S S S S 
Sulphamethoxazole/Thrimethoprim 
25 𝜇g: SXT 25  
S R R R S R S S S R S S S S S 
 S=susceptible; I=intermediate and R=resistant
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Table 3.7 Hemolytic activities of probiotic candidates on sheep blood and tilapia blood. 
Bacterial isolates Hemolytic activities (mm) 
Sheep blood Tilapia blood 
Bacillus sp. RP01 γ hemolysis γ hemolysis 
B. cereus CHP00 β hemolysis (19.5±0.71)  β hemolysis (26.0±0.00) 
B. cereus NP00 β hemolysis (19.5±0.71) β hemolysis (25.0±0.00) 
B. cereus NP01 β hemolysis (22±1.41) β hemolysis (26±0.00) 
Bacillus sp. RP00 γ hemolysis γ hemolysis 
Bacillus sp. CHP01 β hemolysis (9.0±0.00) β hemolysis (7±1.41) 
Bacillus sp. CHP02 γ hemolysis γ hemolysis 
Bacillus sp. RC00 γ hemolysis γ hemolysis 
Bacillus sp. RC01 γ hemolysis γ hemolysis  
Bacillus sp. RC02 β hemolysis (10.5±0.71) β hemolysis (19.5±0.71) 
Enterobacter sp. NP03 γ hemolysis γ hemolysis 
Enterobacter sp. NP02 γ hemolysis γ hemolysis  
Mac. caseolyticus CHP03 γ hemolysis γ hemolysis 
Stap. arlettae CHP04 γ hemolysis γ hemolysis 
Stap. sciuri NP04 γ hemolysis γ hemolysis 
 
3.4.5.6 Bile salt tolerance 
All bacteria tested were able to tolerate the minimum concentration at 6%. However, two strains of 
Bacillus spp. (RP01 & RC00), two strains of Enterobacter spp.(NP02 & NP03), and two strains of 
Staphylococcus spp. (CHP04 & NP04) tolerated 8% of bile salt concentrations. The highest 
tolerance at 12% of bile salt concentrations was found in Bacillus sp. RP01, Enterobacter sp. NP03, 
Stap. arlettae CHP04 and Stap. sciuri NP04 (Table 3.8).  
3.4.5.7 Acid tolerance 
The ability of isolates to resist the low acidic conditions was found that isolates performing under 
pH 4 for 24 hours, which displayed growth on agar plates. The highest resistance, to pH 2 for 24 
hours, was observed in all Bacillus strains, while the other isolates of Enterobacter sp. NP03 and 
NP02, Mac. caseolyticus CHP03, Stap. arlettae CHP04 and Stap. sciuri NP04 were unable tolerate 
to pH 2 (Table 3.8). 
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Table 3.8 Assessment growth of bacterial isolate after stimulating at different levels of bile salts 
and pH 
 
Bacterial isolates % Bile salts pH 
8 10 12  2 4 
Stap. arlettae CHP04 1 1 1 0 1 
Mac. caseolyticus CHP03 1 1 0 0 1 
Stap. sciuri NP04 
 
1 1 1 0 1 
Enterobacter sp. NP02 1 1 1 0 1 
Bacillus sp. RC00 1 1 1 1 1 
Bacillus sp. RC01 0 0 0 1 1 
Bacillus sp. RC02 0 0 0 1 1 
Ba. cereus NP00 0 0 0 1 1 
Bacillus sp. NP01 
 
0 0 0 1 1 
Bacillus sp. CHP01 0 0 0 1 1 
Bacillus sp. CHP02 0 0 0 1 1 
Ba. cereus CHP00 0 0 0 1 1 
Bacillus sp.  RP01 1 1 1 1 1 
Ba. megaterium RP00 0 0 0 1 1 
Enterobacter sp. NP03 1 1 1 0 1 
0 = non-visible growth; 1=visible growth  
 
3.4.5.8 Specific growth rate 
Bacterial isolates were treated at different temperatures (15, 32 and 42oC) to monitor bacterial 
changes by using the parameter of the specific growth rates within 8 and 24 hours. Significant 
differences (P≤0.05) of specific growth rate at three different temperatures both within 8 and 24 
hours were found (Table A.10, A.11, A.12, A.13, A.14 & A.15 in Appendix 2). Overall isolates 
displayed to increase changes in different temperatures of 15, 32 and 42oC (0.061±0.018, 
0.172±0.113 and 0.185±0.134, respectively). Although a greater average of bacterial changes were 
founded in 8 (0.202±0.112) than 24 hours (0.077±0.025). However, highest increasing was displayed 
to be in 8 hours of 42 and 32oC, while the lowest was found in low temperature at 15oC. 
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At 15oC of the incubation times after 8 and 24 hours (Figure 3.6), the highest specific growth rates 
were found in Stap. sciuri NP04 (0.139±0.002), Bacillus sp. RP01 (0.139±0.007), and Enterobacter 
sp. NP03 (0.138±0.002), while the lowest averages in B. cereus CHP00 (0.004±0.003), B. cereus 
NP01 (0.001±0.003) and Bacillus sp. RC02 (−0.009±0.001). At 32oC of incubation times of 8 and 
24 hours (Figure 3.7), the highest averages were found in Bacillus sp. RP00 (0.212±0.005), Mac. 
caseolyticus CHP03 (0.187±0.001) and Bacillus sp. CHP01 (0.186±0.001), while the lowest 
averages in Enterobacter sp. NP03 (0.163±0.001), Bacillus sp. RC02 (0.156±0.003), and 
Enterobacter sp. NP02 (0.140±0.002). At 42oC of incubation times of 8 and 24 hours (Figure 3.8), 
the highest averages were displayed in Mac. caseolyticus CHP03 (0.224±0.000), Bacillus sp. RP00 
(0.220±0.001) and Stap. arlettae CHP04 (0.216±0.001), while the lowest averages for Enterobacter 
sp. NP03 (0.154±0.001), Stap. sciuri NP04 (0.154±0.001) and Enterobacter sp. NP02 
(0.150±0.001). 
 
Figure 3.6 Specific growth rates at 15oC within 8 and 24 hours of potential probiotics. Standard 
error of the mean bars (n=2) and different letters in column denote significant differences (P<0.05) 





























































































































































































































































Figure 3.7 Specific growth rates at 32oC within 8 and 24 hours of potential probiotics. Standard 
error of the mean bars (n=2) and different letters in column denote significant differences (P<0.05) 
in each time.   
 
Figure 3.8 Specific growth rates at 42oC within 8 and 24 hours of potential probiotics. Standard 
error of the mean bars (n=2) and different letters in column denote significant differences (P<0.05) 







































































































































































































































































































































































































































































































3.4.5.9 Probiotic candidate selection 
The results of the multi-parameter data of isolates were converted to numeric scores (Table A.16 & 
A.17 in Appendix 3), which had totaled 900 from nine parameters. The ranking of total score of 
fifteen isolates were displayed as Bacillus sp. CHP02 (711), Bacillus sp. RP01 (705), Bacillus sp. 
RC00 (676), Enterobacter sp. NP02 (657), Bacillus sp. RP00 (643), Bacillus sp. RC01 (613), Stap. 
sciuri NP04 (605), Stap. arlettae CHP04 (542), Mac. caseolyticus CHP03 (517), B. cereus NP01 
(447), Enterobacter sp. NP03 (431), B. cereus CHP00 (416), Bacillus sp. CHP01 (388), B. cereus 
NP00 (387) and Bacillus sp. RC02 (363). Briefly, the description of Z-score calculation was begun 
to use results of in vitro trials transforming to numeric scores and then multiplied with the 
coefficient index of each parameter. Overall mean and square of individual value minus with 
overall mean were estimated. Then, these scores were used calculations using the Z−score equation 
(more detail of calculations was expressed in Appendix 3). 
The ranking of the Z−score are follows: Bacillus sp. CHP02 (1.14), Bacillus sp. RP01 (1.09), 
Bacillus sp. RP00 (0.94), Bacillus sp. RC01 (0.83), Stap. sciuri NP04 (0.63), Bacillus sp. RC00 
(0.61), Enterobactor sp. NP02 (0.50), Stap. arlettae CHP04 (0.45), Mac. caseolyticus CHP03 
(0.32), Enterobacter sp. NP03 (−0.37), B. cereus NP01 (−0.96),  B. cereus CHP00 (−1.10), B. 
cereus NP00 (−1.23), Bacillus sp. RC02 (−1.28), and Bacillus sp. CHP01 (−1.57). These 
























































































































































































Bacillus sp. CHP02  
(Z = 1.14) 
Both 
pathogens 




pH 2 0.126±0.005 
Bacillus sp. RP01  
(Z = 1.09) 




pH 2 0.164±0.001 
Bacillus sp. RP00 
 (Z = 0.94) 
A. 
hydrophila 




pH 2 0.154±0.004 
Bacillus sp. RC01  
(Z = 0.83) 
A. 
hydrophila 




pH 2 0.148±0.001 
Stap. sciuri NP04 
(Z = 0.63) 
A. 
hydrophila 




pH 4 0.151±0.001 
Bacillus sp. RC00 
(Z = 0.61) 
Both 
pathogens 






pH 2 0.129±0.004 
Enterobactor sp. 
NP02 (Z = 0.50) 
Both 
pathogens 






pH 4 0.131±0.003 
Stap. arlettae CHP04  
(Z = 0.45) 
A. 
hydrophila 




pH 4 0.142±0.002 
Mac. caseolyticus 
CHP03 (Z = 0.32) 
A. 
hydrophila 






pH 4 0.151±0.001 
Enterobacter sp. 
NP03 (Z = −0.37) 
A. 
hydrophila 
4.34±2.67 24.45±2.98 −10.44±1.04 32.89±1.64 19.20±1.29 S=11, I=1 (N 30)  



























































































































































































B. cereus NP01  
(Z = −0.96) 
Both 
pathogens 
11.29±1.15 27.10±4.98 3.52±1.66 35.55±2.04 24.90±1.23 S=11 & R= 1 
(SXT 25) 
β hemolysis 6% bile 
salts 
pH 2 0.116±0.002 
B. cereus CHP00  
(Z = −1.10) 
Both 
pathogens 
8.02±0.60 38.68±0.16 6.56±0.71 33.19±0.77 16.02±5.53 S=11 & R= 1 
(SXT 25) 
β hemolysis 6% bile 
salts 
pH 2 0.113±0.002 
B. cereus NP00  
(Z = −1.23) 
Both 
pathogens 
4.88±1.16 28.64±3.62 5.37±1.35 23.59±1.03 17.62±4.09 S=11 & R=1 
(SXT 25) 
β hemolysis 6% bile 
salts 
pH 2 0.129±0.004 




2.17±2.99 9.11±6.31 18.08±1.06 41.44±0.09 43.09±2.42 R=2 (N 30& 
SXT 25) 
β hemolysis 6% bile 
salts 
pH 2 0.115±0.000 




8.16±0.32 54.37±2.11 3.45±0.51 30.41±3.31 17.51±2.21 R=3 (AMP10, 
KF30 & SXT 
25) 
β hemolysis 6% bile 
salts 
pH 2 0.170±0.002 






Bacterial loads in the tilapia GIT depended on culture media, organ studies, seasoning, and 
cultural system (Spanggaard et al., 2000; Al-Harbi and Uddin, 2003; Molinari et al., 2003; 
Brunt and Austin, 2005; Pond et al., 2006; Balcázar et al., 2007; Wu et al., 2010). The Nile 
tilapia gut has reported to be 2×104 to 2×105 cfu.g-1 of microbial culture by using purified agar 
(Difco) (Molinari et al., 2003), hybrid tilapia were found to be 1×107 to 8×107 cfu.g-1 by using 
specialist Lab M agar (He et al., 2013), the same of hybrid tilapia reared in earthen ponds was 
estimated to be 2×106 to 6×107 cfu.g-1 using TSA (Al-Harbin and Uddin, 2003). In addition, 
different seasons of tilapia culture showed microbial variations between 7×105 to 4×109 cfu.g-1 
by culturing in TSA plates (Al-Harbin and Uddin, 2004). The microbial loads of the tilapia GI 
in this study were 1.0-3.7×102 in MRS-agar, 5.4×106 to 2.7×107 in TSA, and 3.2×108 to 
1.32×109 in NA. MRS-agar plates displayed yeast, fungi, and small bacterial colonies. Bacterial 
loads occurred in NA than TSA plates, however, morphological bacterial diversity was 
observed in TSA than NA plates and MRS-agar plates.  
The potential probiotic is to inhibit pathogenic bacteria, which is an important property. In this 
study, fifteen of thirty-four isolates were identified to be Bacillus spp. (ten isolates), a few 
isolates were Enterobacter spp. (two isolates) and Staphylococcus spp. (two isolates), and the 
other species was Macrococcus caseolyticus. These bacteria were shown to inhibit bacterial 
pathogens (A. hydrophila and S. iniae), which displayed to inhibit only on A. hydrophila or S. 
iniae or on both pathogens. According to several pathogenic bacteria as A. hydrophila, (Aly et 
al., 2008b; Balcázar et al., 2008; Pan et al., 2008; El-Rhman et al., 2009; Chantharasophon et 
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al., 2011; Del'Duca et al., 2013; Das et al., 2013; Kumar et al., 2013; Tulini et al., 2013; 
Geraylou et al., 2014), Edwerdsiella tarda, Enterococcus faecalis, Escherichia coli, 
Flavobacterium columnare, Listeria monocytogenes, Pseudoalteromonas sp., Pseudomonas 
spp., Staphylococcus aureus, Streptococcus spp., Vibrio spp. and Yersinia ruckeri were used to 
evaluate the probiotic property for exhibiting pathogens (Hjelm et al., 2004; Balcázar et al., 
2008; Pan et al., 2008; Apún-Molina et al., 2009; Chemlal-Kherraz et al., 2012; Del'Duca et al., 
2013; Kumar et al., 2013; Tulini et al., 2013; Gao et al., 2013; Das et al., 2013; Geraylou et al., 
2014; Prieto et al., 2014). Two species of pathogens have been reported the causes of the mass 
mortalities of tilapia culture in Thailand (Yuasa et al., 2008; Jantrakajorn et al., 2014; 
Chitmanat et al., 2016). Then the potential probiotics inhibit pathogens, which used to consider 
as high potential probiotic.  
Generally, Bacillus spp., are rod-shape, spore forming, with granule in cell, and facultative 
anaerobes. Many commercial Bacillus probiotics such as Bacillus cereus, Bacillus clausii, 
Bacillus pumilus, are general trade for human (Duc et al., 2004). Several Bacillus spp. such as 
B. subtilis, B. pumilus and B. cereus are often reported to be present in freshwater ecosystem 
(Mohanty, et al., 2011). The GI tract of tilapias has been reported to identify several Bacillus 
strains (Al-Harbi and Uddin, 2004; Chantharasophon et al., 2011; He et al., 2013; Del’Duca et 
al., 2013). These strains were also found in both organic fertilizers (poultry, pig, blood meal) 
and fishes fed with organic fertilizers (Ampofo and Clerk, 2010). Moreover, B. brevis was 
isolated from the GI tract of tilapia and proved to be as a potential probiotic in vitro trials 
(Chantharasophon et al., 2011). In this study, the GIT of different areas of tilapia culture were 
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identified ten isolates to be Bacillus spp. and these bacteria were evaluated to be a potential 
bacterial probiotic. 
Enterobacter spp. has been reported to occur generally in aquatic environments, aquatic plants, 
and landscape (Grimont and Grimont, 2006). The character of Family Enterobacteriaceae has a 
rod-shape, motile, non-spore forming, without granule in cell, and facultative anaerobes. 
Currently, C. sakazakii was reclassified to Ent. sakazakii (FAO/WTO, 2008), this bacterium 
causes infections in childern. The gut of rainbow trout, yellow catfish, and tilapia have been 
detected several strains of Enterobacter spp. (Pond et al., 2006; Boari et al., 2008; Wu et al., 
2010). However, this strain can inhibit bacterial pathogen in this study then it could be expected 
to be a candidate probiotic. Another species of Staphylococcus spp. were isolated from the GIT 
of tilapia in this study. Although, Staphylococcus spp. bacteria have been found in the intestinal 
tract, gills, in the scale, fresh fillets, and culturing water of tilapia (Al-Harbi and Uddin, 2004; 
Boari et al., 2008). Staphylococcus spp. and Macrococcus caseolyticus have a similar 
morphology and closed generic relationship. Bacterial phenotypes of them are coccus-shaped, 
non-motile, non-spore forming, and without granules in cell. However, two species have 
different percentages of genomic content; Macrococcus was reported to have DNA G+C 
content higher than 38-45 (Kloos et al., 1998), while, Staphylococcus had 33-40 (Endl et al., 
1983). They severely caused in codfish mortality (Vilhelmsson et al., 1997) and it has been 
used as bacterial pathogen in marine catfish (Pandey et al., 2010). But these strains were 
inhibited A. hydrophila.  
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The study of adhesive potential in vitro assays is every important. The prerequisite of potential 
probiotics is their colonization within the host’s GIT, which in turn, is dependent upon the 
ability of the species to adhere to the host-cells and/or mucus. The adhesive ability of probiotic 
candidates is considered to associate for colonizing to the intestinal tract of fish (Ringø and 
Gatesoupe, 1998; Ouwehand and Salminen, 2003).  The viable adhesive potential of Bacillus 
probiotic candidates has been reported that ranging 0.001 to 0.305% for estimating number of 
bacterial cells per epithelial cells (Prieto et al., 2014). The ability of lactic acid bacteria (LAB) 
to adhere to the intestine mucus has found from 16 to 20% (Balcázar et al., 2007). In this study, 
the average adhesion of all incubation times of bacterial isolates to the intestinal cells of tilapia 
was found variable between 1 to 13%. The highest adhesive-potential to tilapia intestinal cells 
was found in Bacillus spp. CHP02.  
Adhesion to hydrocarbons as a simple method evaluates the ability of bacteria to adhere to non-
specific surface (Rosenberg et al., 1985), which is used a means to assess the potential of 
probiotic candidates to adhere intestinal mucusa (Otero et al., 2004). However, a variable 
adhesive between bacterial adhesion rates to hydrocarbons (n-hexadecane, xylene and toluene) 
has been reported to be both species and hydrocarbon specific, with LAB displayed 6 to 73 % 
(Dhewa et al., 2009), bacterial isolates form shrimp farming displayed 15 to 70% adhesion to P-
xylene, ethyl acetate, and chloroform (Sánchez-Ortiz et al., 2015) and autochthonous Bacillus 
infantis form Labeo rohita displayed 9 to 24% adhesion to hydrocarbons (xylene, ethyl acetate, 
and chloroform) (Dharmaraj and Rajendren, 2014). Bacteria cells contain many molecules 
underpin the morphology, polarity and biochemical properties of the cell, which influence the 
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degree of adhesion hydrocarbons (Sánchez-Ortiz et al., 2015). In this study, we also found vary 
potentials to adhere for hydrocarbons of isolates and the highest adhesive-potential for 
hydrocarbons only was found in Enterobactor sp. displayed 95% to chloroform and 49% to 
hexane. Low adhesions in hexane might be affected by its strong organic solvent for bacteria, 
which indicated using the absorbance at the end of the incubation period.  
An early aggregation of bacteria could provide mass number to colonize to the mucosal surfaces 
of the host (Grześkowiak et al., 2012), which report 1 to 70% of auto-aggregated abilities (Kos 
et al., 2003; Pan et al., 2008; Lazado et al., 2011; Abdulla et al., 2014). This study, the ability 
of isolates to adhere cells-to-cells of the same strain, was evaluated this potential in buffer 
solutions (PBS and 0.85% NaCl), which found ranging 2 to 70% auto-aggregation. A high 
potential was found in Bacillus sp. RC02 displayed a high aggregation in both PBS and 0.85% 
NaCl. We clearly showed that isolates have varying potentials to adhere to different assays.  
Probiotic candidates have been reported to show resistances to a number of different antibiotics 
(Mourad and Nour-Eddine, 2006; Liasi et al., 2009; Nayak and Mukherjee, 2011). This study 
was found variable antibiotic susceptibilities of these isolates. The multi-antibiotic resistance 
was found in Bacillus sp. CHP01 to resist to sulphamethoxazole/thrimethoprim, ampicillin, and 
cephalothin. It was an interested point, which four isolates (Bacillus CHP00 CHP01, Mac. 
caseolyticus CHP03 and Stap. arletae CHP04) originated from offspring tilapia in the closed 
system using tap water. They displayed to antibiotic resistances. The possible reason may be 
related to current practices in many farms in Asia (tilapia farm, shrimp culture and pangasius 
farms) using high levels of antibiotics such as enrofloxacin, chloramphenicol, sulfadiazine, and 
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trimethoprim (Alday et al., 2006; Rico et al., 2013). These residual antibiotics may lead, 
bacteria to resist antibiotic drugs and bacteria containing resist genes can inherit from 
generation to generation. FAO/WTO, (2006) advocate probiotics should need the clarified 
determination of safety parameters such as lack of antibiotic resistance and virulence genes to 
lyse erythrocytes. Thus, bacteria contain virulence genes to blood hemolytic activities, which 
revealed to harmful bacteria (Scheffer et al., 1988). These bacteria can express to positive on 
blood agar plates in vitro assay. We found Bacillus sp. RC02 and all B. cereus strains (CHP00, 
NP00 and NP01) displayed β-hemolysis on blood agar plates. B. cereus is a known human 
pathogen (Ceuppens et al., 2013). 
Potential probiotics need to be able tolerate to pH and bile salt stimulations. Hlophe et al., 
(2013) reported that pH of Nile tilapia stomach varies 1.6 to 5.0 and bile concentrations in 
salmon fish has estimated ranging from 0.4 to 1.3% (Balcázar et al., 2008). Several studies have 
reported that probiotics could tolerate to pH values 1 to 12 and 2 to 12% bile salts (Mourad and 
Nour-Eddine, 2006; Balcázar et al., 2008; Nayak and Mukherjee, 2011; Chemlal-Kherraz et al., 
2012; Geraylou et al., 2014). Most studies reported that probiotic candidates could display 
resistance to pH 2. The result of the current study, we evaluated potential capacities of isolates 
to low pH (24 hours) and found all Bacillus strains tolerated at pH 2. All isolates tolerated 6% 
bile salts and five isolates tolerated to 12% bile salts. The possibility of tolerance to low pH of 
probiotic candidates might be important than bile salts. 
Fish are poikilothermic, thus temperature has a great affect on the bacterial GIT growth, auto-
aggregation/adhesion, and species diversity (Ibrahim et al., 2004; Collado et al., 2008; Kosin 
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and Rakshit, 2010; Rahiman et al., 2010; Nayak and Mukherjee, 2011). The change of isolates 
at different temperatures as un-optimal and optimal conditions for tilapia culture was assessed 
in the present study. All isolates had high capacities to grow at temperatures more than 32oC, 
whilst, at low temperature seemed to be effect on bacterial differences. Four isolates: Bacillus 
sp. CHP01, Stap. sciuri NP04, Bacillus sp. RP01 and Enterobacter sp. NP03 were dominant at 
low temperature (15OC). We can suggest that temperature changes might affect a putative 
number of the intestinal bacteria for tilapia culture.  
Furthermore, antagonistic activities are the popular criterion to simply for probiotic selection 
(Lauzon et al., 2008; Das et al., 2013; Liu et al., 2013). The ranking index by using growth 
properties in vitro testing has been reported to use as the criterion to select probiotics (Vine et 
al., 2004). Balcázar et al., (2008&2016) used pH and bile salt tolerances, adhesion to fish 
mucus and pathogenic inhibition for selecting probiotics, and Grześkowiak et al., (2012) used 
abilities of auto-aggregation and co-aggregation. Earlier reported has suggested that 
hydrophobicity values having than 40% could be suitably used for probiotic selection (Abdulla 
et al., 2014). According to, several articles used many parameters in vitro trials for selecting 
potential probiotics, which found different results (Balcázar et al., 2007&2008; Chemlal-
Kherraz et al., 2012). At the same of results in this study, then, findings of multi-parameter 
were combined together for selecting probiotic candidates, which provided as the Z−score 
method. High potentials of probiotic candidates were found in Bacillus sp. CHP02, Bacillus sp. 
RP01, and Bacillus sp. RP00. Several isolates consisted of Stap. arlettae CHP04, Enterobacter 
sp. NP03, B. cereus NP01,  B. cereus CHP00, Bacillus sp. RC02, B. cereus NP00, and Bacillus 
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sp. CHP01 had minus Z−scores, which expressed antibiotic resistances and positive blood 
hemolytic activities.  
In conclusion, the combined selection using the Z−scores calculation might be used to select 
high potential probiotic candidates. The multi-parameter in vitro assays in the present study, 
parameters consisting of pathogen antagonism, adhesion assays, auto-aggregations, potentials to 
tolerate with pH and bile salt concentrations and bacterial changes at temperature exposures, 
were used to combination for selecting potential probiotics. The highest ranked potential 
candidate was Bacillus sp. CHP02. This strain displays many favorable properties: (i) inhibition 
to pathogens, (ii) high adhesive potential to the tilapia epithelial cells, (iii) adhesive potential for 
hydrocarbons, (iv) auto-aggregations, (v) an antibiotic susceptibility, (vi) non-hemolytic 
activity, (vii) tolerance to 6% bile salts, (viii) resistance to pH 2, and (ix) acceptable growth at 
temperatures approve to tilapia farming. This strain, and other high scoring isolates will be 
tested in vivo in Chapter 4 and 5 to ascertain probiotic efficacy and to determine if the Z-score 





In vivo trial using tilapia larvae  
4.1 Abstract 
Tilapia larvae were fed with one of six different commercial diets containing potential probiotics at 
106-7 cfu.g-1: T1: (Bacillus sp. CHP02), T2: (Bacillus sp. RP01), T3: (Bacillus sp. RP00), T4: 
(Enterobacter sp. NP02), T5: (P. acidilactici) or T6: (control group – no probiotic). One thousand 
eight hundred tilapia larvae (8.1±0.8 mg) were organized into triplicate containers for each 
experimental group. Samples were reared in the containers for 6 weeks. At the end of the trial, 
significant differences (P<0.05) of average body weight, total weight gain, average daily growth, 
and specific growth rate were observed between the treatment groups. The T1 group displayed the 
highest body weight more than the other groups and the lower body weight were found in the T5 
and T6 groups. The weight gain, average daily growth, and specific growth rate were significant 
higher in the T2 group more than the other groups and the lower of these parameters were found in 
the T5 and T6 groups. No significant differences (P>0.05) among treatments were found in 
parameters of length gain, K factors, RIL, survival rate, levels of cultivable microbes in the intestine 
(log cfu.g-1), the density of goblet cells, the proportion of microvilli length per width and microvilli 
area were observed. Bacillus were detected variable samples in treatment studies both the trial mid 
point and the end of the trial. Only the T1 group was observed Bacillus to colonize in all samples. 
At the end of the feeding-trial fish were challenged by A. hydrophila. Probiotic diets displayed 
significantly (P<0.05) improved survival (93 −100%) against A. hydrophila after 7 days of IP 
challenge more than the control group (76%). Collectively, these results indicate that Bacillus sp. 
RP01 has positive effects on tilapia larvae including improved body weight, total weight gain, 





Tilapia farmers require large numbers of larvae with high qualities of growth performance, disease 
resistance and high survival rate. At the initial stage of larval feeding, different sizes of feed are 
required. The survival rate of tilapia through the larval stage has been reported to be as low as 
approximately 60% (Boyd, 2004). It is therefore important to maintain biosecurity to support high 
survival rate of tilapia larvae in hatcheries. However, a sterile environment in the hatchery may also 
lead to poor growth in grow-out farms (Gomes-Gil et al., 2000). Because of larval microbes may 
associate microbial translocations of exogenous pathogenic and beneficial bacteria, which may 
adhere in the digestive tract (Ringø et al., 2007; Giatsis et al., 2014). Probiotics, as a means for 
microbial control, have been reported to improve growth performances and survival rates of tilapia 
(Lara-Flores et al., 2003; Apún-Molina et al., 2009; He et al., 2013). In addition, it has been 
reported that probiotics support good growth performances of tilapia larvae fed a low protein diet 
(Ghazalah et al., 2010). Several researchers have published potential probiotics in tilapia larvae 
after reversing to male phenotypes having 0.1 to 5 g of body weight (Lara-Flores et al., 2003; 
Shelby et al., 2006; Apún-Molina et al., 2009; Ali et al., 2010; Liu et al., 2013; He et al., 2013). 
Then, in this study we evaluated the potential of probiotic candidates on the early larvae without 
sex-reversal of tilapia (total weight of 7 to 9 mg). 
Given the importance of the larval stage in the life cycle, and the relative lack of probiotic research 
on larval tilapia, the aims of this study were to evaluate the potential of probiotic candidates derived 
from Chapter 3 on tilapia fry at the initial feeding stage by observing growth performances, 
bacterial counts in the tilapia intestine, intestinal histological parameters and disease resistance. The 
highest-ranking autochthonous potential probiotics according to the Z−score calculations from 
chapter 3 were Bacillus sp. CHP02 (1.14), Bacillus sp. RP01 (1.09), Bacillus sp. RP00 (0.94), 
Bacillus sp. RC01 (0.83), Stap. sciuri NP04 (0.63), Bacillus sp. RC00 (0.61), Enterobactor sp. 
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NP02 (0.50), Stap. arlettae CHP04 (0.45) and Mac. caseolyticus CHP03 (0.32). The limitation of 
facilities, top three ranking of Bacillus spp. CHP02, RP01 & RP00 and Enterobactor sp. NP02 
(Appendix 1) were selected for these in vivo studies. In addition, the well-documented probiotic P. 
acidilactici was also investigated as a reference strain. 
 
4.3 Materials and methods 
4.3.1 Fry tilapia preparation 
The early swim-up fry of tilapia (O. niloticus) at 4-5 day post-hatch (dph) were provided by AIT, 
Thailand. These larvae were transferred to KMITL within an hour for acclimating in running water 
system for two days (Figure 4.1). At 7 dph fry, without sex reversion had a mean weight of 
0.0081±0.0008 g and mean length of 0.87±0.05 cm. 
4.3.2 Experimental trial 
A total of 1,800 larvae (7 dph) were used in six experiments having triplicate containers per 
treatment. These treatments were randomly assigned to separate cement ponds. One hundred larval 
fish were randomly distributed into the container (13 l) suspending in cement ponds (508 l) with 
aeration and flow-through water (2.5 l.min-1). Larvae were fed one of six different commercial diets 
containing potential probiotics at 106-7 cfu.g-1: T1: (Bacillus sp. CHP02), T2: (Bacillus sp. RP01), 
T3: (Bacillus sp. RP00), T4: (Enterobacter sp. NP02), T5: (P. acidilactici) or T6: (control group – 
no probiotic). The probiotics and fish feed were prepared as described in section 2.4. These fish 
were fed six days a week to apparent satiation five times a day (every 2 hours from 9.00AM to 
5.00PM). Fish excreta of every pond were drained twice per week. During the experiment, dead fish 
were daily recorded and removed from containers.  
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Water quality was monitored weekly during the experiment. These were as follows: 30.3±0.1OC for 
water temperature, 5.60±0.36 mg.l-1 for dissolved oxygen, 7.0±0.0 for pH and 0.38±0.05 mg−N.l-1 
for TAN. 
4.3.3 Growth parameters 
During the six weeks of feeding trials, the body weight and the total length of fry samples were 
obtained weekly (as described in section 2.5). The average body weight was determined every 
week. Parameters of WG, TLG, ADG, SGR, K factors, the RIL were determined at the trial mid 
point (3 weeks) and the trial ending (6 weeks). The SR was determined at the trial ending. These 
parameters were calculated as explains in 2.5.1.  
 
 




4.3.4 Bacterial studies  
4.3.4.1 Plating and colony counts  
The estimation of bacterial loads in the intestine of samples was determined at the middle and the 
end of the trial. Fish were deprived of feed for 24 hours, and the intestines of nine fish of each 
treatment (three fish per replicate container) was removed (Figure 4.2: as described in 2.2) to 
enumerate microbial loads. The GI solution of an individual sample (Figure 2.1: part 4) was used 
estimation of viable microbial count by using serial dilutions (as explained in 2.3.1). A total volume 
of 100 µL of 10-1, 10-3 to -4, 10-3 to -4 and 10-7 to -8 were spread onto duplicate MRS-A, EMB (Himedia, 
India), BA medium and TSA, respectively. Agar plates were incubated at 32 0C for 48 hours to 
record photographs and then the ImageJ 1.48v software (national Institutes of Health, USA) was 
used to manually count microbial loads (cfu.g-1) in each sample. 
 
 




4.3.4.2 Probiotic monitoring  
Three were designed to monitor probiotics colonized in the GIT. Triplicated intestine in each 
replicate (Figure 2.1: part 3) were homogenized in ASL buffer and then samples were centrifuged 
to remove supernatant to mix with Inhibit EX tablet. Samples were centrifuged to remove 
supernatant and then added Proteinase K and AL buffer in samples. Samples were incubation and 
added absolute ethanol. Finally, samples were washed with AW1 and AW2 buffers. Genomic 
bacteria were maintained in AE buffer. The process of genomic DNA extraction was described in 
2.3.5.1 (QIAamp DNA Stool Mini Kit, Qiagen). These samples were monitored probiotics as 
Bacillus spp., Enterobactor sp. and P. acidilactici to colonise in the GIT by using specific probiotic 
primers (Table 2.1). The genomic DNA of each replicate was pooled into a single sample. The total 
volume of PCR was 25 μL: 12.5 µL of the GoTaq® Green Master Mix, 2.5 µl of 10 µM of each 
primer, 1 µL of DNA template and 6.5 µL of sterile distilled water. The cycling conditions were 
depended on different probiotic primers, which explained in 2.3.5.2. The PCR products targeting of 
primer synthesis were checked by using agarose gels 1.5% (w/v) containing RedSafe DNA Stain 
(0.005 %) as explained in 2.3.5.3. Document gels were interpreted comparing with positive 
probiotic bands. 
4.3.5 Microscopic studies 
At the trial mid-point and the trial ending, three samples of each treatment were used the mid-
intestinal tract (Figure 2.1: part 1) to study intestinal morphology and the density of goblet cells by 
using LM. Samples were prepared as described in 2.5.3.1. These samples were counted goblet cells 
using ImageJ 1.48v software (National Institutes of Health, USA) and then the density of goblet 
cells was calculated (cell/0.1mm2). 
At the mid-trial and the trial ending, three samples of each treatment were taken to estimate 
microvilli length and width using TEM (Phillips: Techni20, Holland). The mid-intestinal sample 
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(Figure 2.1: part 2) was prepared as explained in 2.5.5.2. The ImageJ 1.48v software (National 
Institutes of Health, USA) was used to measure microvilli length (hmi) and microvilli width (wmi) 
from the micrographs. Microvilli areas of samples were calculated by using the equation of 
2πrh+πr2 (r=radian of microvilli; wmi/2, and h=microvilli length; hmi as Figure 2.5). 
At the mid-trial and the trial ending, SEM was used to monitor microbial colonizing in GI tract. 
Three pieces of the mid-intestinal sample (Figure 2.1: part 2) of each replicate were prepared as 
described in 2.5.3.3. These samples were dehydrated and coated gold (Cressington Sputter Coater, 
108 auto). Samples were scanned and imaged to assess the microbial colonization on the intestinal 
epithelial cells using a SEM (Carl Zeiss: EVO® HD, USA). 
4.3.6 Disease resistance 
At the ending of the trial, 25 fish from each container were injected with 0.1 ml A. hydrophila 
(1×1010 cfu.ml-1) into the IP cavity of the fish. A. hydrophila were supplied by AAHRI, Thailand, 
which were activated as 3.3.2.1. In addition, 25 residual fish were randomized to inject 0.1 ml of 
sterile 0.85% NaCl. These fish were kept separately in a container for 7 days to monitor fish 
mortality. 
4.3.7 Statistical analysis 
The findings were displayed in terms of mean ± standard deviation. Percentage data recordings and 
viable counts were transformed to normality. Growth performances, log viable counts, and other 
parameters compared by using a one-way analysis of variance (ANOVA). Significant differences 
between groups were accepted at P< 0.05. Pairwise comparison probabilities used to compare 
difference among means of treatments. The Systat software ver. 5.02 (Illinois, USA) was used to 





4.4.1 Growth performance  
The average body weight (g) of all treatments in each week is displayed in Table 4.1. The 
significant difference (P<0.05) among treatments was initially observed in the first week, which 
displayed the highest body weight in the control group than probiotic groups. However, high 
average body weights at the ending of this trial were observed in probiotic groups than the control 
group. The highest was found in T2 samples fed Bacillus BRP01 mixing in feed. At the mid-trial, 
significant differences (P<0.05) between treatments of WG, ADG, and SGR were found and no 
differences (P>0.05) in parameters of TLG, K, and RIL were found (Table 4.2). At the trial ending, 
significant differences (P<0.05) between treatments of WG, ADG, and SGR were found and no 
differences (P>0.05) in the parameters of TLG, K, and RIL were found (Table 4.3). The most 
efficiency on growth performances was found in T2 treatment, which displayed to be 
70496.26±1321.31 of WG, 0.14±0.00 of ADG and 6.78±0.02 of SGR. The survival rate (Figure 4.3) 
of experimental groups showed not significant (P>0.05), which had approximately seventy-five 
percent (74±5). 
 






















Table 4.1 Average wet weight (g) of different treatments in each week of experimental feeding.  
Treatments Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 
T1 0.038±0.007ab 0.239±0.051ab 0.663±0.139b 1.190±0.174b 3.795±0.786b 3.998±1.180b 
T2 0.037±0.005ab 0.253±0.024a 0.795±0.166a 1.535±0.186a 4.456±0.855a 5.718±1.292a 
T3 0.036±0.005a 0.212±0.031ab 0.648±0.117c 1.186±0.170b 3.874±1.105b 4.125±1.432b 
T4 0.039±0.005ab 0.201±0.0252 ab 0.576±0.141cd 1.105±0.142b 2.819±0.888c 3.939±1.227b 
T5 0.038±0.006ab 0.200±0.045 ab 0.569±0.127cd 1.020±0.125b 2.306±0.903cd 3.078±1.404c 
T6 0.043±0.008b 0.202±0.030b 0.540±0.090d 1.029±0.172b 2.068±0.759d 2.868±1.105c 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column.  
Table 4.2 In vivo trial mid point growth performance data. 
Parameters 
Treatments 
T1 T2 T3 T4 T5 T6 
WG, % 8081.03±514.91b 9716.48±107.06a 7894.37±385.95b 7014.74±377.68b 6919.97±77.72c 6563.81±62.97c 
TLG, % 307.85±15.89 318.89±9.81 291.32±27.43 290.95±5.56 275.42±36.74 271.78±9.77 
ADG 0.03±0.00b 0.04±0.00a 0.03±0.00b 0.03±0.00b 0.03±0.00b 0.03±0.00b 
SGR, % 9.106±0.132b 9.485±0.023a 9.059±0.099b 8.818±0.112b 8.792±0.023c 8.684±0.020c 
K 1.488±0.143 1.645±0.097 1.662±0.267 1.464±0.066 1.701±0.536 1.600±0.137 
RIL 2.74±0.44 3.13±0.62 2.98±0.59 2.93±0.40 2.91±0.40 3.06±0.48 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column.  
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Table 4.3 In vivo trial end point growth performance data. 
Parameters 
Treatments 
T1 T2 T3 T4 T5 T6 
WG, % 49261.12±1979.53b 70496.26±1321.3a 50825.50±4466.56b 48525.62±1813.65b 37899.49±564.54c 35302.34±1399.83c 
TLG, % 556.26±66.57 658.01±31.43 609.81±28.19 596.56±8.89 577.00±20.05 558.60±27.18 
ADG 0.10±0.00b 0.14±0.00a 0.10±0.01b 0.09±0.00b 0.07±0.00c 0.07±0.00c 
SGR, % 6.412±0.042b 6.783±0.019a 6.442±0.093b 6.397±0.038b 6.142±0.015c 6.069±0.041c 
K 2.249±0.765 2.011±0.298 1.774±0.349 1.772±0.124 1.511±0.123 1.539±0.234 
RIL 4.08±0.84 4.59±0.59 4.64±0.39 4.50±0.35 4.13±0.35 4.00±0.45 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column.  
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4.4.2 The microbial intestinal count and probiotic monitoring in larval tilapia 
Cultivable microbes in GI tract of tilapia larvae (0.008±0.001 g; N=25) on EMA, BA and TSA were 
3.6 to 3.9, 3.8 to 4.0 and 4.1 to 4.2 log cfu.g-1, respectively. At the mid-trial, both probiotic groups 
(T1 to T5) and the control group (T6) were displayed a few number of microbial cells on MRS agar 
plates and microbial number were increased at the end of the trial (Table 4.4). The comparison of 
the intestinal microbes on the same medium of different treatments at the mid and the trial endings 
were found no significant differences (Table 4.4). However, the highest abundance of the intestinal 
microbes on TSA medium at the end of the trial was found in the T1 group than other groups. We 
observed usually fungi and yeast occurring on MRS-A medium. The number of microbial loads in 
the intestine both Gram-negative bacteria on EMA and Gram-positive bacilli on BA tended to be 
increasing time studies.  
 
Table 4.4 Mean and standard error of cultivable microbial loads (log cfu.g-1) in the tilapia intestine 
of different treatments observed on different media. 
Treatments 
MRS-A EMA BA TSA 
Week 3 Week 6 Week 3 Week 6 Week 3 Week 6 Week 3 Week 6 
T1 nd 2.48±0.59 6.46±0.26 6.49±0.23 4.63±0.35 6.49±0.37 5.29±0.28 8.58±0.36 
T2 nd 2.23±0.44 5.19±0.80 6.24±0.05 5.31±0.11 6.24±0.07 5.58±0.06 7.22±0.05 
T3 0.2 1.84±0.07 4.60±0.52 7.10±0.93 5.29±0.42 6.92±0.06 5.29±0.34 7.47±0.26 
T4 0.4 2.38±0.25 4.02±0.27 6.72±0.66 4.62±0.27 7.13±0.85 5.15±0.08 7.72±0.67 
T5 nd 1.89±0.37 3.79±0.26 6.48±0.04 4.33±0.37 6.49±0.03 4.82±0.55  7.76±0.39 
T6 nd 2.42±0.18 4.72±0.83 7.06±0.87 4.74±0.93 6.51±0.12 5.35±0.64 7.60±0.27 
nd = not detected  
  
 137 
After the mid-trial, samples of all treatment diets were presented Bacillus in the GIT of tilapia 
larvae (Figure 4.4). The T1 and T5 groups were observed Bacillus to colonize in all samples. 







Figure 4.4 Probiotic monitoring using Bacillus primer to detect probiotic colonization in the larval 
intestine at 3 weeks (M=100 bp plus DNA marker (Fermentas); N=Negative control (pure sterile 
water used as DNA template) and P=Positive control (Positive probiotics as used probiotic DNA 
templates); T1= Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, 
T4=Enterobacter sp. NP02, T5=P. acidilactici and T6= the control group). 
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At the end of the trial, the T1 and T3 groups were detected Bacillus to colonize in the GIT of tilapia 
larvae. A few samples of T2, T4 and T6 groups were also observed Bacillus and only the T5 group 
displayed non-colonisation of Bacillus (Figure 4.5). Both Enterobacter sp. and P. acidilactici 







Figure 4.5 Probiotic monitoring using Bacillus primer to detect probiotic colonization in the larval 
intestine at 6 weeks (M=100 bp plus DNA marker (Fermentas); N=Negative control (pure sterile 
water used as DNA template) and P=Positive control (Positive probiotics as used probiotic DNA 
templates); T1= Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, 
T4=Enterobacter sp. NP02, T5=P. acidilactici and T6= the control group). 
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4.4.3 Microscopic studies 
At the mid-trial and the end of the trial, the intestinal morphology of tilapia larvae fed each of 
different diets was examined by light microscopy (Figure 4.6 & 4.7). A simple columnar epithelium 
with mucosal folds were extended into the intestinal lumen was observed in samples. Each mucosal 
fold consisted of lamina propria, surrounded by a polarised layer of enterocytes interspersed by 
goblet cells and intraepithelial leucocytes. No significant differences of the abundance of goblet 
cells between treatments at the mid-trial and the end of the trial were observed (P >0.05) (Figure 
4.8).  
TEM micrographs were used to assess the morphology of the intestinal microvilli at the mid point 
(Figure 4.9) and the end point of the trial (Figure 4.10). Observations revealed well-formed, long, 
intact microvilli on the apical surfaces of enterocytes from all treatment groups. The microvilli 
parameters of length, width, the proportion of length/width, and microvilli area were observed no 
significant-differences between the groups at the mid-trial (Table 4.4). At the end of the trial, 
microvilli length and width (Table 4.4) were observed significant differences (P<0.05). The 
microvilli length in T1, T2, T4, T5 and T6 were higher than T3.  The microvilli width in T1, T4 and 
T5 were differently higher than T1.  
SEM micrographs (Figures 4.11 & 4.12) revealed complex mucosal folds and packed microvilli on 
the apical surfaces, with minor residues of mucus and digesta. Bacteria-like cells were also 
observed adhering to the mucosal epithelium, which were presumably autochthonous bacteria of the 
tilapia intestine. Several bacterial phenotypes (rod-shape and cocci-shape) were observed but no 








Figure 4.6 Light micrographs of the mid-intestine (H&E staining) of tilapia in different groups after 
feeding probiotic at 3 weeks (L=lumen, LP= lumina propria, E=epithelia, GO=goblet cells; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 




































Figure 4.7 Light micrographs of the mid-intestine (H&E staining) of tilapia in different groups after 
feeding probiotic at 6 weeks (L=lumen, LP= lumina propria, E=epithelia, GO=goblet cells; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 
































Figure 4.8 Abundances of goblet cells (mean and standard error) fed of different treatments at the 
mid-trial (3 weeks) and the trial ending (6 weeks). Presented values are means of triplicates ± 
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Figure 4.9 Transmission micrographs of microvilli of the mid-intestine of tilapia in different groups 
after feeding probiotic at 3 weeks (MV= microvilli; L= lumen; T1= Bacillus sp. CHP02, 
T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, T5=P. acidilactici and 























   
 
   
 
   
Figure 4.10 Transmission micrographs of microvilli of the mid-intestine of tilapia in different 
groups after feeding probiotic at 6 weeks (MV= microvilli; L= lumen; T1= Bacillus sp. CHP02, 
T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, T5=P. acidilactici and 




















Table 4.5 Intestinal microvilli parameters of the tilapia of each treatment fed different probiotics at the trial mid point (week 3) and end point (week 6). 
Treatments 
Lenght (μm) Width (μm) Length/Width Area (μm2) 
Week 3 Week 6 Week 3 Week 6 Week 3 Week 6 Week 3 Week 6 
T1 0.578±0.040 1.080±0.036a 0.095±0.012 0.077±0.010b 6.212±0.849 14.370±2.083 0.180±0.029 0.265±0.037 
T2 0.954±0.066 1.011±0.056a 0.082±0.009 0.092±0.01a 11.857±1.596 12.094±1.672 0.250±0.033 0.291±0.041 
T3 0.684±0.047 0.752±0.039b 0.077±0.009 0.080±0.010ab 9.180±1.305 9.723±1.345 0.169±0.022 0.194±0.028 
T4 0.831±0.036 0.900±0.083a 0.096±0.008 0.093±0.013a 8.809±0.967 9.809±1.597 0.256±0.023 0.274±0.051 
T5 0.796±0.062 1.024±0.083a 0.083±0.011 0.100±0.013a 9.839±1.541 10.595±1.774 0.215±0.038 0.330±0.048 
T6 0.774±0.030 0.954±0.056a 0.086±0.008 0.085±0.010ab 9.085±0.960 11.663±1.189 0.215±0.021 0.256±0.038 






     
 
   
 
   
 
Figure 4.11 Scanning micrographs monitored bacterial colonization of the mid-intestine of tilapia 
in different groups after feeding probiotic at 3 weeks (CC=cocci-like-cell, RC=rod cell; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 



















   
 
   
 
   
 
Figure 4.12 Scanning micrographs monitored bacterial colonization of the mid-intestine of tilapia 
in different groups after feeding probiotic at 6 weeks (CC=cocci-like-cell, RC=rod cell; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 




















4.4.4 Disease resistance 
No mortalities were recorded with the mock challenge fish (sterile 0.85% NaCl injection). Fish 
mortalities in experimental diets were observed within 72 hours after injecting A. hydrophila. The 
A. hydrophila challenge led to mortality levels of 24±4% in the control fed fish. Probiotic feeding 
significantly (P<0.05) improved percent survival in all treatment groups (Figure 4.13), with levels 
of 96±4, 100, 98±4, 93±0 and 93±0 in T1, T2, T3, T4 and T5, respectively. 
 
 
Figure 4.13 Survival rate of different groups after injecting pathogenic bacterium A. hydrophila for 
7 days (T1= Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter 
sp. NP02, T5=P. acidilactici and T6= the control group). Significant difference (P<0.05) between 





























After six weeks of the probiotic-feeding in this study, high growth performances, as evidenced by 
body weight, weight gain, average daily growth, and specific growth rate was observed in tilapia 
larvae fed autochthonous Bacillus spp. candidate probiotics (Bacillus spp. BRP01, BCHP02, and 
BRP00) and Enterobacter sp. NP02. Indeed, larvae fed these probiotics displayed the greatest 
weight gain, significantly greater than the control or P. acidilactici fed groups and the Bacillus sp. 
BRP01 fed larvae displayed significantly greater weight gain than all other treatments. Similar 
beneficial effects on growth performance been reported for tilapia larvae fed Bacillus based 
commercial probiotics (Aly et al., 2008; Nouh et al., 2009; He et al., 2013; Nakandakare et al., 
2013). Apún-Molina et al. (2009) reported that an autochthonous Bacillus strain, administered 
directly through the feed and adding in rearing system could improve growth performances in 
tilapia larvae. In the present study, the commercial P. acidilactici investigated did not improve 
growth performance. Similarly, Streptococcus faecium and Lactobacillus acidophilus, and the yeast 
Saccharomyces cerevisae combine have also failed to improve the growth performance of tilapia 
(Lara-Flores et al., 2003). According to this study, more benefits of Bacillus sp. RP01 
supplemented in larval feed, which displayed to be 0.14±0.03 g of average daily growth and 
0.07±0.03 g in the control group. Then, tilapia larvae fed with Bacillus RP01 can grow more than 
two folds without the probiotic-feeding, which might reduce financial farmers.   
They were many evidences that fish feeding-probiotics might be affect high survival rates (84-96%) 
more than the control group (65 to 75%) and different survival rate might be found in different 
probiotic groups (Lara-Flores et al., 2003; Nouh et al., 2009). Non-effectiveness to survival rates of 
different probiotics comparing without probiotics have been reported that 70-85% of probiotic 
groups and 73% of the control groups (He et al., 2013). The highest survival rate both the probiotics 
and the control groups has distribute by Liu et al. (2013), who observed 93-100% in probiotic 
groups and 100% in the control group. Similar results of Nakandakare et al., (2013) reported 
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varying 97-100% both probiotics and the control group. In the present study, approximately 80% of 
the survival rate were not different between probiotic groups and the control group. Moreover, we 
found a few larvae dried causing by escape behavior to accompany with small hole of containers, 
however, treatments managed under the same conditions.    
Probiotics may be associated with increased nutritional digestibility by producing several 
compounds to break down feed intake (El-Rhman et al., 2009). Then, high number of beneficial 
bacteria may reveal to high growth performances and this parameter is generally used to indicate 
the potential of probiotics. In this study, microbial loads showed no difference, both different media 
and group studies of two times. We found a few colonies of yeast, fungi and small colonies of 
bacteria occurring on MRS medium. Microbial loads (log cfu.g-1) on TSA approximately found 
7.15 to 8.94 and bacterial loads culturing by specific media were to be 6.17 to 8.02 of Gram-
negative and 6.18 to 7.98 of Bacillus bacteria. He et al., (2013) reported both total allochthonous 
(approximately 8.48 to 8.88 log cfu.g-1) and autochthonous bacteria (approximately 7.07 to 7.51 log 
cfu.g-1) in the tilapia intestine no differed between the probiotic group (5 × 105 cells.g-1) and the 
control group. Conversely, both allochthonous (approximately 5.09 to 5.41 log cfu.g-1) and 
autochthonous bacillus (approximately 1.90 to 2.08 log cfu.g-1) observed but non-occurrences in the 
control group. During the experiment at the midway and the end of the trial , Bacillus spp. probiotic 
candidates were detected both Bacillus spp. treatments and without receiving Bacillus spp. groups. 
The results indicated that Bacillus spp. corresponded colonization in tilapia larvae having the 
highest adhesive-potential of Bacillus sp. CHP02, which detected in triplicates of this treatment. 
Bacillus spp. might originate from the egg and the initial rearing water, which may allocate to the 
intestine. Several Bacilli are often reported to be diverse in freshwater ecosystem (Mohanty et al., 
2011) and the GI tract of tilapia has been reported to identify several Bacillus strains (Al-Harbi and 
Uddin, 2004; Chantharasophon et al., 2011; He et al., 2013; Del’Duca et al., 2013). Moreover, 
these findings could support putative bacilli in the tilapia GIT and candidate probiotics of Bacillus 
strains display the adhesive-potential for colonization. All candidate probiotics were isolated a 
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single colony as wild type strain and then these colonies were sub-cultured to test the potential of 
probiotic properties in vitro trials for calculating the high potential of probiotic candidates (Chapter 
3). Further studies, Bacillus spp. will be performed in vitro to select generation by generation of the 
adhesive-potential property as selected strain. Several bacterial morphologies colonized in the 
intestine indicating by SEM. 
Probiotics may increase the absorptive surface index, microvilli length/density and/or goblet cell 
abundance in the intestinal tract of fish (Ferguson et al., 2010; Standen et al., 2015&2516; Adeoye 
et al., 2016; Handan et al., 2016). Therefore, histological studies using both light and electron 
microscopy were undertaken. Non-differences of goblet cells and microvilli parameters such as 
length, width, length/width proportion and area both at the midway and at the end of the trial 
between probiotic groups and the control group were found in this study. The results are not clear 
that probiotics may reveal positive effects goblet cells and microvilli characteristic but these 
parameters tend to increase following time studies. Some potential of bacilli probiotics on tilapia 
larvae have been reported to increase the thickness of the epithelial layer (Nakandakare et al., 
2013). The SEM study can indicate several bacteria colonize in the intestine of tilapia larvae.  
Fish feeding-probiotic may possibly be the effective prevention to pathogens. Variable disease 
resistances of fish fed probiotics have been demonstrated in several articles. For instance, tilapia fed 
with autochthonous probiotics Pseudomonas and M. luteus for 90 days and then these fish were 
used to inject pathogenic A. hydrophila. They showed different survival rates and only M. luteus 
increased survival rate (El-Rhman et al., 2009). The relative level of protection to A. hydrophila has 
been found in fish fed allochthonous Bacilli probiotic (1012g-1) for 30 days more than the control 
group (Aly et al., 2008). According to Villamil et al., (2014) used allochthonous probiotic Lac. 
acidophilus (106 cfu.g-1 diet) fed tilapia for 15 days. These fish were infected with pathogenic A. 
hydrophila and displayed 80% of the survival rate more than the control group (50%). Similar result 
was found in this study, tilapia larvae fed probiotics displaying high survival rates (96%) than the 
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control group (76%). Conversely, probiotics have been used to feed fish for 56 days, but fish not 
succeeded to resist pathogens (Nouh et al., 2009).  
In conclusion, three strains of autochthonous Bacillus displayed high potential as probiotics in this 
in vivo larval evaluation. The greatest potential was observed with Bacillus sp. RP01, which 
supported the highest average body weight, total weight gain, average daily growth and specific 
growth rate after feeding for three weeks. Chapter 5 will evaluate the effect of these probiotic 





In vivo trial using tilapia juvenile  
 
5.1 Abstract 
Male tilapia were fed with one of six different commercial diets containing potential probiotics at 
106-7 cfu.g-1: T1, T2, T3, T4, T5 or T6. Two thousand five hundred of tilapia (6.96±1.74 g) into 
triplicate cement ponds (600L of capacity). Samples were reared in the cement ponds (2.5L.min-1 of 
flow rate) for 10 weeks. At the end of the trial, no significant differences between the treatment 
groups (P>0.05) of body weight, increasing weight, total length, increasing length, specific growth 
rate, K factors, RIL, feed conversion ratio and survival rate were observed. The levels of cultivable 
microbes in the intestine (log cfu.g-1), the abundance of intestinal goblet cells and microvilli length 
displayed no significant differences between the treatment groups (P>0.05). Significant differences 
between the treatment groups (P<0.05) were observed for microvilli width, the proportion of 
microvilli length/width and microvilli area. Significant differences (P<0.05) of glucose and plasma 
osmolality between groups were found in stressed fish to induce by pathogenic A. hydrophila, and 
not different for plasma cortisol. The highest level of plasma glucose was found in T3 and the lower 
in T2. Plasma osmolality was found the highest in T1 and the lowest in T2. Fish induced stress by 
using thermal condition, significant differences among groups (P<0.05) were found in plasma 
cortisol and osmolality and plasma glucose displayed no difference. The highest level of cortisol 
was found in T3 and the lowest was found in T4. The highest plasma osmolality was observed in T6 
and lowest in T1. Fish fed different diets were observed low survival rates after injecting pathogen 
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and showed no difference (P<0.05) between treatment groups. The thermal induction was displayed 
100% of survival rates in all treatments (P<0.05). 
 
5.2 Introduction 
Tilapia culture is experiencing great growth annually. In 2030, tilapia production is predicted to 
increase to 7.3 million metric tonnes from 4.3 million metric tonnes in 2010 (The World Bank, 
2013). As a versatile species, tilapia are cultured in many systems such as the earthen pond, cages 
in ponds, plastic tanks, cement ponds and cages in lakes. Generally, high productivity in each crop 
production is a target of farmers, who usually rear at high density with high feed inputs. These high 
stocking densities and high load pollutions can cause poor water qualities and induce stress, which 
can lead to the spread of disease mortalities. Traditionally, veterinary medicines, chemicals, 
antibiotics, parasiticides, feed   additives and probiotics are used to achieve healthy fish and to 
prevent or treat disease outbreaks (Rico et al., 2013). A recent study reported that 84% of probiotics 
use in aquatic farms in Asia is used to as an attempt to improve water quality and reduce stress 
conditions and 16% for mixing in feeds (Rico et al., 2013).  
The previous studies, we selected autochthonous probiotic candidates (Chapter 3) as Bacillus sp. 
CHP02, RP01 & RP00 and Enterobactor sp. NP02 evaluated in tilapia fry (Chapter 4) by 
comparing with a commercial probiotic P. acidilactici as a reference strain and the control group 
(without probiotic in fish feed). The high effective of probiotic candidates was found in Bacillus sp. 
RP01, which revealed to high average body weight, total weight gain, average daily growth, and 
specific growth rate. Bacillus sp. RP01 can display colonization in the intestine of tilapia larvae 
after feeding for three weeks. Then, the aims of this study were to evaluate these probiotic 
candidates in grow-out tilapia, which observed growth performances and microscopic studies (LM, 
TEM and SEM) for evaluating the histological changes of intestine, microvilli and bacterial 
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colonization, in addition, fish samples after the post probiotic-feeding were induced stresses by 
using pathogenic injection and thermal shock to evaluate physiological responses. 
5.3 Materials and methods 
5.3.1 Nile tilapia preparation 
Two thousand five hundred sex reversed male tilapia larvae at the age of 50dph were transferred 
from AIT to KMITL within an hour. These fish were reared in cement ponds with aeration and 
flow-through water (8 l.min-1 of flow rate). After acclimating for a week, 800 fish having body 
weight of 3-4 g received a microchip (8 mm long × 1 mm diameter, low−frequency around 134.2 
kHz which refer to ISO11784/11785 animal ID transponder FDX−B) injected into the ventral 
cavity. These fish were acclimated for 3 weeks in cement ponds to allow for recovery and repairing 
tissue damage which may have resulted from tag implantation (Meeanan et al., 2009). During the 
acclimation period they were fed with twice basal fish feed per day (Premafeed Co., Ltd.: 1.2 mm 
of diameter, 12% of moisture, 30% of crude protein, 3% of total fat, and 12%).  
5.3.2 Experimental trial 
Six different commercial diets containing potential probiotics at 106-7 cfu.g-1: T1: (Bacillus sp. 
CHP02), T2: (Bacillus sp. RP01), T3: (Bacillus sp. RP00), T4: (Enterobacter sp. NP02), T5: (P. 
acidilactici) or T6: (control group – no probiotic) were performed with three replicates in this study. 
A total of 726 tagged fish (6.96±1.74 g of average weights) were distributed into eighteen ponds 
(about 40 tagged fish per pond) having 600L of pond capacity and flow rate of 2.5 l.min-1. Then, all 
ponds were added residual fish adjusting 395.70 to 456.65 g of the total weight (P<0.05). These 
ponds used plastic nets to cover for fish rearing to support reduced time handle (Figure 5.1). 
Probiotics and fish feed were prepared as described in section 2.5. Fish fed three times per day at 
the rate of 10% biomass in the first week, 6% biomass in the second to the third weeks and then 4% 
biomass was used to feed fish to the end of the trial. Fish were starved 24 hours and then fish 
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weight in each pond was recorded. Fish dead was monitored and removed daily, while fish excreta 




Figure 5.1 Fish rearing management at KMITL. A: 600L of the cement ponds use flow through 
system, B: the plastic nets use to support fish handling, and C: Daily fish feed of each pond is 
separately kept in each container. 
 
During the experimental period, water quality parameters were measured weekly, which found to be 
30.6±0.30C of water temperature, 4.70±0.35 mg.l-1 of dissolved oxygen (DO), 6.8±0.2 of pH and 
0.41±0.05 mg−N.l-1 of total ammonia. 
5.3.3 Growth  performances 
After a 24-h of feed deprivation period, the morphometric of tagged fish were recorded each week 





data were used to weekly analyze parameters of growth performances in terms of average body 
weight, increasing weight, WG, average total length, increasing length, TLG, ADG and K factor. At 
the trial mid point and the trial ending, parameters of the RIL and FCR were determined. These 
were calculated equations as described in 2.5.1. The SR (%) at the end of the trial was calculated 
(described as 2.5.2).  
5.3.4 Bacterial studies  
5.3.4.1 Plating and colony counts  
Intestinal cultivable microbial loads were determined at the midway (5 weeks) and at the end of the 
trial (10 weeks). Fish were deprived of feed for 24 hours and then three fish from each pond were 
dissected to remove the GIT (as described in 2.2). An individual sample (Figure 2.1: part 4) was 
used serial dilution to estimate a viable count by spreading method (as explained in 2.3.1). A 
volume of 100 µL of 10-1, 10-3-4, 10-3-4 and 10-7-8 serial dilutions was spread onto duplicate MRS-A, 
EMB (Himedia, India), BA medium and TSA, respectively. Agar plates were incubated at 32 0C for 
48 hours and then recorded photographs of colony-forming units (cfu.g-1) of plates. The ImageJ 
1.48v software (national Institutes of Health, USA) was used to count for microbial colonies.  
5.3.4.2 Probiotic monitoring  
Triplicate intestines from each replicate (section 5.3.4.1) used (Figure 2.1: part 3) to extract 
genomic DNA by using a Qiagen DNA extraction kit (section 2.3.5.1). In brief, triplicated intestine 
in each replicate (Figure 2.1: part 3) were homogenized in ASL buffer and then samples were 
centrifuged to remove supernatant to mix with Inhibit EX tablet. Samples were centrifuged to 
remove supernatant and then added Proteinase K and AL buffer in samples. Samples were 
incubation and added absolute ethanol. Finally, samples were washed with AW1 and AW2 buffers. 
Genomic bacteria were maintained in AE buffer. These genomic samples used to monitor the 
presence of probiotic Bacillus spp., Enterobactor sp. and P. acidilactici in the GIT by using specific 
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probiotic primers (Table 2.1). The genomic DNA of each replicate was pooled into a single sample. 
The total volume of PCR was 25 μl: 12.5 µl of the GoTaq® Green Master Mix, 2.5 µl of 10 µM of 
each primer, 1 µl of DNA template and 6.5 µl of sterile distilled water. The cycling conditions were 
dependent on the different probiotic primers, as explained in 2.3.5.2. The PCR products were 
checked using agarose gels 1.5% (w/v) containing RedSafe DNA Stain (0.005 %) as explained in 
2.3.5.3. Document gels were interpreted comparing with positive probiotic bands created from 
known probiotic isolates. 
5.3.5 Microscopic studies 
At the trial mid point and the end of the trial, samples (section 5.3.4.1) used the mid-intestinal tract 
(Figure 2.1: part 1) for studying the intestinal histology by using LM. Samples were prepared as 
described in 2.5.3.1. These samples were analyzed to determine the density of goblet cells 
(cell/0.1mm2) by using the ImageJ 1.48v software (National Institutes of Health, USA).  
At the mid-trial and the trial ending, the mid-intestine of triplicate samples of each treatment 
(Figure 2.1: part 2) was prepared as explained in 2.5.3.2. Samples were randomized to estimate both 
length and width microvilli by using TEM (Phillips: Techni20, Holland). The ImageJ 1.48v 
software (national Institutes of Health, USA) was used to measure microvilli length (hmi) and 
microvilli width (wmi) from the micrographs. Microvilli areas of samples were calculated by using 
the equation of 2πrh+πr2 (r=radian of microvilli; wmi/2, and h=microvilli length; hmi as Figure 2.5). 
Microbial colonization in the intestine of tilapia at the trial mid point and the end of the trial was 
observed by using a SEM studies. Triplicate samples of the mid-intestine (Figure 2.1: part 2) of 
each treatment were prepared as described in 2.5.3.3. These samples were dehydrated and coated 
gold (Cressington Sputter Coater, 108 auto). Samples were scanned and imaged to assess the 
microbial colonization on the intestinal epithelial cells using a SEM (Carl Zeiss: EVO® HD, USA). 
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5.3.6 Stress inductions   
At the end of the feeding trial (70 days), fish samples were separated into two groups for stressed 
challenges: 1] pathogenic, and 2] thermal shock (Figure 5.2). For the disease challenge, thirty fish 
of each container were IP injected with 0.5 ml of A. hydrophila suspended in sterile 0.85% NaCl 
(1×1010 cfu.ml-1). Duplicate sets of fish (n=30) were IP injected with 0.5 ml of sterile 0.85% NaCl 
as the negative control group. For the thermal challenge: ten individual fish from each container 
were exposed to 40oC water for 30 minutes. These stressed fish were maintained separately in 
ponds for 7 days to monitor fish mortality. 
Triplicated samples of stressed fish in each pond were randomly selected to take blood samples for 
measuring osmolality, glucose and cortisol. A total of 1ml of blood sample was obtained from the 
caudal vein by using a heparinized syringe. The time of this process was less than 1 minute. Blood 
samples were taken to centrifuge at 1000 g for 10 min and plasma samples were collected and 
stored at − 20˚C for further studies. 
Cortisol levels were measured using a cortisol ELISA kit (Cayman Chemical, USA) following the 
manufacturer’s instructions. A total of 500 μl plasma volume was added with tritium-labeled 
cortisol and then adjusted pH to 2 by using 5 M HCl. Samples were extracted by using methylene 
chlorine and heated at 30oC under a gentle stream of nitrogen. Samples were extracted in 0.5 ml of 
ELISA buffer. These samples and cortisol standard were measured the optical density at 420 nm by 
using Micro-plate Reader (Sunrize, Tecan Austria GmbH).  
Plasma glucose was measured by using Dinitrosalicylic colorimetric method (DNS method) 
according to Miller (1959) with some modification. A total volume of 100 ml DNS reagent (1 g of 
dinitrosalycyclic acid: DNS, 1 g of NaOH, 20 g of NaK tartrate (Rochelle salt), 0.05 g of sodium 
sulfite and 0.2 ml of Phenol; melted at 60 0C) was prepared and kept in a dark bottle. A volume of 
25 μl plasma was mixed with 225 μl of distilled water and 250 μl of DNS and then homogenized 
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using vortex mixer. Duplicate negative controls were prepared without plasma sample. Samples 
were heated at 100oC for 3 minutes. Then 50 μl of cool sample was added into duplicate wells of 
96-well microl plate and 50 μl of distilled water was added into duplicate wells as a negative 
control. The absorbance of samples was read with a Micro-plate Reader (Sunrize, Tecan Austria 
GmbH) at a wavelength of 570 nm. A standard glucose curve was constructed by using different 
concentrations of glucose between 0.000 to 0.600 μl.l-1 having 0.0465 to 1.0470 of absorbance 
volumes, which formulated the following equation: y = − 0.0871 + 1.7509X (R2=0.983). The 
estimation of glucose concentrations (mg.ml-1) was calculated by using this standard curve.  
A total volume of 50 μl of plasma of each sample was transferred into microfuge tube having 200 







Figure 5.2 Flow diagrammatic stress inductions in samples after the ending of the trial feeding. 
5.3.7 Statistical analysis 
The results were presented as means and standard deviation. The percentage and viable counts data 
were transformed to ensure normality. Growth performances, log viable counts, blood parameter 
and other parameters were compered using a one-way analysis of variance (ANOVA). Significant 
differences between groups were accepted at P < 0.05. Pairwise comparison probabilities were used 
Fish samples after the post-feeding 
Pathogenic injection Thermal shock 
Plasma parameters 
within 24 hours 
Plasma parameters 
within 30 minutes 
Survival rate estimating 
within 7 days 
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to compere different among means of treatments. Analyses were carried out statistical data by using 
the Systat software ver. 5.02 (Illinois, USA). 
 
5.4 Results 
5.4.1 Growth performances  
The growth performances of body weight during 10 weeks of treatments was presented in Table 
5.1, increasing weight in Table 5.2, total lengths in Table 5.3, increasing lengths in Table 5.4, SGR 
in Table 5.5, ADG in Table 5.6 and K factors in Table 5.7. Significant differences (P<0.05) 
between treatments for growth performances were observed in average body weights of 8 weeks, 
average of increasing weights at 1 week, average of increasing lengths at 1 week, specific growth 
rates at 1 and 2 weeks, average daily growth at 1 week and K factors at 1, 2 and 3 weeks. The total 
weights of the experimental diets were observed in Table 5.8. However, these parameters were no 
longer significantly different at the end of the trial. The RIL (Figure 5.3) and FCR (Figure 5.4) were 
not significantly different (P>0.05) between treatment groups.  
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Table 5.1 Average body weights (g) of different treatments in each week.  
Treatments The initial 
mean of wet 
weight 





































































































































Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column. The number of tagged fish in parenthesis is denoted n values.  
Table 5.2 Average of increasing weights (g) of different treatments in each week. 
Treatments Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 2.62±1.18b 5.53±2.37 9.16±3.91 11.85±5.03 14.96±6.13 19.27±7.80 24.25±9.49 30.44±11.57 40.43±15.76 46.87±18.24 
T2 2.63±1.40bc 5.77±2.59 9.30±4.19 12.26±5.48 15.14±6.19 19.83±7.16 24.45±8.59 30.00±10.34 41.71±13.65 46.55±15.39 
T3 2.64±1.36bcd 5.91±2.65 9.30±4.13 12.32±5.39 15.54±6.56 20.27±8.11 24.53±9.20 30.24±10.83 41.06±14.70 46.74±16.59 
T4 3.28±1.34a 6.44±2.46 9.81±3.79 12.40±4.76 15.76±5.68 20.09±6.93 24.65±8.10 30.30±9.65 42.37±13.41 48.36±14.92 
T5 3.07±1.20a 5.81±2.28 8.86±3.79 11.99±4.69 14.63±5.52 18.39±6.96 22.48±8.35 27.69±9.75 37.56±13.32 43.86±14.75 
T6 3.13±1.34a 5.93±2.78 9.38±4.12 12.14±5.24 15.17±6.37 19.14±7.95 23.25±9.38 29.67±11.10 40.09±14.83 46.21±16.98 




Table 5.3 Average total lengths (cm) of different treatments in each week.  
Treatments The initial 
mean of 
length 
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 7.45±0.75 8.18±0.88 8.82±0.99 9.53±1.10 10.09±1.22 10.63±1.25 11.16±1.35 11.78±1.45 12.49±1.51 13.26±1.68 13.96±1.76 
T2 7.42±0.77 8.10±0.97 8.79±1.10 9.45±1.29 10.09±1.40 10.70±1.41 11.29±1.34 12.01±1.70 12.54±1.43 13.42±1.48 14.00±1.58 
T3 7.46±0.85 8.11±1.02 8.80±1.15 9.45±1.25 10.12±1.36 10.72±1.46 11.22±1.53 12.90±1.51 12.52±1.58 13.26±1.73 13.83±1.79 
T4 7.53±0.67 8.26±0.83 8.95±0.92 9.66±1.04 10.26±1.12 10.78±1.18 11.32±1.20 11.95±1.27 12.60±1.34 13.48±1.50 14.04±1.53 
T5 7.50±0.64 8.18±0.74 8.87±0.86 9.53±0.99 10.13±1.06 10.64±1.12 11.15±1.21 11.63±1.25 12.25±1.34 13.13±1.49 13.77±1.48 
T6 7.48±0.74 8.22±0.92 8.93±1.10 9.56±1.24 10.20±1.35 10.71±1.45 11.25±1.58 11.79±1.66 12.43±1.74 13.22±1.88 13.84±2.04 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column. 
Table 5.4 Average of increasing lengths (cm) of different treatments in each week. 
Treatments Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 0.73±0.23b 1.36±0.39 2.06±0.57 2.62±0.73 3.16±0.83 3.67±0.97 4.27±1.13 4.97±1.22 5.73±1.41 6.44±1.50 
T2 0.68±0.25bc 1.35±0.44 2.00±0.65 2.63±0.80 3.21±0.86 3.75±0.85 4.45±1.26 4.99±0.99 5.87±1.09 6.45±1.19 
T3 0.66±0.22bcd 1.33±0.42 1.98±0.59 2.63±0.74 3.21±0.85 3.71±0.95 4.34±0.97 4.97±1.05 5.71±1.22 6.28±1.30 
T4 0.73±0.23a 1.40±0.40 2.11±0.55 2.71±0.65 3.23±0.76 3.74±0.83 4.37±0.91 5.02±0.97 5.93±1.16 6.46±1.19 
T5 0.70±0.20a 1.37±0.39 2.03±0.57 2.64±0.68 3.14±0.79 3.64±0.91 4.13±0.99 4.75±1.09 5.63±1.28 6.28±1.27 
T6 0.73±0.25a 1.42±0.49 2.08±0.67 2.69±0.81 3.20±0.94 3.73±1.08 4.29±1.19 4.91±1.26 5.69±1.41 6.36±1.56 
 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column.  
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Table 5.5 Specific growth rates of individual fish tagged in different treatments.  
Treatments Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 4.42±1.49bc 4.04±1.06c 3.85±1.00 3.44±0.88 3.18±0.76 3.06±0.70 2.95±0.66 2.91±0.59 2.94±0.57 2.83±0.54 
T2 4.23±2.06c 4.14±1.16abc 3.86±1.01 3.45±0.91 3.16±0.73 3.10±0.56 2.97±0.49 2.89±0.46 3.01±0.46 2.84±0.40 
T3 4.41±1.79bc 4.26±1.14abc 3.92±1.04 3.51±0.89 3.23±0.76 3.15±0.68 2.99±0.57 2.92±0.51 2.99±0.49 2.85±0.48 
T4 5.56±1.07a 4.64±1.03a 4.13±0.89 3.61±0.78 3.35±0.66 3.18±0.59 3.05±0.52 2.96±0.48 3.09±0.45 2.92±0.42 
T5 5.16±1.26ab 4.28±1.05abc 3.81±1.04 3.52±0.85 3.20±0.74 3.04±0.68 2.90±0.63 2.83±0.57 2.91±0.56 2.81±0.48 
T6 5.02±1.23ab 4.09±1.25bc 3.82±1.05 3.40±0.90 3.12±0.81 2.97±0.76 2.84±0.70 2.82±0.60 2.90±0.54 2.80±0.53 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column. 
Table 5.6 Average daily growths of individual fish tagged in different treatments.  
Treatments Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 0.37±0.17c 0.40±0.17 0.44±0.19 0.42±0.18 0.43±0.18 0.46±0.19 0.50±0.19 0.54±0.21 0.64±0.25 0.67±0.26 
T2 0.38±0.20bc 0.41±0.19 0.44±0.20 0.44±0.20 0.43±0.18 0.47±0.17 0.50±0.18 0.54±0.18 0.66±0.22 0.67±0.22 
T3 0.38±0.19bc 0.42±0.19 0.44±0.20 0.44±0.19 0.44±0.19 0.48±0.19 0.50±0.19 0.54±0.19 0.65±0.23 0.67±0.24 
T4 0.47±0.19a 0.46±0.18 0.47±0.18 0.44±0.17 0.45±0.16 0.48±0.17 0.50±0.17 0.54±0.17 0.67±0.21 0.69±0.21 
T5 0.44±0.17abc 0.42±0.16 0.42±0.18 0.43±0.17 0.42±0.16 0.44±0.17 0.46±0.17 0.49±0.17 0.60±0.21 0.63±0.21 
T6 0.45±0.19a 0.42±0.20 0.45±0.20 0.43±0.19 0.43±0.18 0.46±0.19 0.47±0.19 0.53±0.20 0.64±0.24 0.66±0.24 




Table 5.7 K factors of individual fish tagged in different treatments.  
Treatments Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 1.70±0.12b 1.76±0.10b 1.79±0.13abc 1.76±0.13 1.75±0.11 1.81±0.13a 1.84±0.13ab 1.85±0.12 1.95±0.20 1.90±0.23 
T2 1.71±0.15b 1.79±0.12ab 1.83±0.13a 1.77±0.13 1.73±0.13 1.80±0.10abc 1.78±0.16abc 1.81±0.11 1.95±0.11 1.90±0.28 
T3 1.70±0.14b 1.79±0.11ab 1.82±0.12ab 1.76±0.13 1.73±0.11 1.83±0.13a 1.80±0.11ab 1.82±0.11 1.97±0.13 1.95±0.22 
T4 1.74±0.11ab 1.81±0.10a 1.79±0.11abc 1.72±0.10 1.75±0.10 1.81±0.11ab 1.80±0.11ab 1.80±0.11 1.95±0.15 1.94±0.21 
T5 1.77±0.11a 1.77±0.10ab 1.75±0.12c 1.75±0.10 1.73±0.09 1.76±0.11bc 1.79±0.10ab 1.82±0.14 1.89±0.10 1.88±0.18 
T6 1.78±0.10a 1.75±0.11b 1.79±0.10abc 1.73±0.10 1.72±0.11 1.75±0.12c 1.75±0.11c 1.82±0.11 1.95±0.20 1.90±0.12 
Presented values are means of triplicates ± standard error of mean and denoted significant differences (P<0.05) between treatments in each week by using different superscripts in 
each column. 
Table 5.8 Total weights (g) of each treatment in each week during the experimental diets.  
Treatments The initial 
weight 
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 
T1 1337 1848 2404 2404 3520 4026 4438 5010 5915 7404 8280 
T2 1336 1808 2364 2364 3424 3842 4182 4635 5480 7101 8049 
T3 1335 1784 2377 2377 3306 3652 3941 4449 5177 6684 7482 
T4 1339 1802 2322 2363 3326 3926 4173 4728 5556 7315 8239 
T5 1339 1860 2366 2366 3443 3889 3967 4563 5182 6426 7402 




Figure 5.3 RIL of different treatments at the mid-trial (5 weeks) and the end of the trial (10 weeks) 




Figure 5.4 FCR of samples fed different diets at the mid-trial (5 weeks) and the end of the trial (10 



























































The survival ranged from 79 to 83%. There were no significant differences in survival rates 
between treatment studies (Figure 5.4) at the (P>0.05), which displayed  
 
Figure 5.5 Percent survival rate of different treatments at the end of the trial (10 weeks) of 
experimental feedings. Presented values are means of triplicates ± standard error of mean. 
 
5.4.2 The intestinal microbial count and probiotic monitoring in juvenile tilapia 
At the beginning of the trial, sampled tilapia cultivable intestinal counts on EMA, BA and TSA 
were found to be log 1.1 to 3.9, 1.6 to 4.1 and 5.2 to 6.5 cfu.g-1, respectively. The cultivable levels 
on the same media at the trial mid point and end point were not significantly different between the 
groups (Table 5.9).  
At the mid-trial and the trial ending, both Bacillus and P. acidilactici probiotics were not detected 
by PCR using specific primers- in the GIT of all probiotic groups (T1, T2, T3, T4 and T5) and the 
control group (T6). However, Enterobacter probiotic was only detected in one sample in the T6 




















Table 5.9 Log of cultivable microbial loads (log cfu.g-1) in different media of the tilapia GI of each 
treatment fed supplemented probiotic. Presented values are means of duplicates ± standard error of 
mean. 
Treatments 
MRS-A EMA BA TSA 
Week 5 Week 10 Week 5 Week 10 Week 5 Week 10 Week 5 Week 10 
T1 0.84±0.94 0.08±0.07 5.17±0.12 5.29±0.09 5.46±0.22 5.36±0.05 6.47±0.02 6.74±0.10 
T2 0.91±0.44 0.72±0.48 5.50±0.15 5.27±0.08 5.55±0.15 5.35±0.18 6.58±0.29 6.59±0.17 
T3 1.36±0.26 0.34±0.33 5.45±0.12 5.31±0.11 5.57±0.35 5.48±0.28 6.63±0.21 6.64±0.20 
T4 0.60±0.73 1.19±0.46 5.35±0.08 5.21±0.04 5.44±0.04 5.33±0.15 7.05±0.23 6.62±0.25 
T5 2.18±0.55 0.51±0.44 5.64±0.48 5.15±0.05 5.85±0.17 5.34±0.13 6.75±0.38 6.58±0.19 
T6 0.87±0.64 0.61±0.84 5.77±0.39 5.37±0.26 5.61±0.12 5.24±0.06 6.89±0.37 6.59±0.18 
 
5.4.3 Microscopic studies 
The intestinal morphology of tilapia samples fed each of different diets was examined by light 
microscopy at the trial mid point and the trial ending (Figure 5.7 & 5.8). A simple columnar 
epithelium with mucosal folds were extended into the intestinal lumen was observed in samples. 
Each mucosal fold consisted of lamina propria, surrounded by a polarised layer of enterocytes 
interspersed by goblet cells and intraepithelial leucocytes. No significant differences of the 
abundance of goblet cells between treatments at the mid-trial and the end of the trial were observed 
(P >0.05) (Figure 5.9). Goblet cells observed to be increasing following the time studies, which 
found to be 1941±692 (n=5), 2447±564 (n=18) and 2619±673 (n=18) cells.mm-2 at the initial trial, 
the mid-trial and the trial ending, respectively. 
 TEM micrographs were used to assess the morphology of the intestinal microvilli and microvilli 
parameters at the mid point (Figure 5.10) and the end point of the trial (Figure 5.11). Samples 
revealed well-formed, long, intact microvilli on the apical surfaces of enterocytes from all treatment 
groups. At the initial study, microvilli length was to be 0.588±0.049 μm, 0.055±0.009 μm of 
microvilli width, 10.919±2.194 of the proportion of microvilli length/ width and 0.106±0.021 μm2 
of microvilli areas. Significant differences (P<0.05) of microvilli length, width, the proportion of 
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length/width between treatments found at the mid-trial and microvilli width, the proportion of 
length/width and the proportion of microvilli length/ width between treatments found at the trial 
ending (Table 5.10). At the end of the trial, microvilli width was found the highest in T5, T3 and T4 
and the lowest in T1 and length/width proportion was observed the highest in T1 and the lowest in 
T5. Furthermore, microvilli area was found the highest in T3, T4 and T1 and the lowest in T2. 








Figure 5.6 Probiotic monitoring using Enterobacter primer to detect probiotic colonization in the 
larval intestine at 10 weeks (M=100 bp plus DNA marker (Fermentas); N=Negative control (pure 
sterile water used as DNA template) and P=Positive control (Positive probiotics as used probiotic 
DNA templates); T1= Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, 
T4=Enterobacter sp. NP02, T5=P. acidilactici and T6= the control group). 
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Figure 5.7 Light micrographs of the mid-intestine (H&E staining) of tilapia in different groups after 
feeding probiotic at 5 weeks (L=lumen, LP= lumina propria, E=epithelia, GO=goblet cells; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 




































Figure 5.8 Light micrographs of the mid-intestine (H&E staining) of tilapia in different groups after 
feeding probiotic at 10 weeks (L=lumen, LP= lumina propria, E=epithelia, GO=goblet cells; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 

































Figure 5.9 Abundances of goblet cells fed different treatments at the mid-trial (5 weeks) and the 
end of the trial (10 weeks). Presented values are means of triplicates ± standard error of mean. 
 
The SEM micrographs at the trial mid point (Figures 5.12) and the end of the trial (Figures 5.13) 
clearly revealed complex mucosal folds and packed microvilli on the apical surfaces, with minor 
residues of mucus and digesta. Bacteria-like cells were also observed adhering to the mucosal 
epithelium, which were presumably autochthonous bacteria of the tilapia intestine. Several bacterial 
phenotypes (rod-shape and cocci-shape) were observed but no qualitative changes in abundance or 
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Figure 5.10 Transmission micrographs of microvilli of the mid-intestine of tilapia in different 
groups after feeding probiotic at 5 weeks (MV= microvilli; L= lumen; T1= Bacillus sp. CHP02, 
T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, T5=P. acidilactici and 



















     
 
     
 
      
 
Figure 5.11 Transmission micrographs of microvilli of the mid-intestine of tilapia in different 
groups after feeding probiotic at 10 weeks (MV= microvilli; L= lumen; T1= Bacillus sp. CHP02, 
T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, T5=P. acidilactici and 




















Table 5.10 Quantitative data of microvilli of the mid-intestine of tilapia samples of each treatment fed supplemented probiotic (mean ± standard error 
of mean). 
Treatments 
Lenght (μm) Width (μm) Length/Width Area (μm2) 
Week 5 Week 10 Week 5 Week 10 Week 5 Week 10 Week 5* Week 10 
T1 0.875±0.117a 0.933±0.038 0.071±0.009b 0.079±0.010c 12.480±1.962a 12.182±1.554a 0.200±0.042 0.236±0.032a 
T2 0.641±0.039a 0.766±0.049 0.094±0.008a 0.086±0.010ab 6.878±0.714c 9.176±1.301d 0.197±0.023 0.213±0.029b 
T3 0.779±0.048a 0.847±0.053 0.079±0.008b 0.091±0.008a 10.035±1.165b 9.420±0.835c 0.198±0.023 0.248±0.031a 
T4 0.621±0.040ab 0.890±0.047 0.080±0.011b 0.086±0.010ab 8.029±1.161bc 10.684±1.226bc 0.161±0.023 0.243±0.034a 
T5 0.773±0.061a 0.704±0.040 0.087±0.007a 0.101±0.008a 8.939±1.028b 7.000±0.658e 0.218±0.025 0.233±0.022ab 
T6 0.484±0.035ab 0.852±0.054 0.091±0.010a 0.082±0.011b 5.393±0.791c 11.389±2.071b 0.151±0.019 0.216±0.035ab 
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Figure 5.12 Scanning micrographs monitored bacterial colonization of the mid-intestine of tilapia 
in different groups after feeding probiotic at 5 weeks (CC=cocci-like-cell, RC=rod cell; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 


















       
 
      
 
     
 
Figure 5.13 Scanning micrographs monitored bacterial colonization of the mid-intestine of tilapia 
in different groups after feeding probiotic at 10 weeks (CC=cocci-like-cell, RC=rod cell; T1= 
Bacillus sp. CHP02, T2=Bacillus sp. RP01, T3=Bacillus sp. RP00, T4=Enterobacter sp. NP02, 
T5=P. acidilactici and T6= the control group) scale bar=10 μm (T1 & T5); scale bar=2 μm (T2, T3, 




















5.4.4 Stress inductions 
5.4.4.1 Pathogenic induction 
No significant differences between treatments of plasma cortisol levels was observed A. hydrophila 
challenged fish fed the different treatments 24 hrs after the IP challenge (Figure 5.14), whereas, 
significant differences of plasma glucose (Figure 5.15) and osmolality levels (Figure 5.16) were 
detected. A high level of plasma cortisol was observed in the T6 group, while a low level was 
observed in the T4 group. Stressed fish in T2 displayed a low level of plasma glucose, which was 
significantly lower than that of T3, T4 and T5 fish. In addition, a level of plasma glucose was also 
lowest in T2 fish and was significantly lower than T1 and T5 fish. The survival rates (Figure 5.17) 
after injecting pathogen into the IP cavity of fish fed each probiotic (T1, T2, T3, T4 and T5) and 
without probiotic (T6) was low after 7 days, ranging from 2 to 10% with no significant differences 
between the treatments (P>0.05). No mortalities occurred in the negative control groups (injected with 
sterile 0.85% NaCl)  
 
Figure 5.14 Plasma cortisol concentrations of fish fed different diets for 10 weeks and induced 
stress condition by using A. hydrophila injection. Presented values are means of triplicates ± 










































Figure 5.15 Plasma glucose concentrations of fish fed different diets for 10 weeks and induced 
stress condition by using A. hydrophila injection. Presented values are means of triplicates ± 
standard error of mean. Significant difference (P<0.05) between treatments denotes by different 
superscripts. 
 
Figure 5.16 Plasma osmolality concentrations of fish fed different diets for 10 weeks and induced 
stress condition by using A. hydrophila injection. Presented values are means of triplicates ± 
























































































Figure 5.17 Survival rates of fish fed different diets for 10 weeks and induced stress condition by 
using A. hydrophila injection after monitoring for 7 days. Presented values are means of triplicates 
± standard error of mean. 
 
5.4.4.2 Thermal shock 
The level of plasma cortisol in stressed fish displayed a significant difference (P<0.05) between fish 
fed different diets (Figure 5.18). The highest of cortisol level was detected in the T3 fed fish, which 
was significantly higher than T4 fed fish, which displayed the lowest cortisol levels and were 
significantly lower than that of T1 fed fish as well as T3fed fish. Plasma glucose in fish stressing of 
all treatments displayed no significant differences (Figure 7.19). Plasma osmolality in stressed 
samples (Figure 5.20) of treatments displayed significant differences with the levels of T4, T5 and 
T6 being significantly higher than T3, T2 and T1. The lowest osmolality was observed in T1, which 
was significantly different from all of the other groups. The thermal challenge did not cause any 
























Figure 5.18 Plasma cortisol concentrations of fish fed different diets for 10 weeks and induced 
stress condition by thermal induction. Presented values are means of triplicates ± standard error of 
mean. Significant difference (P<0.05) between treatments denotes by different superscripts. 
 
Figure 5.19 Plasma glucose concentrations of fish fed different diets for 10 weeks and induced 
stress condition by using thermal induction. Presented values are means of triplicates ± standard 

































































Figure 5.20 Plasma osmolality concentrations of fish fed different diets for 10 weeks and induced 
stress condition by using thermal induction. Presented values are means of triplicates ± standard 
error of mean. Significant difference (P<0.05) between treatments denotes by different superscripts. 
 
5.5 Discussion 
The ability of probiotic candidates, three strains of Bacillus spp. (CHP02, RP01 and RP00), one 
strain of Enterobacter NP03, was evaluated in comparison with a commercial probiotic (P. 
acidilactici) and a control group. In the present study, dietary probiotic concentrations of 106-7 
cfu.g-1 were fed to tilapia juveniles (6.9 to 7.1 g) for 10 weeks. Previous studies reported that a 
single dose of probiotic candidates as B. amyloliquefaciens, B. firmus, B. pumilus, B. subtilis, Citro. 
freundii, L. acidophilus, Lactobacillus sp. and P. acidilactici at concentrations of 106 to 12 cfu.g-1 
diets have been supplemented in tilapia feed for evaluating tilapia having 5.2 to 9.1 g of mean 
weights and rearing for two to thirty-four weeks (Aly et al., 2008a,b&c; Standen et al., 2013).  
In the present study, during the experiment, some parameters such as increasing weights, weight 



































end of the trial no significant differences between in growth performance metrics were observed 
between the groups. The high ability of probiotics on growth performances may focus FCR 
parameter to reveal an amount of feed intake and a cost per yield. The Bacillus probiotic candidates 
in this study were not detected in the intestine 24hrs after cessation of feeding, and contrary to 
Chapter 4, did not affect FCR or other growth parameters. These finding are agreements that non-
improvements on FCR of probiotics such as P. acidilactici (2.81 × 106 cfu. g-1 diet) fed tilapia for 
six weeks (Standen et al., 2013), B. subtilis (5 × 106 cfu. g-1 diet) fed tilapia for 12 weeks (Telli et 
al., 2014) and mixed probiotics (B. subtilis, S. cerevisiae and A. oryzae) fed tilapia for 4 weeks 
(Iwashita et al., 2015). The positive effect on FCR of probiotics such as a commercial probiotic 
(Biogens: B. subtilis Natto (not less than 6 × 107.g-1) and the other components) fed tilapia for 17 
weeks (EL-Haroun et al., 2006) and B. amyloliquefaciens (108 cfu. g-1 diet) fed tilapia 61 days 
(Ridha and Azad, 2012). It is evident from the results of the present study and those of Chapter 4 
that the efficacy of probiotics can be dependent on life stage. This should be further explored in 
future studies, and probiotic concentrations of more than 106-7 cfu.g-1 should be studied. 
Several articles reported that tilapia feeding probiotics displayed 90% survival rate, which did not 
differ between probiotic groups and the control group (Standen et al., 2013; Telli et al., 2014; 
Hamdan et al., 2016). Similar result was observed in the present study, with survival rates of 
approximately 80%. 
Microbial loads and probiotic identifications in the fish intestine are routinely studied to reveal the 
potential of probiotics. Microbial abundance and activities in the intestine of fish also relate to 
enzymatic activities and nutritional digestibility, which may lead to improved growth performances 
(Balcazar et al., 2006). In the present study no significant differences of cultivable microbial 
abundances on the different media were detected from tilapia intestinal samples from the different 
treatments either at the trial mid point or end point.  Similar results reported by other researchers 
(Standen et al., 2013; Iwashita et al., 2015). High microbial loads from all experimental groups 
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were present on TSA. The numbers of cultivable intestinal bacteria on BA in all treatments were 
similar to those on EMA. Moreover, Bacillus strains are usually observed in the intestine of tilapia 
and freshwater ecosystem (Al-Harbi and Uddin, 2004; Chantharasophon et al., 2011; Mohanty et 
al., 2011; Del’Duca et al., 2013; He et al., 2013). However, three strains of Bacillus candidates 
were not detected in the intestine. P. acidilactici colonies were not detected from any of the 
samples. Enterobacter were only detected in some samples after 10 weeks. Moreover, the intestinal 
length of tilapia was found vary 23 to 31 cm in the initial study, 31 to 51 cm at five weeks and 62 to 
80 cm at ten weeks. Then, microbial loads and probiotic monitoring may be randomized from a 
whole intestine. A tiny sample of the fish intestine may be affected the results.  
Microscopic studies, including both LM and TEM were used to observe potential histological 
changes and SEM was used to observe bacterial colonization in the intestine of the host. Hamdan et 
al. (2016) reported that the positive effect of probiotics (Lac. plantarum AH 78) on microvilli 
length in tilapia juvenile (24.5 g). However, no significant differences of goblet cells and microvilli 
parameters such as length, width, length/width proportion and area between the groups at the mid or 
end points of the trial have been reported by Standen et al. (2015) and Adeoye et al. (2016). 
However, SEM micrographs from the present study revealed to varieties of bacteria-like cells of 
various morphologies that had colonized the tilapia intestine of probiotic groups and the control 
group. No discernable differences between abundances or colonization patterns were apparent. 
The potential of probiotics to modulate immunological parameters enhancing the health status 
(Cerezuela et al., 2012) has been reported. Probiotic fed fish have been reported to display higher 
cortisol and glucose levels than the control group (Telli et al., 2014; Iwashita et al., 2015). 
However, no significant differences of plasma osmolality were observed in Lac. rhamnosus fed 
tilapia reared at low density (Gonçalves et al., 2011). In the present study, stress was induced by 
both pathogenic injection and thermal shock, after feeding probiotic diets, in order to evaluate fish 
physiological responses and the IR index. No significant differences of plasma cortisol levels were 
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observed 24 hrs after infection by A. hydrophila. The differences in the level of glucose and 
osmolality were observed differences between probiotic groups, but no different from the control 
group. Probiotic groups of T1, T3, T4 and T5 not different from the control group and these groups 
were differently found from the T2. It showed the lowest level of glucose. Parameters of cortisol 
and osmolality were found different in stressed fish, inducing by thermal condition. Only T4 group 
displayed a lower cortisol level than the other probiotic groups and the control group, while the T1 
was observed lower osmolality than the other groups. These findings may reveal fish fed probiotics 
displaying different responses to the acute conditions, both pathogen and temperature change, 
whilst fish fed probiotic may suppress low levels of plasma parameters than the control group. The 
variation of plasma parameters in these samples may possible be related potential probiotics and 
sources of fish samples. These selected probiotics are used to evaluate in the present study as the 
wide types of potential probiotics without processing of probiotic selection in vitro conditions. 
After Thailand having flood crisis in 2011, many farms were lost tilapia bloodstock and new brood 
stocks have been transferred from some public and private areas, which might affect high genetic 
variability.  
Fish fed probiotics displayed enhanced resistance against pathogenic diseases due to modulations of 
non-specific immune responses (Hamdam et al., 2016). Pirarat et al., (2006) reported that fish fed 
probiotic Lac. rhamosus for two weeks displayed high survival rate for protecting fish from E. 
tarda pathogen. Aly et al., (2008a) used B. pumilus fed tilapia for 2 weeks and these fish displayed 
high survival rate resisting A. hydrophila. Iwashita et al., (2015) reported that mixed probiotics fed 
tilapia for five weeks provided to against A. hydrophila and S. iniae. Furthermore, fish fed 
probiotics (B. pumilus or commercial probiotic) for long-term period (8 months) displaying high 
resistance to pathogenic infection more than a short-term period of feeding (Aly et al., 2008c). In 
the present study, fish of all experimental groups displayed survival rates less than 10% after 
injecting a pathogen. It is clear in this scenario the mortality levels were too high to allow for a 
comparison of probiotic efficacy, which was what planned according to doses evaluated in 
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preliminary studies. The reason for the difference between the baseline mortality level and the 
preliminary experiment is not clear, though the results can be observed in all experiment groups 
(Figure 5.17) and thus, can still be credible.  
In conclusion, the benefits observed with the autochthonous probiotics in Chapter 4 were not fully 
replicated in the current chapter. Probiotic groups were not the effect on growth performances, 






General discussion and conclusions 
 
The objectives of this thesis were to identify, evaluate and determine probiotic properties (multi-
parameter) such as adherence with the intestinal epithelial cells of tilapia, adhesion to hydrocarbons, 
auto-aggregation, antibiotic resistance, blood hemolysis, bile salt and acid tolerances, and 
temperature exposures of the autochthonous bacteria originated from the intestinal of tilapia in in 
vitro trials (Chapter 3). Accordingly, bacteria were selected as high potential probiotic candidates 
by using the Z−scores. The potential of probiotic candidates were evaluated both tilapia fry 
(Chapter 4) and on-growing stage (Chapter 5). These objectives are represented in the overall 
protocols in Figure 1.7 (Chapter 1).  
The results will be discussed in all experimental chapters, which begins with Chapter 3 about the 
screening and selection the potential probiotics in vitro assays. Probiotic properties of bacterial 
isolates were used to select a high potential of probiotic candidates by using a classicla methods as 
the Z-scores. This technique is combined with multi-parameter properties together with expecting 
the positive results in in vivo trials both in larval and juviniel stgaes of tilapia experiments, 
moreover, it will propose how to select probiotics for tilapia cultures.  
Chapter 3, thirty-four bacterial colonies isolated from the intestine of tilapia; fifteen of these isolates 
antagonised the tilapia bacterial pathoginics A. hydrophila or/and S. iniae. The genomic 
identification of these isolates were displayed as seven strains of Bacillus spp. (RP00, RP01, 
CHP01, CHP02, RC00, RC01 and RC02), three strains of B. cereus (CHP00, NP01 and RP00), two 
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strains of Enterobacter spp. (NP02 and NP03), Mac. caseolyticus (CHP03), Stap. arlettae (CHP04) 
and Stap. sciuri (NP04). The dominant cultivable bacteria of the tilapia intestine in this study was 
Bacillus species, which have phenotypes of rod-shape, spore forming, with granule in cell, and 
facultative anaerobes. Several Bacillus spp. strains such as B. subtilis, B. pumilus and B. cereus are 
often distributed in freshwater ecosystem (Mohanty, et al., 2011) and they were observed in the 
intestine of tilapia on several occasions (Al-Harbi and Uddin, 2004; Chantharasophon et al., 2011; 
He et al., 2013; Del’Duca et al., 2013). 
In the present study, multiple parameters: antagonistic activity, cell-adhesive potentials, hemolytic 
activities, antibiotic resistance, pH and bile salt tolerances and specific growth rates were used for 
evaluating potential probiotics. These parameters are based on the review of literature in Table 1.2 
(Chapter 1) as classical model of probiotic selection (Figure 6.1). At the same of this study, nine 
properties of potential probiotics were set to evaluate bacteria isolates having the purified stocks. 
The difference of probiotic selection was differed from several articles. Because of the condition of 
probiotic selection based on three groups of probiotic properties consisting of general parameters, 
safety parameters and survival parameters. General parameters included pathogenic antagonism and 
adhesion assays. Three parameters were divided into sub-parameters, which have different scores. 
Accordingly, the coefficient index was then calculated by using these scores, which had 
assumptions proposing in 3.3.5.9 the protocol to select probiotic candidates (Chapter 3), which 
yielded interesting results (Table 3.9 in Chapter 3).  
Based on fifteen isolates, if probiotic selection based on antagonistic activities alone, ten isolates 
would have been classified as showing promise. If probiotic potential was based on antibiotic 
resistance, six isolates might be selected for further study. If the parameters for probiotic selection 
were based on antagonistic activities and hemolytic assays, then eleven isolates were selected for 
further study. If the parameter based on antagonistic activities, hemolytic assays and antibiotic 
resistance, only four isolates were selected for further studies. Such a restrictive approach would 
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have meant that some isolates having good potentials of many parameters could be, perhaps 
erroneously or unwisely, eliminated. Therefore, the approach used in the present study included a 
combined multi-parameter approach, using average mean of each parameter and the standard score 
(Z−score) was used to analyze these data for selecting potential probiotics (Table 3.8). Similarly, 
Vine et al., (2004) suggested selecting the potential of probiotics by using the ranking index (RI) by 
using able growth characteristics (lag-period and doubling-time) of isolates as an individual 








Figure 6.1 The classical model of probiotic selection. 
 
According to the results from Chapter 3 screening of potential probiotics by using combined 
selection led to the identification of 4 isolates with positive Z scores that could be further studied in 
vivo. The benefit of such in vitro studies as a preliminary tool prior to in vivo studies reduces the 
number of fish used in research studies by refining the number of viable isolates worthy of testing 
in vivo, which in turn reduces costs. 









Potential probiotics for in vivo trials 
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The autochthonous probiotic candidates, consisting of three strains (CHP02, RP01 and RP00) of 
Bacillus spp. and Enterobacter sp. NP02 were evaluated in tilapia fry (Chapter 4) and on-growing 
stage (Chapter 5). In addition, the other groups were a commercial probiotic (P. acidilactici) as the 
positive control and a control group (without probiotic-feeding) as the negative control were used to 
compare the efficacy of the autochthonous probiotic candidates. The selected isolated have vary 
sources, which found Bacillus CHP02 originating from Chitralada strain in the closed system at 
KMITL, Bacillus RP00 and RP01 from red tilapia cultured in a pond and Enterobacter NP02 from 
tilapia reared in a pond.  
Chapter 4 and 5 will be discussed together, these fish having different ages and sizing were both 
transport from AIT. In Chapter 4, tilapia fry without sex-reversal approximately having 81 mg of 
total weigh were used to evaluate the potential of probiotic selection, while tilapia weighted 7 g 
were used in Chapter 5. In fry stage, fish were fed six days a week to apparent satiation every 2 
hours from 9.00 am to 5.00 pm and juvenile stage were fed three times per day at the rate of 10% 
biomass in the first week, 6% biomass in the second to the third weeks and then 4% biomass were 
used to feed fish until the end of the trial. Based on each rearing tanks were used to each probiotic 
for protecting the contamination in both trials. In this programme of research, significant 
improvements of growth performances were achieved with autochthonous probiotic feeding in fry 
(Chapter 4), while these benefits were not replicated in the on-growing trial (Chapter 5). 
The effect of probiotic on 2 to 6 g tilapia were reported different findings. Nouh et al., (2009) used 
the mixed commercial probiotics (B. subtilis and L. acidophilus) and reported that probiotic feeding 
tilapia for one month could promote disease resistance and healthy fish. Lac. acidophilus 
supplemented feeding for 15 days have also been reported to improve survival rates during a 
pathogenic challenge (Villamil et al., 2014). A commercial B. subtilis probiotic and autochthonous 
probiotic (Micro. luteus) could provide growth performances improvements when fed to tilapia for 
3 months (Soltan and El-Laithy, 2008; El-Rhman et al., 2009). Autochthonous LAB mixes in fish 
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feed and Bacillus spp. (originated in tilapia pond) adding in the rearing system, these can promote 
growth and high survival rate (Apún-Molina et al., 2009). A commercial probiotic (containing 
Strep. faecium and Lac. Acidophilus) has also displayed positive effects on growth performances in 
tilapia larvae (Lara-Flores et al., 2003). On the contrary, Shelby et al., (2006) reported that several 
commercial probiotics could not caused to support growth performances in tilapia larvae.  
These are therefore not clear if the reduced probiotic efficacies are direct results relating to different 
life stages, or if they are caused indirectly, by the different rearing protocols necessitated for 
culturing different life stages. For example, probiotic candidates may have more easily and 
abundantly populated the rearing water and rearing environment the larvae given the more frequent 
feeding frequency, and the higher feed residence time in the water in Chapter 4 in comparison with 
the quick feeding fry exposed to fewer feeding periods in Chapter 5. Indeed, in the present studies, 
contradictory results were observed for probiotic recovery in the GIT between Chapters 4 and 5, 
which may support this speculative theory. The possible to evaluate the potential probiotics should 
be continuously mixed in rearing system for testing in growing stage. 
The cultivated microbial loads in the intestine of tilapia fed different diets seemed to be similarly in 
both tilapia larvae (Chapter 4) and the growing stage (Chapter 5). A good recovery of probiotics in 
the GIT of probiotic feeding tilapia has reported by Bucio Galindo et al. (2009), Standen et al., 
(2013) and Iwashita et al., (2015). The discrepancy between these studies and that of the current 
study, particularly in regards to chapter 5, may be due to the dosage administered to the probiotic 
strain used. However, the fact that the tilapia in the present study were deprived of feed (and thus 
probiotic provision) for 24 hours prior to sampling is likely to be a key factor for the infrequent 
recovery of the probiotics. Moreover, Galindo et al., (2009) that probiotic persistence and recovery 




Stress inductions were used in this study by exposing pathogenic and thermal stressors after the post 
probiotic-feeding. Stressed fry (Chapter 4) were too small (3.95±0.356 g) to take a blood samples to 
monitor stress biomarkers, however, and blood samples were taken from juveniles (Chapter 5) to 
determine physiological stress responses (plasma cortisol, glucose and osmolality). The fish stress 
response has function stress hormones in progress to blood circulation, which raise cortisol and 
glucose levels (Reid et al. 1998) as react to the homeostatic situation (Iwama et al. 1999). Fish 
reared in stressful conditions may generally respond increasing gill permeability for exchanging 
ions and caused by plasma ionic losing (Cataldi et al., 2005). The differences of plasma cortisol and 
glucose in tilapia feeding probiotics displayed varying in each week (Iwashita et al., 2015). In the 
present study (Chapter 5), fish fed Enterobacter ENP02 displayed low cortisol after both 
pathogenic and thermal shock challenges. Fish fed Bacillus BRP02 displayed low glucose both 
pathogenic and thermal inductions, while plasma osmolality was differently occurrences both 
pathogenic injection and thermal shock. Results can suggest potential probiotics display no patterns 
both increased and decrease releasing of plasma parameters. It might be associated with probiotic 
strains and individual tilapia.  
As Gonçalves et al. (2011) reported modulation of physiological stress responses that fish fed 
probiotics both under optimal and stress conditions, with decreased plasma cortisol levels in tilapia 
fed probiotics, while Telli et al. (2014) reported plasma cortisol and glucose levels of fish reared at 
different densities were not modulated by probiotic feeding. Conversely, El-Rhman et al. (2009) 
reported that glucose levels in probiotic groups lower than non-probiotic groups.  
In conclusion, fifteen isolates from the intestinal of tilapia displayed to inhibit pathogens (A. 
hydrophila or/and S. iniae). The putative isolate was found in ten Bacillus spp. of fifteen bacteria. 
The combined multi-parameter approach and inclusion of ranking by Z-scoring was used to select 
high potentials of probiotic candidates, which found top three ranking autochthonous probiotic 
candidates as Bacillus sp. CHP02, RP01 and RP00. These strain contained good qualities and 
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favourable properties: (i) inhibition to pathogens, (ii) high adhesive potential to the tilapia epithelial 
cells, (iii) adhesive potential to hydrocarbons, (iv) auto-aggregations, (v) an antibiotic susceptibility, 
(vi) non-hemolytic activity, (vii) tolerance to 6% bile salts, (viii) resistance to pH 2, and (ix) 
acceptable growth at temperatures approve to tilapia farming.  
These probiotic candidates (Bacillus sp. CHP02, RP01 and RP00), the fifth ranking scores as 
Enterobacter sp. NP02, a commercial probiotic (P. acidilactici) and the control group were 
evaluated in tilapia larvae. It appears that successful outcomes in fry tilapia depended on high 
volume of Z-scores. The most effective probiotic candidate was Bacillus sp. RP01, which improved 
average body weight, total weight gain, average daily growth, and specific growth rate in tilapia 
larvae. Bacillus sp. can colonise in the intestine of tilapia larvae after feeding for three weeks. The 
effective on growth performances of autochthonous probiotic than allochthonous probiotic is clear 
in fry stage. In vivo juvenile trial, the potential of autochthonous probiotics were not differed from 
the allochthonous probiotic and the control group. This study has shown the effective of the 
protocol to select probiotic as multi-parameter in vitro assays. High effectiveness of probiotic on 
tilapia culture may begin at the larval than growing stage.   
Future studies should assess the followings: selective probiotic as the same of aquatic animals and 
then prove in vivo trials, which follow a range of probiotic dietary inclusion levels, supply via the 
rearing water, long term feeding trials with fish reaching market size, and assessment of 
immunological parameters. Moreover, high throughput sequencing to generate libraries or 
metagenomics to elucidate possible effects of probiotic feeding on the total microbial community 
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Appendix 2: Statistic analysis 












































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 0.208 1.000 1.000             
B. cereus NP00 1.000 1.000 0.033 1.000            
B. cereus NP01 0.794 1.000 1.000 0.122 1.000           
Bacillus sp. RC00 1.000 1.000 1.000 1.000 1.000 1.000          
Bacillus sp. RC01 1.000 1.000 0.153 1.000 0.584 1.000 1.000         
Bacillus sp. RC02 1.000 0.035 0.001 1.000 0.003 0.231 1.000 1.000        
Bacillus sp. RP00 1.000 1.000 0.299 1.000 1.000 1.000 1.000 0.786 1.000       
Bacillus sp. RP01 1.000 1.000 1.000 0.752 1.000 1.000 1.000 0.014 1.000 1.000      
Enterobactor sp. NP02 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.097 1.000 1.000 1.000     
Enterobacter sp. NP03 1.000 0.518 0.009 1.000 0.032 1.000 1.000 1.000 1.000 0.193 1.000 1.000    
Mac. caseolyticus 
CHP03 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.021 1.000 1.000 1.000 0.311 1.000   
Stap. arlettae CHP04 1.000 1.000 0.051 1.000 0.192 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000  

















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.050 1.000              
Bacillus sp. CHP02 0.000 0.004 1.000             
B. cereus NP00 1.000 0.000 0.000 1.000            
B. cereus NP01 0.537 0.000 0.000 1.000 1.000           
Bacillus sp. RC00 0.222 1.000 0.001 0.001 0.000 1.000          
Bacillus sp. RC01 1.000 0.376 0.000 0.172 0.071 1.000 1.000         
Bacillus sp. RC02 0.000 0.000 0.000 0.006 0.014 0.000 0.000 1.000        
Bacillus sp. RP00 0.318 1.000 0.001 0.001 0.001 1.000 1.000 0.000 1.000       
Bacillus sp. RP01 1.000 1.000 0.000 0.022 0.009 1.000 1.000 0.000 1.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.006 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000     
Enterobacter sp. NP03 0.116 0.000 0.000 1.000 1.000 0.000 0.016 0.061 0.000 0.002 0.000 1.000    
Mac. caseolyticus 
CHP03 1.000 0.636 0.000 0.102 0.043 1.000 0.000 0.000 1.000 1.000 0.000 0.010 1.000   
Stap. arlettae CHP04 0.001 0.000 0.000 0.138 0.336 0.000 1.000 1.000 0.000 0.000 0.000 1.000 0.000 1.000  


















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 1.000 0.024 1.000             
B. cereus NP00 1.000 1.000 0.943 1.000            
B. cereus NP01 1.000 1.000 0.028 1.000 1.000           
Bacillus sp. RC00 1.000 0.410 1.000 1.000 0.471 1.000          
Bacillus sp. RC01 1.000 1.000 1.000 1.000 1.000 1.000 1.000         
Bacillus sp. RC02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000        
Bacillus sp. RP00 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000       
Bacillus sp. RP01 1.000 1.000 0.195 1.000 1.000 1.000 1.000 0.000 1.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000     
Enterobacter sp. NP03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000    
Mac. caseolyticus 
CHP03 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 0.000 0.000 1.000   
Stap. arlettae CHP04 0.005 1.000 0.000 0.039 1.000 0.002 0.012 0.000 0.015 0.186 0.000 0.000 0.006 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 1.000 1.000 1.000             
B. cereus NP00 0.010 0.147 0.003 1.000            
B. cereus NP01 1.000 1.000 1.000 0.019 1.000           
Bacillus sp. RC00 1.000 1.000 1.000 0.015 1.000 1.000          
Bacillus sp. RC01 1.000 1.000 1.000 0.185 1.000 1.000 1.000         
Bacillus sp. RC02 1.000 1.000 1.000 0.001 1.000 1.000 1.000 1.000        
Bacillus sp. RP00 1.000 1.000 1.000 0.600 1.000 1.000 1.000 0.501 1.000       
Bacillus sp. RP01 0.432 1.000 0.095 1.000 0.827 0.674 1.000 0.033 1.000 1.000      
Enterobactor sp. NP02 1.000 1.000 1.000 0.001 1.000 1.000 1.000 1.000 0.465 0.031 1.000     
Enterobacter sp. NP03 1.000 1.000 1.000 0.173 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000    
Mac. caseolyticus 
CHP03 1.000 1.000 1.000 0.001 1.000 1.000 1.000 1.000 0.749 0.048 1.000 1.000 1.000   
Stap. arlettae CHP04 1.000 1.000 0.959 0.924 1.000 1.000 1.000 0.325 1.000 1.000 0.302 1.000 0.486 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 1.000 1.000 1.000             
B. cereus NP00 1.000 0.921 1.000 1.000            
B. cereus NP01 1.000 0.012 0.607 1.000 1.000           
Bacillus sp. RC00 1.000 1.000 1.000 1.000 0.027 1.000          
Bacillus sp. RC01 1.000 1.000 1.000 1.000 1.000 1.000 1.000         
Bacillus sp. RC02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000        
Bacillus sp. RP00 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000       
Bacillus sp. RP01 1.000 0.064 1.000 1.000 1.000 0.143 1.000 0.000 1.000 1.000      
Enterobactor sp. NP02 1.000 0.062 1.000 1.000 1.000 0.139 1.000 0.000 1.000 1.000 1.000     
Enterobacter sp. NP03 0.885 0.010 0.509 1.000 1.000 0.023 1.000 0.000 0.940 1.000 1.000 1.000    
Mac. caseolyticus 
CHP03 1.000 0.579 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000   
Stap. arlettae CHP04 0.089 1.000 0.154 0.018 0.000 1.000 0.026 0.000 0.084 0.002 0.002 0.000 0.012 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.205 1.000              
Bacillus sp. CHP02 0.001 1.000 1.000             
B. cereus NP00 0.440 1.000 0.589 1.000            
B. cereus NP01 0.000 0.359 1.000 0.167 1.000           
Bacillus sp. RC00 1.000 1.000 0.085 1.000 0.025 1.000          
Bacillus sp. RC01 0.042 1.000 1.000 1.000 1.000 1.000 1.000         
Bacillus sp. RC02 0.000 0.051 1.000 0.025 1.000 0.004 0.255 1.000        
Bacillus sp. RP00 0.247 1.000 1.000 1.000 0.298 1.000 1.000 0.043 1.000       
Bacillus sp. RP01 1.000 1.000 0.008 1.000 0.003 1.000 0.484 0.000 1.000 1.000      
Enterobactor sp. NP02 0.122 1.000 1.000 1.000 0.601 1.000 1.000 0.085 1.000 1.000 1.000     
Enterobacter sp. NP03 1.000 1.000 0.018 1.000 0.005 1.000 1.000 0.001 1.000 1.000 1.000 1.000    
Mac. caseolyticus 
CHP03 0.000 0.047 1.000 0.023 1.000 0.004 0.234 1.000 0.039 0.000 0.078 0.001 1.000   
Stap. arlettae CHP04 0.001 0.760 1.000 0.354 1.000 0.052 1.000 1.000 0.631 0.005 1.000 0.011 1.000 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 1.000 1.000 1.000             
B. cereus NP00 1.000 1.000 1.000 1.000            
B. cereus NP01 1.000 1.000 1.000 1.000 1.000           
Bacillus sp. RC00 1.000 1.000 1.000 1.000 1.000 1.000          
Bacillus sp. RC01 1.000 1.000 1.000 1.000 1.000 1.000 1.000         
Bacillus sp. RC02 0.011 0.001 0.009 0.001 0.075 0.014 0.001 1.000        
Bacillus sp. RP00 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.166 1.000       
Bacillus sp. RP01 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.006 1.000 1.000      
Enterobactor sp. NP02 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.001 1.000 1.000 1.000     
Enterobacter sp. NP03 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.041 1.000 1.000 1.000 1.000    
Mac. caseolyticus 
CHP03 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.144 1.000 1.000 1.000 1.000 1.000   
Stap. arlettae CHP04 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.053 1.000 1.000 1.000 1.000 1.000 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 1.000 1.000 1.000             
B. cereus NP00 1.000 1.000 1.000 1.000            
B. cereus NP01 1.000 1.000 1.000 1.000 1.000           
Bacillus sp. RC00 1.000 1.000 1.000 1.000 1.000 1.000          
Bacillus sp. RC01 1.000 1.000 1.000 1.000 1.000 1.000 1.000         
Bacillus sp. RC02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000        
Bacillus sp. RP00 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000       
Bacillus sp. RP01 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000      
Enterobactor sp. NP02 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000     
Enterobacter sp. NP03 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000    
Mac. caseolyticus 
CHP03 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 0.084 1.000 1.000   
Stap. arlettae CHP04 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.000 1.000              
Bacillus sp. CHP02 1.000 0.000 1.000             
B. cereus NP00 0.001 0.000 0.010 1.000            
B. cereus NP01 1.000 0.000 1.000 0.000 1.000           
Bacillus sp. RC00 0.908 0.000 1.000 0.227 0.052 1.000          
Bacillus sp. RC01 0.000 0.000 0.000 0.000 0.000 0.000 1.000         
Bacillus sp. RC02 1.000 0.000 0.696 0.000 1.000 0.028 0.000 1.000        
Bacillus sp. RP00 0.172 0.000 1.000 1.000 0.011 1.000 0.000 0.006 1.000       
Bacillus sp. RP01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 1.000     
Enterobacter sp. NP03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 1.000    
Mac. caseolyticus 
CHP03 0.000 0.000 0.000 1.000 0.000 0.002 0.000 0.000 0.011 0.000 0.000 0.000 1.000   
Stap. arlettae CHP04 0.000 0.000 0.001 1.000 0.000 0.017 0.000 0.000 0.087 0.000 0.000 0.000 1.000 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 1.000 1.000              
Bacillus sp. CHP02 0.000 0.000 1.000             
B. cereus NP00 0.025 0.348 0.001 1.000            
B. cereus NP01 1.000 1.000 0.000 0.545 1.000           
Bacillus sp. RC00 1.000 1.000 0.000 0.059 1.000 1.000          
Bacillus sp. RC01 0.000 0.000 0.001 0.000 0.000 0.000 1.000         
Bacillus sp. RC02 0.002 0.000 0.000 0.000 0.000 0.001 0.000 1.000        
Bacillus sp. RP00 0.000 0.000 1.000 0.000 0.000 0.000 0.092 0.000 1.000       
Bacillus sp. RP01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.000 0.000 0.000 0.000 0.223 0.000 0.000 0.223 1.000     
Enterobacter sp. NP03 0.000 0.000 0.000 0.000 0.000 0.000 0.003 0.000 0.000 1.000 1.000 1.000    
Mac. caseolyticus 
CHP03 0.000 0.001 0.223 1.000 0.002 0.000 0.000 0.000 0.002 0.000 0.000 0.000 1.000   
Stap. arlettae CHP04 0.000 0.001 0.348 0.850 0.001 0.000 0.000 0.000 0.003 0.000 0.000 0.000 1.000 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.002 1.000              
Bacillus sp. CHP02 1.000 0.035 1.000             
B. cereus NP00 1.000 0.012 1.000 1.000            
B. cereus NP01 1.000 0.008 1.000 1.000 1.000           
Bacillus sp. RC00 0.196 0.000 0.012 0.035 0.053 1.000          
Bacillus sp. RC01 1.000 0.035 1.000 1.000 1.000 0.012 1.000         
Bacillus sp. RC02 0.018 0.000 0.001 0.004 0.005 1.000 0.001 1.000        
Bacillus sp. RP00 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000       
Bacillus sp. RP01 0.592 1.000 1.000 1.000 1.000 0.000 1.000 0.000 0.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.000 0.000 0.000 0.003 0.000 0.028 0.000 0.000 1.000     
Enterobacter sp. NP03 1.000 0.000 1.000 1.000 1.000 1.000 1.000 0.305 0.000 0.035 0.000 1.000    
Mac. caseolyticus 
CHP03 1.000 0.305 1.000 1.000 1.000 0.002 1.000 0.000 0.000 1.000 0.000 0.158 1.000   
Stap. arlettae CHP04 1.000 0.000 0.381 1.000 1.000 1.000 0.381 1.000 0.000 0.010 0.000 1.000 0.043 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.002 1.000              
Bacillus sp. CHP02 0.002 1.000 1.000             
B. cereus NP00 0.007 1.000 1.000 1.000            
B. cereus NP01 1.000 0.003 0.003 0.014 1.000           
Bacillus sp. RC00 0.000 0.002 0.002 0.000 0.000 1.000          
Bacillus sp. RC01 0.723 0.723 0.723 1.000 1.000 0.000 1.000         
Bacillus sp. RC02 1.000 0.000 0.000 0.001 1.000 0.000 0.066 1.000        
Bacillus sp. RP00 0.000 0.000 0.000 0.000 0.000 0.723 0.000 0.000 1.000       
Bacillus sp. RP01 0.030 1.000 1.000 1.000 0.066 0.000 1.000 0.003 0.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000     
Enterobacter sp. NP03 0.723 0.000 0.000 0.000 0.324 0.000 0.002 1.000 0.000 0.000 0.003 1.000    
Mac. caseolyticus 
CHP03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.066 0.000 0.000 0.000 1.000   
Stap. arlettae CHP04 0.000 0.000 0.000 0.000 0.000 0.146 0.000 0.000 1.000 0.000 0.000 0.000 1.000 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.000 1.000              
Bacillus sp. CHP02 0.000 0.981 1.000             
B. cereus NP00 0.000 0.012 1.000 1.000            
B. cereus NP01 0.193 0.000 0.001 0.086 1.000           
Bacillus sp. RC00 0.000 0.000 0.000 0.000 0.000 1.000          
Bacillus sp. RC01 0.058 0.000 0.004 0.289 1.000 0.000 1.000         
Bacillus sp. RC02 0.004 0.000 0.058 1.000 1.000 0.000 1.000 1.000        
Bacillus sp. RP00 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000       
Bacillus sp. RP01 0.058 0.000 0.004 0.289 1.000 0.000 1.000 1.000 0.000 1.000      
Enterobactor sp. NP02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000     
Enterobacter sp. NP03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.058 1.000    
Mac. caseolyticus 
CHP03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 1.000   
Stap. arlettae CHP04 0.000 0.000 0.000 0.000 0.000 0.128 0.000 0.000 0.193 0.000 0.000 0.000 0.006 1.000  
















































































































































































































B. cereus CHP00 1.000               
Bacillus sp. CHP01 0.046 1.000              
Bacillus sp. CHP02 1.000 1.000 1.000             
B. cereus NP00 0.001 1.000 0.046 1.000            
B. cereus NP01 0.002 1.000 0.084 1.000 1.000           
Bacillus sp. RC00 0.000 0.000 0.000 0.003 0.002 1.000          
Bacillus sp. RC01 0.002 1.000 0.084 1.000 1.000 0.002 1.000         
Bacillus sp. RC02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000        
Bacillus sp. RP00 0.000 0.000 0.000 0.000 0.000 0.284 0.000 0.000 1.000       
Bacillus sp. RP01 0.524 1.000 1.000 0.524 0.965 0.000 0.965 0.000 0.000 1.000      
Enterobactor sp. NP02 1.000 0.000 0.025 0.000 0.000 0.000 0.000 0.000 0.000 0.003 1.000     
Enterobacter sp. NP03 0.284 0.000 0.005 0.000 0.000 0.000 0.000 0.000 0.000 0.001 1.000 1.000    
Mac. caseolyticus 
CHP03 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.524 0.000 0.000 0.000 1.000   
Stap. arlettae CHP04 0.000 0.000 0.000 0.000 0.000 0.046 0.000 0.000 1.000 0.000 0.000 0.000 1.000 1.000  





Appendix 3: The method of Z-score calculations 
Step 1: Samples are calculated to get scores of parameter studies by using conditions of I to VI (Chapter 3), which display in Table A.17. 
Step 2: Samples are calculated 𝑇𝑖 score by using parameter properties to multiply with the coefficient index in Table 3.1. Scores and overall mean (?̅?) 
are represented in Table A.18. 
Step 3: The Z-score equation is broken down to find (𝑇𝑖 − ?̅?), and (𝑇𝑖 − ?̅?)
2 and then these items are calculated (Table A.19 & A.20). 
𝑍𝑖 =





                                                                








 = 29.956 
Step 4: Finally, isolates are estimated Z-scores in Table A.21. 
 
Where: T𝑖 is the total score of isolated bacterial 𝑖, ?̅? is the overall mean score, and 𝑛 is the total isolate number. 
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Total count of S 12 11 11 11 12 11 12 12 12 11 10 11 11 12 12 
Total count of I 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 
Total count of R 0 1 1 1 0 3 0 0 0 1 1 1 1 0 0 
Scores of S 100 91.7 91.7 91.7 100 91.7 100 100 100 91.7 83.3 91.7 91.7 100 100 
Scores of I 0    0 0 0 -50 0  -50  0 0 0 
Scores of R 0 −33.3 −33.3 −33.3 0 −100 0 0 0 −33.3 −33.3 −33.3 −33.3 0 0 















































































































































Bacillus sp. RP01 50.0 82.0 47.2 29.0 100.0 100 100 100 96.43 
B. cereus CHP00 100.0 61.4 52.9 27.3 58.3 -100 50 100 66.42 
B. cereus NP00 100.0 37.4 44.8 20.7 58.3 -100 50 100 75.63 
B. cereus NP01 100.0 86.5 65.6 18.0 58.3 -100 50 100 68.14 
Bacillus sp. RP00 50.0 62.7 56.8 33.2 100.0 100 50 100 90.57 
Bacillus sp. CHP01 100.0 62.6 51.7 32.4 -8.3 -100 50 100 100.00 
Bacillus sp. CHP02 100.0 100.0 62.3 24.3 100.0 100 50 100 74.01 
Bacillus sp. RC00 100.0 62.3 52.8 34.8 50.0 100 100 100 75.81 
Bacillus sp. RC01 50.0 45.3 52.3 28.6 100.0 100 50 100 86.68 
Bacillus sp. RC02 50.0 20.7 92.8 23.4 58.3 -100 50 100 67.24 
Enterobacter sp. NP03 50.0 33.3 56.2 2.3 0.0 100 100 0 89.24 
Enterobactor sp. NP02 100.0 66.2 55.7 100.0 58.3 100 100 0 76.76 
Mac. caseolyticus CHP03 50.0 71.9 68.7 29.5 58.3 100 50 0 88.42 
Stap. arlettae CHP04 50.0 21.3 78.7 8.4 100.0 100 100 0 83.54 














































































































































Bacillus sp. RP01 0.03 0.15 0.06 0.06 0.25 0.25 0.04 0.10 0.06 
B. cereus CHP00 1.50 12.31 2.83 1.74 25.00 25.00 4.00 10.00 5.79 
B. cereus NP00 3.00 9.22 3.17 1.64 14.58 -25.00 2.00 10.00 3.98 
B. cereus NP01 3.00 5.61 2.69 1.24 14.58 -25.00 2.00 10.00 4.54 
Bacillus sp. RP00 3.00 12.98 3.94 1.08 14.58 -25.00 2.00 10.00 4.09 
Bacillus sp. CHP01 1.50 9.40 3.41 1.99 25.00 25.00 2.00 10.00 5.43 
Bacillus sp. CHP02 3.00 9.39 3.10 1.95 -2.08 -25.00 2.00 10.00 6.00 
Bacillus sp. RC00 3.00 15.00 3.74 1.46 25.00 25.00 2.00 10.00 4.44 
Bacillus sp. RC01 3.00 9.34 3.17 2.09 12.50 25.00 4.00 10.00 4.55 
Bacillus sp. RC02 1.50 6.79 3.14 1.71 25.00 25.00 2.00 10.00 5.20 
Enterobacter sp. NP03 1.50 3.11 5.57 1.41 14.58 -25.00 2.00 10.00 4.03 
Enterobactor sp. NP02 1.50 4.99 3.37 0.14 0.00 25.00 4.00 0.00 5.35 
Mac. caseolyticus CHP03 3.00 9.93 3.34 6.00 14.58 25.00 4.00 0.00 4.61 
Stap. arlettae CHP04 1.50 10.78 4.12 1.77 14.58 25.00 2.00 0.00 5.30 
Stap. sciuri NP04 1.50 3.19 4.72 0.50 25.00 25.00 4.00 0.00 5.01 


























































































































































Bacillus sp. RP01 −4.67 6.14 −3.34 −4.42 18.84 18.84 −2.17 3.84 −0.38 32.68 
B. cereus CHP00 −3.17 3.05 −2.99 −4.53 8.42 −31.17 −4.17 3.84 −2.18 −32.89 
B. cereus NP00 −3.17 −0.56 −3.48 −4.92 8.42 −31.17 −4.17 3.84 −1.63 −36.82 
B. cereus NP01 −3.17 6.82 −2.23 −5.08 8.42 −31.17 −4.17 3.84 −2.08 −28.82 
Bacillus sp. RP00 −4.67 3.23 −2.76 −4.17 18.84 18.84 −4.17 3.84 −0.73 28.25 
Bacillus sp. CHP01 −3.17 3.22 −3.06 −4.22 −8.25 −31.17 −4.17 3.84 −0.17 −47.13 
Bacillus sp. CHP02 −3.17 8.84 −2.43 −4.71 18.84 18.84 −4.17 3.84 −1.72 34.15 
Bacillus sp. RC00 −3.17 3.17 −3.00 −4.08 6.34 18.84 −2.17 3.84 −1.62 18.16 
Bacillus sp. RC01 −4.67 0.63 −3.03 −4.45 18.84 18.84 −4.17 3.84 −0.96 24.86 
Bacillus sp. RC02 −4.67 −3.05 −0.60 −4.76 8.42 −31.17 −4.17 3.84 −2.13 −38.28 
Enterobacter sp. NP03 −4.67 −1.17 −2.79 −6.03 −6.17 18.84 −2.17 −6.17 −0.81 −11.13 
Enterobactor sp. NP02 −3.17 3.77 −2.82 −0.17 8.42 18.84 −2.17 −6.17 −1.56 14.98 
Mac. caseolyticus CHP03 −4.67 4.61 −2.04 −4.39 8.42 18.84 −4.17 −6.17 −0.86 9.57 
Stap. arlettae CHP04 −4.67 −2.97 −1.44 −5.66 18.84 18.84 −2.17 −6.17 −1.15 13.45 




Table A.20 Representation calculate to square of ′(𝑇𝑖 − ?̅?)



















































































































































Bacillus sp. RP01 21.76 37.71 11.13 19.56 354.76 354.76 4.69 14.71 0.14 819.21 
B. cereus CHP00 10.02 9.31 8.96 20.49 70.87 971.26 17.35 14.71 4.75 1127.71 
B. cereus NP00 10.02 0.31 12.09 24.21 70.87 971.26 17.35 14.71 2.65 1123.46 
B. cereus NP01 10.02 46.45 4.97 25.85 70.87 971.26 17.35 14.71 4.31 1165.77 
Bacillus sp. RP00 21.76 10.45 7.59 17.39 354.76 354.76 17.35 14.71 0.53 799.30 
Bacillus sp. CHP01 10.02 10.37 9.37 17.80 68.04 971.26 17.35 14.71 0.03 1118.93 
Bacillus sp. CHP02 10.02 78.06 5.89 22.15 354.76 354.76 17.35 14.71 2.97 860.65 
Bacillus sp. RC00 10.02 10.07 8.99 16.63 40.13 354.76 4.69 14.71 2.61 462.60 
Bacillus sp. RC01 21.76 0.40 9.16 19.81 354.76 354.76 17.35 14.71 0.93 793.62 
Bacillus sp. RC02 21.76 9.33 0.36 22.64 70.87 971.26 17.35 14.71 4.54 1132.80 
Enterobacter sp. NP03 21.76 1.37 7.79 36.34 38.01 354.76 4.69 38.01 0.66 503.38 
Enterobactor sp. NP02 10.02 14.18 7.96 0.03 70.87 354.76 4.69 38.01 2.43 502.94 
Mac. caseolyticus CHP03 21.76 21.28 4.18 19.31 70.87 354.76 17.35 38.01 0.74 548.26 
Stap. arlettae CHP04 21.76 8.83 2.08 32.08 354.76 354.76 4.69 38.01 1.33 818.28 
Stap. sciuri NP04 21.76 0.00 4.40 7.38 354.76 354.76 4.69 38.01 0.72 786.48 
 











𝐙 − 𝐬𝐜𝐨𝐫𝐞𝐬 =
∑  𝑖 (𝑇𝑖 − ?̅?) ∗





Bacillus sp. RP01 (32.68⁄ 29.96) = 1.09 
B. cereus CHP00 (-32.89⁄ 29.96) = −1.10 
B. cereus NP00 (-36.82⁄ 29.96) = −1.23 
B. cereus NP01 (-28.82⁄ 29.96) = −0.96 
Bacillus sp. RP00 (28.25⁄ 29.96) = 0.94 
Bacillus sp. CHP01 (-47.13⁄ 29.96) = −1.57 
Bacillus sp. CHP02 (34.15⁄ 29.96) = 1.14 
Bacillus sp. RC00 (18.16⁄ 29.96) = 0.61 
Bacillus sp. RC01 (24.86⁄ 29.96) = 0.83 
Bacillus sp. RC02 (-38.28⁄ 29.96) = −1.28 
Enterobacter sp. NP03 (-11.13⁄ 29.96) = −0.37 
Enterobactor sp. NP02 (14.98⁄ 29.96) = 0.50 
Mac. caseolyticus CHP03 (9.57⁄ 29.96) = 0.32 
Stap. arlettae CHP04 (13.45⁄ 29.96) = 0.45 
Stap. sciuri NP04 (18.99⁄ 29.96) = 0.63 
 
* in Table A.19 











Appendix 4: Training and courses attended to date 
 
 
- Originality and plagiarism (Wednesday 11st December 2013) 
- Scientific Writing Skills Course (Friday 7th March 2014) 
- The Transfer Process (Friday 14th March 2014) 
- Academic writing workshop (Wednesday 12nd February 2014) 
- Introduction to R (Wednesday 8th January 2014) 
- Presenting at conferences (Thursday 5th February 2015) 
- Preparing for VIVA (Tuesday 8th March 2016) 
- Preparing to submit on Pearl including copyright and open access (Wednesday 10th March 
2016)   
